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Background: Polycystic Ovary Syndrome (PCOS) is a common endocrine 
disorder in women of reproductive age, associated with complications of metabolic, 
reproductive, and psychological health. Adolescence is an optimal time for early 
identification of PCOS in order to mitigate long-term health risks. Pediatric primary care 
providers (pedPCPs) are the first-line for early identification and coordination of long-
term comprehensive management. Limited information exists to describe how PCOS is 
addressed in primary care and if adolescent-specific guidelines are applied.  
 Objectives: Describe practice behaviors of pedPCPs in the diagnosis and 
management of PCOS, and identify barriers and facilitators to inform future interventions 
to optimize comprehensive care for adolescents with PCOS.  
 Methods: A mixed-methods sequential explanatory design included survey 
research and semi-structured interviews. A barrier assessment framework, combined with 
behavior change models, underpin the conceptual framework that guided survey 
development. Snowball sampling recruited physicians, physician assistants and nurse 
practitioners in primary care in Virginia, Maryland and Washington D.C. through 
professional associations and academic institutions. Descriptive statistical analysis of 
survey data was conducted utilizing SPSS. Respondents from the survey research who 
volunteered for follow up participated in 1:1 semi-structured interviews, which were 
vii 
audio recorded, transcribed verbatim and coded. Nvivo 12 was used to code using 
thematic analysis. 
 Results: Fifty-two completed survey responses were analyzed for practice 
behaviors and attitudes/beliefs. Qualitative data from 20 interviews offered rich 
descriptions of pedPCPs’ experience in addressing PCOS. Integration of the quantitative 
and qualitative results demonstrated that level of engagement to address PCOS varied 
among pedPCPs. Differences in provider confidence, collaboration with colleagues 
and/or specialists, practice structure and policies, and pedPCPs’ perception of patient 
factors explain some variations observed across practices. 
 Conclusion: PedPCPs play an important role in the identification and 
management of PCOS in adolescence. Research results provide a model to map 
intervention components that will overcome barriers and enhance facilitators to address 
PCOS in primary care. Interventions should include case based learning and a platform 
for pedPCPs to collaborate with experts. Improving the capacity of pedPCPs to diagnose 
and manage PCOS is key to optimize care for adolescents and reduce risks of immediate 
and long-term complications of PCOS. 
 
Keywords: Polycystic Ovary Syndrome, Adolescents, Diagnosis, Treatment, 
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CHAPTER 1: INTRODUCTION 
 
Overview 
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that is 
characterized by ovulatory dysfunction and hyperandrogenism (Ibanez et al., 2017; 
Witchel et al., 2020). PCOS is considered one of the most common endocrine disorders 
in women, the leading cause of infertility in the U.S., and a major risk factor for 
metabolic syndrome and type 2 diabetes (T2DM) (Dokras et al., 2014; Witchel et al., 
2019). Symptoms of PCOS often begin in adolescence, but it is commonly not diagnosed 
until adulthood when women present with complications such as infertility (Gibson-Helm 
et al., 2017). The prevalence of PCOS in adolescents is unclear due to variations in 
populations studied and diagnostic guidelines, but estimated prevalence in women of 
reproductive age in the U.S. is 8-13% and 6% in adolescent girls (Witchel et al., 2020). 
Many experts agree that there is a missed opportunity when PCOS is not diagnosed until 
adulthood as this condition is associated with several complications of reproductive, 
metabolic, and mental health (Dokras et al., 2014). Early identification is critical to 
prompt early intervention and reduce risk from both immediate and chronic 
complications of PCOS (Gibson-Helm et al., 2017). Pediatric primary care providers 
(PedPCP) within the United States (e.g., MDs, PA-Cs, ARNP) are on the first-line for 
early identification and diagnosis of PCOS, and for coordination of comprehensive 
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management. However, no empirical research to date has evaluated pedPCP practice 
behaviors and the role of the primary care provider in the identification, diagnosis and 
management of PCOS in adolescents. 
PCOS is associated with complications of both reproductive and metabolic health, 
including infertility, endometrial hyperplasia, endometrial cancer (Rosenfield, 2015; Yii 
et al., 2009), metabolic syndrome, T2DM, sleep disorders, insulin resistance (IR), and 
cardiovascular disease (Dokras et al., 2018; Kamboj & Bonny, 2017). Additionally, 
research demonstrates psychological implications and a negative impact on quality of life 
in both adolescent and adult populations (Dokras et al., 2018; Rofey et al., 2009; Snyder, 
2005; Trent et al., 2003; Trent et al., 2005; Yii et al., 2009). Symptoms of PCOS usually 
manifest during adolescence and include hirsutism, severe acne, and/or irregular menses 
(Dokras et al., 2017; Powers et al., 2015). Research has shown that the symptoms of 
PCOS and concern for long-term complications of PCOS, such as infertility, can have an 
immediate and significant negative impact on adolescents at a vital time for social, 
emotional and physical development (Snyder, 2005; Trent et al., 2003; Trent et al., 2005). 
Women (ages 18-35 years) with PCOS have also reported dissatisfaction in their 
care due to a delay in diagnosis of PCOS (most women reported over 2 years and visits to 
multiple clinicians prior to a diagnosis), and lack of information provided to them at the 
time of diagnosis (Gibson-Helm et al., 2017). Research also demonstrates an association 
between length of time before receiving a diagnosis of PCOS and higher anxiety and 
depression (Gibson-Helm, et al., 2011).  
Adolescence may be a critical period for the initial identification of PCOS. 
Dokras and Witchel (2014) describe a missed opportunity for optimal care when PCOS is 
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not diagnosed during adolescence. They argue that health care is often not a priority for 
emerging adults and as a result, care for PCOS is suboptimal or absent early in young 
adulthood, resulting in both short-term (i.e., presenting symptoms are not addressed) and 
long-term (i.e., diagnosis is delayed) gaps in care. This results in not only a lack of early 
and effective treatment, but also a missed opportunity to screen for other comorbid 
conditions and appropriately transition adolescents into adult care as a young adult 
(Dokras & Witchel, 2014). The end-result is women not seeking care until they 
experience complications of PCOS, such as infertility or PCOS-related comorbidities, 
such as T2DM (Dokras & Witchel, 2014). 
The complexity of PCOS requires comprehensive and multidisciplinary treatment 
with a long-term management approach. This is best facilitated by the primary care 
provider for three reasons: First, often specialists will not accept self-referrals and require 
a referral from a pedPCP. Second, many third-party payers require an initial assessment 
by a pedPCP to justify a referral to a specialty provider. Third, there may be limited 
access to specialty providers due to provider shortages in certain geographical regions. 
Primary care providers are in an optimal position for early identification and diagnosis to 
ensure optimal management. Treatment and management of PCOS includes not only 
addressing the presenting clinical manifestations of PCOS, but also screening for 
comorbid conditions associated with PCOS. Similar to other chronic conditions and 
complex disorders, pedPCPs play a crucial role in initial identification of PCOS, carrying 
out secondary disease prevention, and referring to specialty care when appropriate. 
The complexity of PCOS may be overwhelming for some pedPCPs, and the 
diagnosis of PCOS in the adolescent population is challenging due to difficultly 
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distinguishing between manifestations of PCOS and normal physiologic changes of 
puberty. Providers must be aware of adolescent-specific guidance for the diagnosis and 
management of PCOS and evidence in the literature that addresses the unique 
considerations of PCOS in adolescence. Adolescent-specific guidance for the diagnosis 
and management of PCOS have been discussed in the literature for nearly a decade, but 
have not been widely disseminated outside of the specialty literature (Vassalou et al., 
2019). The most up to date guidance, which is promoted by the Pediatric Endocrine 
Society (PES), is from the International Consortium of Paediatric Endocrinology (ICPE) 
2017 Consensus Statement. The aim of the 2017 consensus statement was to improve 
worldwide care of adolescent girls with PCOS (Ibanez et al., 2017). The international 
consensus statement addresses the unique considerations to diagnose PCOS during 
adolescence, provide symptom-focused treatment recommendations, and guidelines to 
screen for metabolic disorders associated with PCOS (Ibanez et al., 2017).  
Peer-reviewed literature on PCOS in adolescence is mainly distributed in medical 
specialty journals (e.g., The Journal of Clinical Endocrinology and Metabolism, 
Hormone Research in Paediatrics), resulting in limited knowledge dissemination to 
PedPCPs who are unlikely to routinely subscribe to these journals given the niche target 
audience inconsistent with their general practice. Thus, PedPCPs likely have little to no 
exposure to adolescent specific guidelines supported by the PES. This limits 
identification and management of PCOS to the lens of a specialist. Evidence of 
dissemination of PES PCOS guidelines to pedPCPs, or investigation of knowledge gaps 
in the diagnosis and management of PCOS amongst pedPCPs, is scarce. Literature that 
examines differences in the diagnosis and management of PCOS across the specialty 
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providers (e.g., gynecologist, endocrinologist), demonstrates that limited awareness and 
familiarity with practice guidelines is a key barrier to appropriate diagnosis and treatment 
(Dokras et al., 2017). The literature remains silent regarding primary care providers; 
therefore, it can only be hypothesized that lack of awareness and familiarity with 
adolescent specific PCOS guidelines is also a major barrier to appropriate diagnosis and 
management of PCOS among pedPCPs.  
A 2012 executive summary of a National Institutes of Health (NIH) workshop on 
PCOS calls for greater engagement of primary care providers in the development and 
implementation of PCOS guidelines. There is little evidence of efforts aimed at engaging 
pedPCPs, or even understanding current trends in practice behaviors to address PCOS. 
An example from the Australia National Health and Medical Research Council 
(NHMRC) Centre for Research Excellence in PCOS (CRE PCOS) (2017) highlights 
efforts focused on the dissemination and implementation of updated PCOS guidelines to 
include comprehensive needs assessment research with primary care health professionals. 
There is no evidence of current efforts in the Unites States.  
Frameworks that explain factors that influence provider practice behaviors suggest 
knowledge is only one barrier to the implementation of guidelines in practice (Cabana et 
al., 1999; Cochrane et al., 2007). Awareness of clinical practice guidelines has limited 
effect on provider behaviors as adherence to guidelines is influenced by multiple factors 
that will vary in different settings (Cabana et al., 1999). The overarching hypothesis of this 
study is that practice behaviors among pedPCPs in the identification, diagnosis and 
management of PCOS are influenced by multiple factors to include knowledge, practice 
characteristics such as geographical region, and provider attitude and beliefs. 
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The ultimate goal of this research is to support pedPCPs as a key player in the 
diagnosis and management of adolescents with PCOS. This research aimed to identify 
current practice behaviors, and explain, through a mixed-methods research design, the 
factors that influence pedPCPs behaviors to diagnose and manage PCOS. This study is 
the first to generate knowledge specific to the behaviors of and barriers for pedPCPs in 
addressing PCOS. Knowledge gained from this study will inform future interventions for 
the dissemination and implementation of clinical guidelines into practice among 
pedPCPs.  
Statement of the Problem 
The literature examining knowledge gaps in diagnosis and treatment of PCOS has 
mostly focused on specialty providers and lacks insight into the knowledge, behaviors, 
attitudes, and beliefs of pedPCPs. No empirical research has systematically evaluated 
pedPCP practice behaviors and the role of the primary care provider in the identification, 
diagnosis and management of PCOS in adolescents. Primary care providers are not only 
the first line for early identification but they are also well positioned to coordinate the 
management of this complex condition that often requires a long-term multidisciplinary 
approach. There is lack of understanding of current practices and the potential barriers 
that must be addressed in order to influence practice behaviors and develop strategies to 
support a comprehensive approach to optimal management of PCOS among pedPCPs. 
Purpose and Research Questions 
The goal of this dissertation is to describe practice behaviors of pediatric PCPs in 
the diagnosis and management of PCOS, and identify barriers and facilitators to inform 
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interventions to change practice behaviors. Specific aims and accompanying research 
questions include:  
Aim 1. Identify current practice behaviors among pediatric primary care providers 
in the identification, diagnosis and management of PCOS in adolescents. RQ1: What are 
the practice behaviors of pediatric primary care providers in the identification, diagnosis 
and management of PCOS in adolescents? 
Aim 2. Evaluate the factors (provider knowledge, practice characteristics and 
provider attitudes and beliefs) that influence practice behaviors to address PCOS in a 
pediatric primary care setting. RQ 2: What factors, both modifiable and non-modifiable, 
influence practice behaviors of pediatric providers to address PCOS in a primary care 
setting? 
Aim 3. Understand barriers and facilitators to the identification, diagnosis and 
management of PCOS in adolescents in a primary care setting in order to inform future 
interventions to influence practice behaviors. RQ 3: How do pediatric primary care 
providers experience barriers and facilitators in the identification, diagnosis and 
management of PCOS among adolescents, and how can they be addressed in order to 
optimize care?  
Statement of Potential Impact 
This research will inform the future development of interventions for the 
dissemination and implementation of adolescent PCOS diagnostic and treatment 
guidelines into practice. The opportunity exists for primary care providers to diagnose 
and effectively manage PCOS at younger ages and mitigate the risk of long term 
complications and poor health outcomes. The long-term goal is to provide clinical 
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support tools to guide pedPCPs in the delivery of evidence based patient-centered care 
for adolescents with PCOS. This research will provide a foundation for future work and 
makes a significant contribution to expanding what is known in the primary care 
literature, which has limited focus on PCOS in the primary care setting.  
Translational Nature of the Study 
The Biomedical Research Translation Continuum (Drolet & Lorenzi, 2011) 
highlights the pathway from basic science to clinical practice, noting “chasms” between 
areas of action where knowledge from research is applied. Translation chasm #3 relates to 
the implementation and adoption of current practice guidelines, driven by evidence, into 
practice (Drolet & Lorenzi, 2011). This research is applicable to this translational chasm as 
it aims to understand barriers and facilitators in order to facilitate implementation and 
adoption of guidelines for management of PCOS in adolescents. It is important to highlight 
the paucity of research that identifies current primary care behaviors and potential barriers 
in practice. Straus and colleagues (2013) state that barriers and facilitators must be 
understood prior to the implementation of strategies to drive knowledge into practice 
(Straus et al., 2013). Knowledge generated from this research will direct next steps and the 
appropriate tools needed for either dissemination and/or support implementation of 
adolescence PCOS guidelines into practical clinical settings. Findings from this research 
will clarify if next steps will require efforts focused on dissemination of knowledge prior to 
implementation, or translation of knowledge with efforts specifically aimed at 
implementation.  
Similarly, the NIH Translational Science Spectrum highlights various stages of 
research from basic discovery to public health outcomes research. The NIH Translational 
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Science Spectrum is not linear, but rather it recognizes that each phase builds upon and 
informs the others. There are still areas of growing knowledge related to underlying 
pathophysiology and optimal diagnostic tools for adolescent PCOS, but moving current 
evidence toward implementation is timely. Knowledge generated from this study will not 
create an end-point, but rather contribute to ongoing research efforts in PCOS and potentially 
inform future research in other areas to include public health and clinical research.  
Finally, translational research is recognized as research that “fosters 
multidirectional and multidisciplinary integration of basic research, patient-oriented 
research, and population-based research with the long-term aim of improving” (p. 470) 
public health (Rubio et al., 2010). This research focuses on provider practice to affect 
change that will improve patient health and long term population-health. Furthermore, it 
investigates provider behavior across a variety of practice settings and locales to identify 
potential health disparities at an early stage in the life-span continuum that would also 
have an impact on population health outcomes. 
Conceptual Framework 
The conceptual framework driving this study is a combination of a barrier 
assessment framework for behavior change (Cabana et al., 1999; Cochrane et al., 2007) and 
the Health Belief Model (Glanz, Rimer, & Viswanath, 2015). The barrier assessment 
framework is supported in the literature as a methodology to explore “Barriers to Physician 
Adherence to Practice Guidelines in Relation to Behavior Change” (Cabana et al., 1999; 
Cochrane et al., 2007). The Theory of Planned Behavior (TPB) underpins this framework. 
TPB states that intentions to carry out a certain behavior are influenced by attitudes, 
subjective norms, and perceived control of one’s behavior and the ability to make a 
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difference (Grol, 2013). The framework for Barriers to Physician Adherence to Practice 
Guidelines in Relation to Behavior Change further offer that external barriers will also 
influence attitudes and behavior (Cabana et al., 1999; Cochrane et al., 2007).  
The Health Belief Model (HBM), traditionally used to predict whether or not a 
patient will take action to participate in a certain health behavior, will be applied to 
further explore provider perceptions and beliefs that reflect likelihood for behavior 
change (Glanz et al., 2015). In this setting the behavior is the diagnosis and management 
of adolescents with PCOS in a primary care setting.  
The combine TPB and HBM framework aligned with the research goal to 
describe current practice behaviors and identify barriers to determine target areas for 
future intervention. Constructs of the HBM explore perceptions and state that a person 
will take action if they feel a negative health consequence can be avoided, can expect 
positive results from taking action and that they can successfully participate in that action 
(Glanz et al., 2015). To identify target areas for future intervention, current behaviors 
versus intended behaviors must be investigated in order to determine the need for change 
and provide the foundation to understand barriers and facilitators for change. Constructs 
in the TPB explore behavior intention by focusing on attitudes, perceived social norms, 
and perceived behavior control (Glanz et al., 2015). 
HBM was utilized to frame questions in this study around perception of the 
prevalence of PCOS within a provider’s patient population, perception of the 
severity/significance of PCOS, perception of the benefit to patient health outcomes if 
PCOS is addressed in primary care setting, and perceived barriers to adopting current 
guidance on the diagnosis and management of PCOS in their own practice. TPB, within 
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the barrier assessment model, explored provider attitude about PCOS, norms in how other 
colleagues approach PCOS, and their perception of control that they have over their 
practice behaviors. Combining constructs within these two models enabled this research 
to generate information not only about current practice, but what pedPCPs perceive are 
barriers to participating in these behaviors. These two models set the framework for 
building the quantitative survey and also guided the development of the qualitative 
interview questions.  
Summary of Methodology 
The study’s mixed methods design used an explanatory sequential approach. The 
quantitative arm utilized a survey that was distributed to primary care providers across the 
District of Columbia, Maryland and Virginia who treat female patients age 12-17 years. 
The quantitative inquiry collected data regarding provider and practice characteristics, 
provider behaviors, and knowledge, attitudes and beliefs about PCOS. Development of the 
survey instrument (Appendix A) was informed by previous surveys regarding provider 
knowledge about PCOS and the conceptual framework for this study.  
Providers who participate in the quantitative arm were invited to participate in 
semi-structured interviews that built upon the quantitative results and further explored 
barriers and facilitators to practice behaviors related to the identification, diagnosis and 
treatment of PCOS in adolescents. Twenty 1:1 interviews with providers were completed. 
Limitations & Delimitations 
This study collected survey data from diverse clinical practice settings across the 
state of Maryland, Virginia and the District of Columbia. An unexpected finding in this 
research is the variety of practice settings that providers identified as primary care. 
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Several pedPCPs who participated in this study were not from traditional pediatric or 
family medicine practice settings. Non-traditional practice settings include urgent care 
practices, and community or public health clinics. Some of the barriers and facilitators 
identified may be unique to these non-traditional practice settings.  
The explanatory design allowed the dissertation research to gather more specific 
information to explain the survey results, clarify some of the differences in provider 
behaviors observed from the survey responses, and highlighted similarities and 
differences in barriers and facilitators to practice. It is unclear though if this variety of 
practice settings is an accurate representation of where adolescents seek medical care. 
Modern medical practice has resulted in patients seeking primary care within non-
traditional settings, such as urgent care clinics, but trends in adolescent health-seeking 
behaviors is unknown.  
In addition, clinical practice providers are extremely busy and often over 
burdened by patient care. Their responses to surveys and interviews may be influenced by 
feelings pressured for time. Providers may also find this inquiry itself burdensome in 
reflecting on what they need to change or improve in their practice. With many 
competing priorities in patient care, time constraints of providers may create a bias.  
Parameters for this study are providers in the States of Virginia and Maryland, 
and the District of Columbia versus a national sampling. This is done to improve 
participant responses by engaging a smaller, regional population in which the researcher 
may have a greater ability to engage providers and achieve a higher response rate 
(Portney and Watkins, 2015). A well-designed study with a high response rate sets the 
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foundation for this study to be replicated in a different location with a different 
population of pedPCPs.  
Definition of Key Terms 
Amenorrhea. The abnormal absence of menstruation. 
Anovulation. The absence of ovulation resulting in either frequent menstrual 
bleeding patterns of < 21 days, or infrequent bleeding at intervals > 35 days  
Endometrial cancer. A malignancy of the uterus. 
Endometrial hyperplasia. An abnormal thickening of the lining of the uterus. 
Hirsutism. An unwanted male-pattern hair growth in females; excessive amounts 
of dark, coarse hair on body areas where men typically grow hair. 
Hyperandrogenism. An excess production of androgens, resulting in increases 
androgen levels in circulation.  
Infertility. The inability to conceive after twelve months of regular sexual 
intercourse without protection.  
Metabolic syndrome. A combination of conditions to include hypertension, high 
blood sugar, high cholesterol levels and/or excess fat around the waist.  
Oligomenorrhea. Menstrual cycles lasting longer than 45 days. 
Secondary amenorrhea. The absence of cycles for more than three months. 







CHAPTER 2: LITERATURE REVIEW 
Introduction 
The literature review is summarized in three sections. First a brief overview of the 
current knowledge about PCOS as an endocrine disorder; adolescent-specific practice 
guidelines for the diagnosis and management of PCOS, and unique considerations in the 
adolescent patient with PCOS. The second section discusses what is known about 
provider practice behaviors in addressing PCOS and potential barriers for pedPCPs 
addressing PCOS among adolescents. The final section provides an overview of the 
theoretical framework for this research inquiry. 
The literature search was initiated in PubMed with the search terms: Polycystic 
Ovary AND Adolescents* with limitations of literature in English published from 
January 2013 to present. Parameters of five years was established as it has been within 
the last five years that the Endocrine Society updated their practice guidelines (Legro et 
al., 2013) and that an international consortium update has been published related to the 
diagnosis and treatment of adolescents with PCOS (Ibanez et al., 2017). Abstracts were 
reviewed and articles that were most relevant to this research were selected. This search 
included: general reviews of pathophysiology, etiology, clinical presentation, and 
complications of PCOS specific to adolescents; articles that discuss guidelines for 
diagnosing PCOS in adolescents; research or reviews of treatment/management of PCOS 
among adolescents; targeted discussions of specific clinical features or complications of 
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PCOS in adolescents that are well documented such as obesity, mental health 
complications and considerations of quality of life. Articles that discussed new research 
related to biochemical markers of PCOS among adolescents or new discoveries related to 
pathogenesis of various complications of POCS that are early in the translational 
spectrum of research were not included.  
The search was then expanded to SCOPUS and CINAHL with the same criteria 
applied. Most articles were found to be duplicates from the PubMed search, indicating 
saturation in the literature search. Additional articles were selected from the reference list 
of the initially selected articles that were noted to be significant in contributing to the 
growing body of knowledge around PCOS in adolescents. This included some articles 
that were outside the time limited parameters of five years.  
Finally, a search of updated practice guidelines and/or practice bulletins from 
professional associations most relevant to primary care practice to include: The American 
Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), 
and the American College of Obstetricians and Gynecologists (ACOG, 2018). AAP 
offers a review that summarizes the consensus of international pediatric subspecialty 
societies on diagnostic criteria for adolescents with PCOS (Rosenfield, 2015). AAFP 
offers a review article on diagnostic and management guidelines as part of a continuing 
medical education activity (Williams et al., 2016).  
Polycystic Ovary Syndrome (PCOS) in Adolescents 
PCOS was first described by Doctors Stein and Leventhal in 1935. Their 
evaluation of seven women who had excess body weight, amenorrhea, and infertility 
revealed a common finding of multiple ovarian cysts (Christensen et al., 2013). The 
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condition was initially understood as a primary ovarian disorder, and later named 
polycystic ovary syndrome (Christensen et al., 2013). However, research over the last 
several decades has demonstrated that PCOS is a complex endocrine disorder, involving 
several endocrine signaling pathways, and is not solely defined by ovarian dysfunction 
(Ibanez et al., 2017). Attention has been directed away from relying on polycystic ovarian 
morphology (PCOM) as a main diagnostic feature, and many believe the current name of 
this condition to be a misnomer (Teede et al., 2014). This is especially true in the 
adolescent population where increased ovarian volume and polycystic morphology is a 
normal finding in puberty (Witchel et al., 2020). 
Pathophysiology 
 The pathophysiology of PCOS is complex and the exact etiology of PCOS is 
unknown. Several publications on PCOS have emerged over the last two decades, with an 
increase of annual publications on PCOS more than doubling from 2008 to 2016 (Ibanez 
et al., 2017). These publications address multiple aspects of PCOS but almost all address, 
to some degree, the complexity of the pathophysiology of PCOS. Ibanez and colleagues 
(2017) offer a review of the literature on the pathophysiology of PCOS by an international 
collaboration of pediatric endocrine and other societies, providing an up to date look at a 
global understanding of the pathophysiology of PCOS and how this relates to adolescents.  
Androgen excess is a hallmark of the PCOS, present in approximately 60-80% of 
patients with PCOS. Hyperandrogenism, usually marked by high levels of testosterone, is 
a major player in disrupting the balance of the key hormones of the menstrual cycle, 
leading to menstrual irregularities (Ibanez et al., 2017). There is not one specific 
mechanism known to be the origin of this imbalance, but rather there are several 
 
 17 
pathophysiologic components that may be involved (Ibanez et al., 2017). These 
components include primary ovarian dysfunction, insulin resistance, alteration in 
signaling from neuroendocrine hormones, genetics, epigenetics, and alterations in 
sympathetic nerve activity. PCOS is the result of aberrant signaling among these various 
pathophysiologic components, but not all components are involved in all cases of PCOS 
(Ibanez et al., 2017). Discussed below are two of the pathophysiologic components for 
which there is the most information in the literature and are most relevant and relatable to 
the presentation and management of PCOS in primary care practice: primary ovarian 
dysfunction and insulin resistance/hyperinsulinemia.  
Primary Ovarian Dysfunction 
Patients with PCOS have arrest of follicular maturation within the ovaries, leading 
to anovulation. This is a result of a disturbance in the balance of follicle stimulating 
hormone (FSH), luteinizing hormone (LH) and anti-Mullerian hormone (AMH); key 
hormones within the hypothalamic pituitary ovarian (HPO) axis that regulate the 
menstrual cycle. (Ibanez et al., 2017; Nicandri & Hoeger, 2012; Rothenberg et al., 2018). 
Patients with PCOS have an abnormal ratio of LH to FSH, and higher than normal levels 
of LH drive theca cells to produce androgens (Rothenberg et al., 2018). High levels of 
LH prevent sufficient production of FSH and conversion of androgens to estradiol within 
the granulosa cells of the ovary (Ibanez et al., 2017; Rothenberg et al., 2018). High levels 
of AMH are also thought to contribute to excess androgen production by disrupting FSH-
stimulatory effect on granulosa cells (Nicandri & Hoeger, 2012; Rothenberg et al., 2018). 
These high levels lead to failure to select a dominant follicle in the ovary and ultimately 
anovulation, which manifests as menstrual irregularities (either oligomenorrhea or 
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anovulatory bleeding). Androgen excess, from the excess production of ovarian androgen 
from the theca cells, leads to higher circulating levels of testosterone in the body and 
results in clinical findings of cutaneous hyperandrogenism (hirsutism or moderate-severe 
acne) (Witchel et al., 2016).  
Insulin Resistance/Hyperinsulinemia  
Insulin resistance (IR) and hyperinsulinemia are common findings in PCOS 
(Ibanez et al., 2017). IR does not seem to be dependent upon increases in adipose tissue 
as it a finding in both lean patients with PCOS and PCOS patients with excess body 
weight or obesity. IR drives the pancreas to produce more insulin, and increased insulin is 
thought to contribute to hyperandrogenism through multiple mechanisms. First, high 
insulin levels may play a role in increasing production of adrenal androgens (Fitzgerald et 
al., 2018). It is noted in PCOS that increased activity within the adrenal gland contributes 
to androgen excess, measure by elevated levels of hormones secreted by the zona 
reticularis: dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and 
androstenedione (Ibanez et al., 2017; Nicandri & Hoeger, 2012; Rothenberg et al., 2018). 
Second, high levels of insulin have been found to decrease production of sex-hormone 
binding globulin (SHBG) in the liver, thus decreasing the circulation of SHBG to bind 
free testosterone (Ibanez et al., 2017; Nicandri & Hoeger, 2012; Rothenberg et al., 2018).  
Clinical Presentation 
The most common presenting signs and symptoms of PCOS in adolescents are 
associated with ovarian dysfunction and hyperandrogenism (Ibanez et al., 2017). Ovarian 
dysfunction manifests as irregular menses, and hyperandrogenism as hirsutism and/or 
moderate-to-severe acne (also referred to as cutaneous hyperandrogenism) (DiVall & 
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Merjaneh, 2019). Irregular menses and cutaneous hyperandrogenism can also be normal 
findings during puberty, creating obscurity in differentiating between normal and 
abnormal findings that require further evaluation.  
Diagnosis of PCOS in Adolescents 
Diagnosis of PCOS in the adolescent population is challenging due to difficultly 
distinguishing between manifestations of PCOS and normal physiologic changes of 
puberty; therefore, providers must be aware of adolescent-specific guidelines. In 2015, 
the first consensus statement for the diagnosis of PCOS in adolescents was developed by 
an international panel of pediatric and endocrine experts (Rosenfield, 2015). This 
consensus statement was reaffirmed in 2017, resulting in the International Consortium of 
Paediatric Endocrinology (ICPE) 2017 Consensus Statement (Ibanez et al., 2017). The 
ICPE 2017 Consensus Statement is supported by the Pediatric Endocrine Society (2017) 
(posted to the PES Clinical Resources webpage), and aligns with diagnostic criteria for 
adolescents in the 2018 International Evidence-Based Guidelines for the Assessment and 
Management of PCOS across the Lifespan (Pena et al., 2020). Additionally, the PES has 
published on its website, Primary Care provider guidelines for the Adolescent Female 
with Suspected PCOS, that aligns with the ICPE 2017 consensus statement. 
The appropriate diagnostic criteria for PCOS, especially among adolescents, has 
been debated for several decades. The more commonly known diagnostic criteria (NIH, 
Rotterdam, and Androgen Excess and PCOS Society criteria), published between 1990 
and 2009, did not account for physiologic differences in the adolescent population 
(Vassalou et al., 2019; Christensen et al., 2013). The first official diagnostic criteria to 
address the adolescent population, known as the Amsterdam Consensus, was published in 
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2012 (Vassalou et al., 2019). Since then, experts have sought to clarify specific criteria 
regarding when menstrual cycles are considered irregular, the appropriate evaluation for 
hyperandrogenism, and whether or not polycystic ovarian morphology (PCOM) should 
be consider for diagnostic criteria in an adolescent (Vassalou et al., 2019). Figure 1 
Development of Adolescent-Specific PCOS Diagnostic Criteria, provides a timeline from 
the development of adolescent-specific diagnostic guidelines since the Amsterdam 
Consensus, identifies the expert organizations involved in the development of guidelines, 
and briefly identifies the evolution of the diagnostic criteria (Vassalou et al., 2019).   
Figure 1  
Development of Adolescent-Specific PCOS Diagnostic Criteria 
 
  
 Adolescent-specific guidelines, based on the ICPE 2017 Consensus Statement, 
























































Figure	adapted	from	Vassalou H,	Sotiraki M,	Michala L.	(2019)	Figure	2:	Diagnosis	of	PCOS	over	time.	
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adolescents who are at least two-years post-menarche, the presence of persistent clinical 
or biochemical hyperandrogenism, and exclusion of other causes of these findings (E.g. 
thyroid disease and non-classic congenital adrenal hyperplasia) (Ibanez et al., 2017). In 
addition, the consensus statement acknowledges that insulin resistance and obesity are 
common characteristic among adolescents with PCOS, but that adequate evidence is not 
available for these to be considered diagnostic criteria (Ibanez et al., 2017). Table 1 
Diagnostic Criteria for Polycystic Ovary Syndrome in Adolescents, summarizes 


















Table 1  
Diagnostic Criteria for Polycystic Ovary Syndrome in Adolescents 










Comprehensive history and physical/menses 
tracking. 
Irregular menses defined as: 
• From 1-3 years post-menarche: <21 or >45 
days 
• From 3 years post-menarche:<21 days or >35 
days, or < 8 cycles per year 
• Menstrual cycle >90 days for any one cycle > 1 
year post-menarche 
• Primary amenorrhea by age 15 years or age 13 
years with absence of menses and no secondary 

















• Progressive hirsutism 
• Complete physical exam, use of validated 
visual scale to evaluate hirsutism 
• Moderate to severe acne, follow up with 
evaluation for biochemical hyperandrogenism 
Biochemical hyperandrogenism 





Moderate to severe 




must utilize follow 
up testing  
 
Rule out other 
disorders of 
hyperandrogenism 
Laboratory evaluation for pregnancy, thyroid 
disorders, non-classic congenital adrenal 
hyperplasia, Cushing syndrome, androgen 
secreting tumor, etc.  





* Ultrasound should not be utilized to evaluate for PCOS in patients < 8 years post menarche. 
Ultrasound should be reserved for evaluation of other conditions as needed, such as evaluation for 






Irregular Menses  
Irregular menses can be normal in the early post-menarchal years as the 
hypothalamus- pituitary-ovarian (HPO) axis matures. It can take up to five-years post-
menarche for maturation of the HPO axis, but most adolescents will have regular 
ovulatory cycles within 1-2 years post menarche (Ibanez et al., 2017). Based on this 
evidence, the guidelines define parameters of when irregular menses may be considered 
abnormal, which is presented in Table 1 Diagnostic Criteria for Polycystic Ovary 
Syndrome in Adolescents. It may be challenging for adolescents to accurately track their 
menstrual cycle; therefore, more general guidance suggests irregular menses that persist 
two-years post-menarche be considered for evaluation of PCOS (Ibanez et al., 2017; Pena 
et al., 2020). 
Primary amenorrhea may also be a sign of ovulatory dysfunction in PCOS if the 
adolescent otherwise has normal pubertal development. The guidelines define primary 
amenorrhea as lack of menses by 15 years of age or greater than 3 years post-thelarche 
(Ibanez et al., 2017).  
Hyperandrogenism 
Findings of irregular menses must occur along with evidence of excess androgens 
(Ibanez et al., 2017; Pena et al., 2020). Excess androgens can present as clinical and/or 
biochemical hyperandrogenism. While clinical hyperandrogenism, along with menstrual 
irregularities, is suggestive of PCOS, confirmation of biochemical hyperandrogenism is 




 Clinical Hyperandrogenism. is defined as moderate to severe hirsutism (Ibanez 
et al., 2017). Hirsutism is the presence of dark coarse hair growth in a male-like pattern 
(upper lip, chin, sideburns, neck, periumbilical, chest, upper back, around nipple area) 
(Ibanez et al., 2017; Pena et al., 2020). Dark hair growth on arms and lower legs is not 
hirsutism and may represent ethnogenetic variation. Physical exam and use of a validated 
numerical scale, such as the modified Ferriman-Gallway scale, to assess hirsutism is 
recommended.(Pena et al., 2020) Measurement scales should be utilized with caution 
however as normative cut offs for adolescents have not been established (Pena et al., 
2020). 
Moderate or severe inflammatory acne, resistant to topical treatment, is suggestive 
of clinical hyperandrogenism, but requires follow testing for biochemical 
hyperandrogenism (Ibanez et al., 2017). While mild comedonal acne is considered a 
normal finding of puberty, severe inflammatory acne is uncommon and is present in less 
than 5% of adolescents during early post-menarchal years (Pena et al., 2020). 
Biochemical Hyperandrogenism. Measurement of total testosterone or 
calculated free testosterone with a high-quality assay (liquid-chromatography 
spectrometry and extraction/chromatography immunoassays) is recommended to 
document biochemical hyperandrogenism (Ibanez et al., 2017; Pena et al., 2020). Other 
laboratory tests to evaluate hyperandrogenism include androstenedione, 
dehydroepiandrosterone sulfate (DHEAS) and 17-hydroxyprogesterone (Ibanez et al., 
2017). These three tests are not used to diagnose PCOS, but rather to excluded other 
causes of hyperandrogenism such as non-classic congenital adrenal hyperplasia, adrenal 
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tumors, and other androgen secreting tumors (Pena et al., 2020).  
Exclusion of Other Causes 
PCOS is a diagnosis of exclusion. Other conditions that can result in irregular 
menses or excess androgens must be excluded prior to a diagnosis of PCOS; these 
include pregnancy, thyroid dysfunction, non-classic congenital adrenal hyperplasia, and 
androgen-secreting adrenal or ovarian tumors (Ibanez et al., 2017). Cushing syndrome 
and/or hypothalamic pituitary insufficiency may also be considered depending on clinical 
presentation (Ibanez et al., 2017). Diagnostic laboratory tests suggested for the initial 
evaluation for PCOS, to include tests that will help to rule out other endocrine disorder, 
are summarized in Table 2 Diagnostic Testing for Adolescents with Suspected PCOS 















Table 2  





Beta-hCG pregnancy test 
 








Part of testing to rule out non-classic congenital adrenal 
hyperplasia 
 
Total testosterone, free 
testosterone  
 
To document hyperandrogenism, elevated in PCOS. Required for 
diagnosis of PCOS 




Reserve for patients with amenorrhea to rule out premature 
ovarian failure (high FSH, low estradiol). LH:FSH ratio of 2:1 or 
greater common in PCOS but is not absolute (LH and FSH levels 









Part of testing to rule out non-classic congenital adrenal 




Produced in both the ovaries and adrenal glands, part of testing to 
rule out androgen secreting tumor 
 
Two labs that are not recommended for initial evaluation, but are often discussed 
in the literature regarding PCOS in adult women are sex-hormone binding globulin 
(SHBG) and anti-Müllerian hormone (AMH) (Ibanez et al., 2017). SHBG is suppressed 
by elevated androgen concentrations, which contributes to higher free testosterone 
concentrations. SHBG levels provide additional information if free testosterone levels are 
elevated, but they are not diagnostic of PCOS (Ibanez et al., 2017). Elevation of AMH is 
reported in the literature as a common finding in women with PCOS, but research has 
demonstrated a weaker association among adolescents with PCOS (Ibanez et al., 2017).  
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Excess body weight and obesity are common findings of PCOS in both 
adolescents and adult women. However, excess body weight is not present in all patients 
with PCOS and is not a criterion for diagnosis (Witchel et al, 2020). The relationship of 
obesity with PCOS is complex and not completely understood. Pre-clinical models 
investigating the pathophysiology of PCOS have suggested a bidirectional relationship 
between obesity and PCOS (Ibanez et al., 2017). Obesity exacerbates the metabolic 
complications of PCOS, but has not been proven to be a distinct feature or cause of 
PCOS (Witchel et al., 2020). From the opposite direction, PCOS has been associated with 
inefficient energy oxidation and metabolic inflexibility, which are markers of reduced 
metabolism, resulting in an increased risk of obesity (Rimmer et al., 2019). 
Ultrasound for Polycystic Ovarian Morphology (PCOM)  
Current adolescent-specific diagnostic criteria do not require the presence of 
PCOM to diagnose PCOS (Ibanez et al., 2017). PCOM can be a normal finding in 
adolescent girls with a prevalence of up to 54% (Witchel et al., 2015). Increased 
gonadotropin stimulation during adolescence results in increased ovarian volume and 
follicular maturation resulting in the appearance of polycystic morphology that is normal 
in an adolescent (Witchel et al., 2019). Guidelines state that pelvic ultrasound should not 
be used for the diagnosis of PCOS. Evaluation of ovarian morphology is not 
recommended prior to 8 years post menarche (Pena et al., 2020). Additionally, 
transvaginal ultrasound in adolescent girls is an invasive test that can cause significant 
discomfort and is not recommended in non-sexually active adolescents (Ibanez et al., 
2017). A transabdominal approach may not be reliable especially in adolescents with 
excess weight or obesity (Ibanez et al., 2017). 
 
 28 
Management/Treatment of PCOS in Adolescents  
There are three main principles that guide the treatment and management of 
PCOS in adolescents. First, lifestyle modifications should be considered for first-line of 
treatment for all adolescent patients with either PCOS or determined to be at risk for 
PCOS prior to confirmation of diagnosis (Ibanez et al., 2017). Second, additional 
treatments should be individualized to optimize symptom relief (Witchel et al., 2019). 
Third, screening for short and long-term complications of PCOS should be part of the 
management plan (Witchel et al. 2019; Witchel et al., 2020).  
Each patient and their clinical presentation is unique. Interventions should be 
patient-centered and address the patient’s main concern. Additionally, adequate age and 
culturally appropriate patient education and counseling about PCOS is vital. Discussions 
about PCOS may need to be repeated over time as the adolescent ages and should include 
recommendations for life-long management and screening for co-morbid conditions 
associated with PCOS (Witchel et al., 2019). 
Treatment  
The ICPE 2017 consensus statement recommends treatment based upon the 
clinical presentation that is unique to the individual patient. Table 3 Recommendations 
and Medication Options for the Management of PCOS in Adolescents, outlines symptom-
specific treatment recommendations as per the international consensus statement (Ibanez 
et al., 2017).  
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Table 3  




Potential Impact (level of evidence) 
Lifestyle modifications 
• Lifestyle modifications based on combination of calorie-
restricted diet, exercise and behavior treatment (Level A) 
• First-line therapy in girls with excess weight or obesity 
(Level C) 
• Decrease androgen levels (Level A) 
• Normalize menstrual cycles (Level A) 
• Improve markers of cardiometabolic health (Level B) 
• Increasing physical activity effective to reduce development 
of metabolic syndrome in normal weight girls (Level C) 
Metformin (850 
mg/day up to 1g twice 
a day) 
 
• Beneficial in adolescents with PCOS and excess weight or 
obesity based on short term data (Level A) 
• Improves hyperinsulinemia, ovulation and testosterone 







• Normalizes menstrual cycles, but there is no high quality 




such as photoepilation 
or 
Topical eflornithine 
(13.9% twice a day) 
 
• Photoepilation is first-line for long-term removal of 
unwanted hair growth (Level B) 
• Topical eflornithine adjuvant to photoepilation in girls with 





mg/day), or  
Flutamide (62.5 
mg/day to 250 mg/day) 
• Features of hyperandrogenism that do not resolve after 6 
months of COCP or cosmetic procedures* 
• Reduce androgen excess features more than metformin in 
monotherapy (Level B) 
• Spirinolactone is most commonly used and recommended 
due to lack of data on flutamide use in adolescents (Level C) 
• Anti-androgens should only be used when contraceptive 
measures are guaranteed, because of risk of impairment of 




Based on recommendations from the ICPE 2017 Consensus Statement (Ibanez et al., 2017) and 
2018 International Evidence Based Guidelines (Pena et al., 2020) 
*Only referenced in Pena et al. 2020  
Screening for Complications 
  PCOS is associated with complications of metabolic, reproductive, and 
psychological health. Short and long-term management of PCOS includes screening for 
these co-morbid conditions (Witchel et al. 2019; Witchel et al., 2020).  
 Metabolic Health. In terms of metabolic health, complications of PCOS include 
excess body weight, obesity, hyperinsulinemia, insulin resistance (IR), impaired glucose 
tolerance (IGT), dyslipidemia, hypertension, metabolic syndrome, nonalcoholic fatty 
liver disease (NAFLD), gestational diabetes, T2DM, cardiovascular disease (CVD) and 
obstructive sleep apnea (OSA) (Ibanez et al., 2017; Witchel et al., 2020). Adolescent girls 
diagnosed with PCOS have a higher prevalence of IR, IGT, metabolic syndrome, and 
T2DM when compared to adolescents without PCOS (Divall & Merjaneh, 2019; Witchel 
et al., 2019). It is important to highlight that complications of IR and hyperinsulinemia 
are also present in lean girls with PCOS (Ibanez et al., 2017; Witchel et al., 2020). 
Glycemic status should be evaluated in all women at the time of diagnosis and screened 
regularly (Witchel et al., 2020). 
Increased risk for CVD in patients with PCOS is theoretical, though, studies have 
identified increased arterial stiffness in adolescent girls with obesity and a diagnosis of 
PCOS (Witchel et al., 2020). To date, there is limited data that demonstrate increased 
cardiovascular events in patients with PCOS, however, some patients with PCOS have 
early onset and higher incidence of features of metabolic syndrome, placing them at 
greater risk for the development of CVD (Witchel et al., 2019). 
 
 31 
The impact of OSA on health outcomes in adolescents with PCOS has not been 
determined; however, current literature has reported OSA in adolescent girls with PCOS 
(Nandalike et al., 2012). The association with OSA is also not clear, and mostly related to 
the other long-term sequelae associated with PCOS such as obesity (Witchel et al., 2020).  
Risks of the aforementioned metabolic complications related to PCOS persist 
throughout the lifespan. The implication is for primary care provider to be aware of 
potential long-term sequela and recognize PCOS as a chronic condition that will require 
screening for complications during adolescence and guidance for life-long management. 
Guidelines do not make specific recommendations for frequency of screening of co-
morbid conditions associated with PCOS (Divall & Merjaneh, 2019). 
Reproductive Health. Patients with PCOS have an increased risk of infertility, 
endometrial hyperplasia, and endometrial cancer (Witchel, 2020). Though adolescents 
may not desire pregnancy during adolescence, research has demonstrated that adolescent 
patients diagnosed with PCOS are concerned about future fertility (Trent et al. 2003). 
Endometrial hyperplasia and endometrial cancer may also not be a concern during 
adolescence as the risk of these conditions is a result of long-term exposure to unopposed 
estrogen due to anovulatory cycles. Educating adolescents with PCOS on long-term risks 
to reproductive health and addressing any concerns they may have around future fertility 
is an important consideration. However, providers need to be mindful of delivering 
patient education that is culturally and age appropriate, as well as ensure they are offering 
a balanced view about long-term risks. Several studies have noted frustration among 
adult women with PCOS that providers were too focused on fertility (Weiss & Bulmer, 
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2011), and that adolescents’ concerns about fertility had a negative impact on quality of 
life (Trent et al, 2003; Hahn et al., 2005). 
Psychological Health and Well-being. Current research also suggests that PCOS 
is also associated with mental health disorders and/or can have a negative impact on 
quality of life in adolescents (Dokras et al., 2018; Kaczmarek et al., 2016). Psychological 
co-morbidities include depression, anxiety, eating disorders, negative body image, and 
psychosexual dysfunction (Witchel et al., 2020). PedPCPs should be aware of the 
increased risk of anxiety and depression in adolescents with PCOS and screen for 
symptoms of anxiety and depression as part of routine care (Pena et al., 2020; Witchel et 
al., 2020). A recent study investigating coping and depression in adolescents with PCOS, 
revealed two aspects of PCOS that contributed to psychological distress: (1) not knowing 
what is going on with their bodies; (2) not feeling in control of their symptoms (Hopkins 
et al., 2019) Furthermore, there is a higher prevalence of clinical and subclinical eating 
disorders in adolescents with PCOS, which calls for a thoughtful patient-centered 
approached to addressing lifestyle modifications (Kamboj & Bonny, 2017).  
While a majority of the literature related to psychological implications and health 
related quality of life (HRQoL) is focused on adult women, literature over the past five 
years demonstrates this association in adolescents with PCOS (Brutocao et al., 2018). 
Brutocao and colleagues (2018) reviewed 57 studies of females with PCOS, one study 
specific to adolescents and three with a mixed population of adult and pediatric patients, 
and found that females with PCOS had a higher likelihood of having a psychiatric 
diagnosis, including depression (odds ratio (OR), 2.79; 95% CI, 2.23-3.50), anxiety (OR, 
2.75; 95% CI 2.10-3.60), bipolar disorder (OR, 1.78; 95% CI, 1.43-2.23) and obsessive 
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compulsive disorder (OCD) (OR, 1.37; 95%CI 1.22-1.55). The authors noted a lack of 
significant difference in the odds ratio between studies that included and did not include 
adolescents. There was not an association of PCOS with increased diagnosis of social 
phobia or panic disorder (Brutocao et al., 2018). 
It has been hypothesized that risk of psychological conditions and impact on 
quality of life is related to the undesirable physical features of obesity and/or 
hyperandrogenism that is commonly present in adolescents with PCOS (Kaczmarek et 
al., 2016). The literature varies on this position. Some studies suggest that body mass 
index in overweight girls with PCOS contributes to reduced quality of life, and higher 
risk for depression and anxiety (Jones et al., 2011; Moran et al., 2010; Trent et al., 2005). 
Other research suggests that fertility concerns have a negative impact on quality of life 
(Trent et al., 2003; Weiss & Bulmer, 2011). In contrast, other studies suggest that 
elevated findings of psychological conditions in adolescent and women with PCOS are 
independent of clinical features of increased body weight, hyperandrogenism or fertility 
concerns (Dokras et al., 2018; Upadhya & Trent, 2007; Zachurzok et al., 2018). Another 
study of quality of life in adolescents with menstrual irregularities demonstrated that 
menstrual problems have a significant impact on quality of life (Nur Azurah et al., 2013), 
but the study examined menstrual problems in general and was not specific to a diagnosis 
of PCOS.  
Considerations related to mental health, quality of life, and screening for 
comorbid conditions such as metabolic syndrome and T2DM are important aspects of 
managing PCOS in adolescents and fall within the scope of primary care practice. In 
addition, pedPCPs have a salient role in facilitating care between specialists, who they 
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may refer to for certain aspects of PCOS treatment. By collecting information related to 
PCPs perceptions, attitudes and beliefs about PCOS and their roles in treatment and 
management, and comparing these factors across a variety of practice settings, this 
dissertation research will attempt to identify target areas where future interventions that 
support best practices can be most meaningful.  
Unique Considerations in the Adolescent Patient with PCOS 
Communication 
There are several unique considerations in managing PCOS in adolescents 
compared with adults that need to be considered when investigating the behaviors of 
pediatric PCPs. First, the challenge of triadic communication is unique to the adolescent 
population. Triadic communication is the term given to communication that takes place 
between patient, parent/guardian, and provider. Since adolescents are under age 18 years 
of age, the involvement of a parent or guardian is still required to some degree. Research 
related to triadic communication over the past decade highlights that adolescent’s 
contributions to their own care is often limited (Van Staa, 2011). Triadic communication 
can be problematic in addressing sensitive and complex topics related to PCOS such a 
lifestyle modifications, mental health, quality of life and reproductive health concerns.  
A second consideration unique to addressing PCOS with adolescents is provider-
patient communication regarding sensitive topics of fertility and sexual behavior. 
Concerns around reproductive health in PCOS are divergent. On one side is concern with 
risk of infertility. Adolescent girls with PCOS have been found to be 3-4 times more 
concerned about future fertility when compared to peers without PCOS (Kudesia et al., 
2017) and concerns with future fertility has been found to have a negative impact on 
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quality of life among adolescents (Trent et al, 2003; Hahn et al., 2005). In contrast, some 
research has found that some adolescents with PCOS may engage in risky sexual 
behavior. One study highlighted that adolescents with PCOS who are sexually active 
have a low baseline rate of contraception use (Malcolm et al., 2015).  
Some research has found that while adolescents are interested in discussing 
reproductive health topics with their health care provider, health care providers are more 
likely to not engage in these discussions (Kudesia et al., 2017). Kudesia and colleagues 
(2017) presents an algorithm with a suggested script to provide guidance for health care 
providers engaging in discussions around fertility awareness with adolescents. The 
development of this algorithm was not specifically focused on adolescents with PCOS. 
Nonetheless, it is relevant to this inquiry as pedPCPs can play a key role in addressing 
fertility awareness and sexual behaviors as an important part of PCOS management in 
adolescents. 
Transition of Care 
Lastly, management and treatment goals for PCOS related outcomes should be 
consider both short and long-term. As adolescent patients approach adulthood, long-term 
management should include considerations of transition to adult primary care. PCOS is a 
life-long condition that may require long-term therapies as well as life-long screening for 
comorbid conditions. While there is a lack of literature related to transitions of care for 
adolescents with PCOS, there is research related to transitions of care for adolescents 
with chronic illnesses, such as T1DM, that can be considered within the context of 
PCOS. Research related to transitions of care in T1DM patients highlight several factors 
that may lead to gaps in care following transfer to adult care. These include loss of long-
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standing comfortable relationships with pediatric providers, shorter clinic visits in adult 
care, and changing or loss of health insurance (Monaghan et al., 2013). Communication 
with health care providers is important for transition to adult care as providers have a role 
in educating patients about their medical condition and long term health care needs 
(Monaghan et al., 2013). Adolescents with PCOS require guidance from their pedPCPs 
prior to transition in order to develop the knowledge and skills need to be advocates for 
their own health needs as their experience with PCOS related complications will 
inevitably alter individual treatment goals over time.  
Health Disparities 
Discussion in the PCOS literature support ethnic and racial variations in the 
presentation of PCOS (Wang & Alvero, 2013), but there is a lack of population studies to 
specifically assess racial and ethnic disparities in the prevalence of PCOS. There are 
studies that have examined differences in complications associated with PCOS, such as 
metabolic syndrome and risk factors for cardiovascular disease, between racial groups 
with PCOS. In one study, a retrospective chart review of adolescents with PCOS at a 
PCOS center compared age and race data matched from the National Health and 
Nutrition Examination Survey (NHANES) from 1999-2006 (Hillman et al., 2014). This 
demonstrated that Black adolescents had a significantly higher prevalence of metabolic 
syndrome than White adolescents with PCOS. The most common characteristic of 
metabolic syndrome founds in Black adolescents compared to White adolescents were 
elevated BMI and hypertension (Hillman et al., 2014). Only non-Hispanic White and 
non-Hispanic Black adolescents were included in this study population.  
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A case-controlled study in non-Hispanic White and non-Hispanic Black adults did 
not reveal the same findings in an adult population. While there were some racial 
differences in PCOS characteristics between Black women and White women, they were 
minor and some outcomes such as quality of life were more favorable in Black women 
(Ladson et al., 2011). Moreover, in contrast to the adolescent population discussed in the 
previous study, Black women had less risk factors for metabolic syndrome compared to 
White women (Ladson et al., 2011) 
In terms of socioeconomic status, one study of women aged 34-49 years, who 
were part of a study on coronary artery risk development, demonstrated a link between 
socioeconomic status (SES) and risk of PCOS. Specifically, the study found that women 
who experienced low childhood SES, but later achieved higher education levels, had 
significantly higher risk of PCOS, especially among women with obesity. Women of low 
childhood SES who did not attain higher personal education did not have an increased 
risk of PCOS (Merkin et al., 2011).  
One study that reviewed data of the National Health Care Surveys to examine 
behavioral health services associated with PCOS, demonstrated different findings related 
to SES status. Specifically, a review of patients ages 11-60 years old who had a PCOS-
related medical visit between 2005-2010 revealed that a high proportion of PCOS-related 
visits paid by private insurance were among White women, compared to those visits 
without private insurance (Sanchez, 2018). Overall a larger proportion of PCOS-related 
visits were by White women (Sanchez, 2018). These findings suggest potential disparities 
in access to care if ethnic groups who may be more susceptible to PCOS than White 
patients are not being seen for PCOS (Sanchez, 2018). Certainly, there are many 
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unknown factors that can contribute to these findings as they relied on ICD-9 diagnostic 
codes to identify patients with PCOS and, in regard to this research, the data was not 
limited to adolescent populations. The study did not have results specific to mental health 
services associated with PCOS, but did find that in general Hispanic adolescents are less 
likely to be screened for depression than non-Hispanic White adolescents (Sanchez, 
2018). This dissertation research provides the opportunity to ask providers about their 
behaviors in screening adolescents with PCOS for depression and other mental health 
disorders and investigate any differences between various settings and reported patient 
populations.  
The literature suggests that there may be differences in the impact PCOS has on 
HRQoL across different cultures. While not specific to adolescents, Upadhya and Trent 
(2007) carried out a review of the literature related to impact on quality of life and found 
cross-cultural variations globally in whether or not aspects of PCOS (within physical, 
psychological and sexual domains) have a negative impact on HRQoL. While some 
studies suggest a correlation between quality of life and attributes of obesity, menstrual 
dysfunction and fertility concerns, HRQOL did not correlate with specific clinical and 
biological measures related to these attributes (Upadhya & Trent, 2007). The authors 
suggest that the impact of PCOS on HRQOL may be influenced by individual patient 
values, perception and culture. This study will not collect data about patients’ perceptions 
and beliefs, but there is an opportunity to investigate whether individual providers’ 
perception and values influence whether or not they consider HRQOL in adolescents with 
PCOS. As data is compared across a variety of settings potential findings may emerge to 
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suggest differences in how subjective community norms within communities of practice 
impact how providers view and address quality of life. 
This review demonstrates a significant gap in knowledge of disparities in PCOS 
care among adolescents. While this dissertation research will not include a patient 
population study to determine disparities in prevalence or risk of complications of PCOS, 
it will examine disparities in practice trends that have not previously been reported. 
Investigating perceptions and behaviors of pedPCPs across a variety of settings (E.g. 
urban, suburban and rural; private practices versus community based clinics, etc.) will 
help to contribute new knowledge about potential disparities in access to comprehensive 
care for adolescents with PCOS.  
Practice Behaviors 
The purpose of this dissertation is to explain practice behaviors of pediatric PCPs 
in the diagnosis and management of PCOS, and identify barriers and facilitators to 
addressing PCOS in a primary care setting. As discussed in the problem statement, there 
is a lack of understanding the role of the primary care provider in the identification, 
diagnosis and management of PCOS. Additionally, there is limited knowledge of the 
potential barriers to overcome in order to optimize a comprehensive management 
approach to PCOS in pediatric primary care practice.  
Literature search terms were expanded from the original search to include a 
combination of the following: polycystic ovary syndrome; pediatrics; physician behavior; 
research utilization; practice improvement; physician behavior change; evidence-based 
practice; evidence-based medicine; barriers; facilitators; clinical practice guidelines; 
guidelines adherence; implementation; knowledge translation. Databases used for the 
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literature search included PubMed, CINAHL and Scopus. There were few findings, from 
the previous search and in this expanded search, of literature that addressed pediatric 
primary care provider behaviors specifically to address PCOS. Therefore, literature was 
considered regarding provider behaviors in addressing and documenting findings of 
hirsutism and menstrual irregularities in an adolescent. Search terms were extended to: 
menstrual cycle, documentation, primary care, pediatric in one search; hirsutism, 
documentation, primary care, pediatric in another search.  
A summary of the results is categorized in two sub-sections: (1) literature that 
discusses current practice trends in the diagnosis and management of PCOS; (2) general 
information about barriers to evidence-based practice and implementation of practice 
guidelines.  
Current Trends in Practice Behaviors 
Ten articles were identified that aimed to obtain information relate to provider 
practice for the diagnosis and/or management of PCOS. Five of them involved survey 
research to inquiry about provider knowledge and behaviors regarding the diagnosis 
and/or management of PCOS (Bonny et al., 2012; Conway et al., 2014; Dhesi et al., 
2016; Dokras et al., 2017; Teede et al., 2014); four were retrospective chart reviews 
(Auble et al., 2013; Broder-Fingert et al., 2009; Powers et al., 2015; Sebastian et al., 
2018); and one was a qualitative study in Australia investigating physician perspective on 
diagnosis PCOS (Copp et al., 2019).  
The retrospective charts reviews all involved a population of providers who 
address PCOS among adolescents. The research aimed to determine accuracies in 
diagnosis and differences in management of PCOS among adolescents, and compared 
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practice behaviors between different specialty clinics within an individual institution. 
Significant variation in the diagnosis and treatment of PCOS was noted across specialties 
(Auble et al., 2013; Powers et al., 2015; Sebastian et al., 2018). One study suggested an 
over diagnosis of PCOS (Auble et al., 2013); whereas, another study, which compared 
general pediatric practice with pediatric endocrinology, demonstrated an under evaluation 
of PCOS within pediatric primary care practice (Broder-Fingert et al., 2009). Another 
finding was related to screening for complications of PCOS, and found a general lack of 
screening for known comorbid conditions across both the general pediatric practice and 
specialty practices (Auble et al., 2013; Broder-Fingert et al., 2009; Powers et al., 2015; 
Sebastian et al., 2018). Of note, none of the studies addressed screening for known 
psychological implications of depression, anxiety and/or reduced measures of quality of life.  
The target population for most of the survey studies were specialty physicians 
with mostly an adult patient population; only one survey study focused on adolescents, 
but the study population of providers were most specialists versus primary care providers 
(Bonny et al., 2012). All of the survey studies demonstrated similar results with 
significant heterogeinty in diagnostic evaluations and management, and limited 
awareness of current diagnostic and management guidelines (Bonny et al., 2012; Conway 
et al., 2014; Dhesi et al., 2016; Dokras et al., 2017). It is important to note however, that 
there were not adolescent-specific guidelines published at the time of the study by Bonny 
et al. (2012).  
The research by Bonny and colleagues (2012) primarily investigated approach to 
treatment among 127 providers who responded to a survey disseminated by the North 
American Society for Pediatric and Adolescent Gynecology (NASPAG). Specialty 
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providers who treated adolescents with PCOS identified oral contraception and life-style 
modifications as the most commonly selected treatment, and less than 30% reported 
prescribing metformin (Bonny et al., 2012). Research by Dhesi and colleagues (2016) 
aimed to describe how often OBGYN providers screened for complication of metabolic 
health associated with PCOS. Survey responses from 281 OBGYNs demonstrated that 
they are not routinely screening for glycemic status and lipid profile among patients with 
PCOS (Dhesi et al., 2016). Similarly, a study by Teede and colleagues (2014) that 
explored the perceived risks of PCOS among 104 primary care providers in Australia, 
found that less than half of the PCPs perceived that metabolic complications were 
associated with PCOS. Only 4% of providers perceived that depression and anxiety are 
also potential features associated with PCOS (Teede et al., 2014). In contrast, a survey 
study by Conway and colleagues (2014), with mostly endocrinologist participating, 
demonstrated that long-term metabolic risks for obesity and T2DM among patients with 
PCOS was well recognized and addressed.  
Dokras and colleagues (2017) surveyed members of American College of ObGyn 
and American Society of Reproductive Medicine to identify gaps in knowledge and 
practices among physicians. Results demonstrated significant gaps in knowledge related 
to the diagnosis and complications of PCOS (Dokras et al., 2017). The study population 
(n=630) did not include primary care providers and was not specific to providers who 
care for adolescent populations. Nonetheless, this study provides a significant 
contribution to this dissertation as the survey tool used is based on a previous survey 
instrument from a PCOS center for research excellence in Australia that was informed by 
a multidisciplinary panel and consumer input (Dokras et al., 2017). This instrument 
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provided an evidence-based tool for reference in the development of the survey for this 
dissertation study.  
Qualitative inquiry by Copp et al. (2019) offers provider perspective on 
diagnosing PCOS. Thirty-six clinicians in Australia participated in 1:1 interviews to 
discuss their experience in diagnosing PCOS. Most clinicians were specialty providers 
with an adult patient population, gynecologists and endocrinologists, and 15 were 
primary care providers. The focus on the inquiry was specifically on diagnosing PCOS 
and did not address management. Results of this qualitative study demonstrated that 
providers have a range of uncertainty regarding the diagnosis of PCOS and concerns 
about under- and over-diagnosis. In general, providers were aware of PCOS guidelines, 
but the study did not discuss adolescent patients or adolescent specific guidelines (Copp 
et al., 2019).  
Limited parallels can be drawn from the aforementioned studies to understand 
behaviors among primary care providers in addressing PCOS because all of these studies 
were conducted prior to the updated PCOS guidelines from the Endocrine Society 
specific to adolescence (Legro et al., 2013) and the international consensus first published 
in 2015 (Witchel et al., 2015). Furthermore, most of the research only addressed basic 
knowledge and did not include an investigation of provider attitude and beliefs, or 
barriers and facilitators to the uptake of evidence from the existing PCOS literature at the 
time of the study. Copp et al. (2019) added new information to the literature regarding 
provider perspective regarding diagnosis. However, this was not specific to providers 
with an adolescent patient population and did not inquire about practice behaviors beyond 
diagnosing PCOS.  
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An additional study was available to note behaviors to identify signs/symptoms 
associated with PCOS. McShane et al. (2018) carried out a chart review for women ages 
12-21 years old who were seen in either the department of pediatrics, family medicine or 
adolescent medicine. Clinical notes were searched for elements of menstrual history 
taken during annual well-visits to include: menarche, last menstrual period, length of 
cycle, and presence or absence of associated symptoms of pain and/or excessive bleeding. 
Findings revealed significant deficiency in taking a menstrual history in pediatric and 
family practice settings compared to adolescent medicine setting. Specifically, adolescent 
medicine was 6.44 times more likely to take a complete menstrual history than family 
medicine and 5.89 times more likely than pediatrics (McShane et al., 2018). All findings 
were found to be statistically significant. While this study was not specific to PCOS, 
screening for menstrual abnormalities plays an important role in identifying reproductive 
disorders such as PCOS. This literature illustrates a gap in the behaviors of pediatric and 
family medicine physicians collecting adequate information related to menstrual history 
and underscores the importance of this research to better understand pediatric PCP 
behaviors as it relates to identifying and diagnosing PCOS. 
PedPCPs are well positioned for the early identification and diagnosis of PCOS, 
and to manage, or facilitate the management, of the multiple aspects of this disorder; 
especially as it relates to screening for short and long-term metabolic and psychological 
health complications associated with PCOS. There is a lack of literature to explore the 
behavior of primary care providers in screening for these disorders among adolescent 
patients with PCOS and their perceptions and beliefs about the risk of these 
complications associated with PCOS. This dissertation research advances knowledge in 
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the field to better understand pedPCP’s behavior in diagnosis and treatment of PCOS, 
screening for comorbid conditions associated with PCOS, and their perceptions about 
impact on long-term health. Furthermore, sampling pedPCPs across a variety of settings 
provided a unique perspective not previously captured in the literature. Previous studies 
either carried out chart reviews from one institution, or survey research among a 
homogenous group of specialty providers. Understanding a wider range of pedPCP’s 
perspectives across a variety of practice settings provides valuable information to inform 
practical interventions for practice improvement.  
Barriers to Diagnosis and Management of PCOS in Adolescents 
The literature does not address dissemination and uptake of current adolescent-
specific practice guidelines for the diagnosis and management of PCOS. While the 
discussion above reveals variations in practice trends, it is not in context of up to date 
practice guidelines. Understanding the dissemination and uptake of guidelines among 
pedPCPs and barriers and facilitators to their use is a vital component of this research.  
Literature related to evidence based practice (EBP) highlights some of the main 
barriers to the applications of guidelines into practice, specifically among pediatric health 
care professionals. These include: lack of knowledge on subject area, lack of critical skill 
to appraise research, lack of time to reference or read new research, and lack of interest 
and/or motivation (Cline et al., 2017; Maaskant et al., 2013). Facilitators included 
integration of guidelines into clinical tools and policies that provide time to read and/or 
interact with colleagues in acquiring new knowledge (Maaskant et al., 2013).  
Cabana and colleagues (1999) developed the Barriers to Adherence Framework 
that outlines the various barriers to adherence guidance among physicians. This was 
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developed from an in-depth literature review of articles that described at least one barrier 
to uptake of clinical guidelines, policies or consensus statements. The framework offers a 
spectrum of barriers under the categories of knowledge, attitudes, and behavior. 
Knowledge, which includes familiarity and awareness, drive attitudes, which then 
influences behavior. Certain attitudes, also influence whether or not physicians seek new 
knowledge. The framework also suggests that physician behaviors are influenced by 
external factors such as patient issues, guideline factors and environmental factors 
(Cabana et al., 1999). This framework provides a basic understanding of the multiple 
barriers that should be considered when determining provider adherence to and 
implementation of guidelines.  
Lack of knowledge of adolescent-specific guidelines for diagnosis and 
management of PCOS is likely a barrier to provider practice in a primary care setting. 
Previous discussed research, under Current Trends in the Diagnosis and Management of 
PCOS in Adolescents, demonstrated lack of knowledge among specialty providers 
regarding PCOS guidelines for adults, which have been published for several decades 
(Dokras et al., 2017). ICPE 2017 Consensus Statement are newer and have had limited 
dissemination outside of endocrinology specialty literature. For example, the American 
College of Obstetricians and Gynecologists (ACOG) updated practice bulletin does not 
address unique considerations in the diagnostic or management criteria of PCOS in 
adolescents (ACOG, 2018). The American Academy of Pediatrics (AAP) published a 
journal article to present the 2015 international consensus statement on the diagnosis of 
PCOS in adolescents (Rosenfield, 2015), but AAP provides no other practice resources. 
The American Academy of Family Physicians (AAFP) had a CME publication in 2016 
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that endorses diagnostic guidelines that conflict with both the Endocrine Society 
guidelines published in 2013 (Legro et al., 2013) and the 2015 international consensus 
statement (Rosenfield, 2015). Specifically, AAFP promotes the ESHRE/ASRM 
Amsterdam Consensus from 2012, which advises that all three Rotterdam criteria must be 
met before a diagnosis of PCOS is made in adolescent patients (Williams et al., 2016). 
Guided by the conceptual framework discussed below, this dissertation research 
investigated factors beyond knowledge to explain barriers and facilitators to address 
PCOS among adolescents in a primary care setting.  
Conceptual Framework 
The Barriers to Adherence Framework (Cabana et al., 1999; Cochrane et al., 
2007) provides a foundation for this dissertation in which a key aim is to identify barriers 
to the diagnosis and management of PCOS in a primary care setting. However, there is no 
clear evidence from existing literature to support if there is a deficit in adherence of 
guidelines, or if there are other barriers to early identification and optimal management of 
PCOS among adolescent patients in a primary care setting. Therefore, this basic 
framework was not enough to meet the goals of this research.  
The Theory of Planned Behavior (TPB) underpins the Barriers to Adherence 
Framework (Cabana et al., 1999; Cochrane et al., 2007). TPB states that intentions to 
carry out a certain behavior are influenced by attitudes, subjective norms, and perceived 
control of one’s behavior and the ability to make a difference (Grol, 2013). However, this 
does not address provider beliefs about the condition itself, how it relates to their practice 
and impacts patient population. Therefore, a second model, the Health Belief Model 
(Glanz et al., 2015), was combined with the TPB as the conceptual framework for this 
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dissertation. A search of the literature on provider behavior mostly revealed systematic 
reviews, similar to the reviews which generated the Barriers to Barriers to Adherence 
Framework (Cabana et al., 1999; Cochrane et al., 2007), but lacks a richer exploration of 
constructs known to influence behavior. The Health Belief Model (HBM) has 
traditionally been applied to patient behaviors and no literature was found that has 
applied this to provider behaviors (Glanz et al., 2015). The HBM is an older model, 
dating back to the 1950s when the U.S. Public Health initiated the development of a 
psychological model to enhance effectiveness of public health education programs (Glanz 
et al., 2015). Research over several decades demonstrated significant links between 
individual beliefs about susceptibility and severity of a disease or condition, and 
anticipated benefit if they participate in a certain behavior (Glanz et al., 2015). Later, 
research from the 1970s specifically aimed at studying constructs within the HBM, 
demonstrated that susceptibility, severity and anticipated benefit are antecedents to the 
belief that an individual had the ability to make an impact on health outcomes if they 
engaged in certain behaviors (Glanz et al., 2015). This concept is also referred to as self-
efficacy or perceived behavior control, which is a main construct in the Barriers to 
Adherence Framework and TBP (Cochrane et al., 2007; Grol, 2013). However, the 
Barriers to Adherence Framework and TBP do not adequately address the factors that are 
found within the HBM to influence the construct of perceived behavior control. Glanz et 
al. (2015) discuss the evolution of the HBM, which later added cues to action and 
summarized two main aspects that influence the perception of behavior control: threat 
perception and behavior evaluation. Threat perception includes perceived susceptibility 
and disease severity. Behavior evaluation includes perceived benefit and barriers to 
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enacting behavior (Glanz et al., 2015). In this dissertation, the HBM was applied to 
provider perception. Where susceptibility and severity traditionally have been applied to 
patient perspective (Glanz et al., 2015), it was applied to provider perspective about the 
provider’s patient population. Figure 2 Conceptual Framework represents the 
foundational framework developed to guide this dissertation research. The framework 
combines constructs of the Barriers to Adherence Framework, a barrier assessment 
framework that is underpinned by TBP (Cochrane et al., 2007; Grol, 2013), and HBM 
(Glanz et al., 2015). 
Figure 2  
Conceptual Framework 
 































































 CHAPTER 3: METHODOLOGY 
Research Methodology 
The long-term goal of this research is to inform future interventions that will 
optimize comprehensive care for adolescents with PCOS. The primary objective of this 
dissertation is to describe practice behaviors of pediatric primary care providers 
(pedPCPs) in the diagnosis and management of PCOS, and identify barriers and 
facilitators in order to inform future interventions that support the translation of 
adolescent specific guidelines for the diagnosis and management of PCOS in adolescents 
into primary care practice. It is hypothesized that practice behaviors among pedPCPs in 
the identification, diagnosis and management of PCOS are influenced by multiple factors 
(to include knowledge, attitudes, beliefs and external factors such as access to specialty 
resources), which may serve as a barrier and/or facilitator to addressing PCOS in the 
adolescent population from the primary care perspective.  
Specific aims for this dissertation research include:  
Aim 1. Identify current practice behaviors among pediatric primary care providers 
in the identification, diagnosis and management of PCOS in adolescents.  
Aim 2. Evaluate the factors (provider knowledge, provider attitudes and beliefs, 
and practice characteristics) that influence practice behaviors to address PCOS in a 
pediatric primary care setting.  
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Aim 3. Understand barriers and facilitators to the identification, diagnosis and 
management of PCOS among adolescents in a primary care setting in order to inform 
future interventions to influence practice behaviors.  
Exploring current behaviors among pedPCPs helped to describe how providers 
are currently engaged in the diagnosis and management of PCOS in the adolescent 
population. Examining provider characteristics and inquiring about knowledge, attitudes 
and beliefs about PCOS allow for evaluation of what influences individual behavior, and 
what may be a barrier or facilitator in addressing PCOS in a primary care practice setting. 
Knowledge, attitudes and beliefs are factors that can be modified in order to optimize 
comprehensive management of PCOS among an adolescent population. Considering non-
modifiable factors, such as provider characteristics and practice location, provided 
evidence to support whether future interventions should be targeted for specific context.  
A pragmatic approach to this research allows for a comprehensive understanding 
of the various factors that may influence pedPCPs behavior in addressing PCOS in 
adolescents. A pragmatic ontology acknowledges that reality is influenced by a variety of 
factors in real-world settings (Creswell et al., 2011; Menikoff et al., 2017). In the case of 
PCOS there are several variables, both modifiable and non-modifiable, that may 
influence how PCOS is address by pedPCPs. Non-modifiable variables relate to external 
factors such as practice setting, practice location, and patient’s insurance status. This 
results in multiple circumstances and perspectives that must be taken into account. There 
will not be one single answer or finding that will be able to explain why a provider does 
or does not engage in a specific practice behavior related to the diagnosis and treatment 
of PCOS among adolescents. The research will not be deductive to identify a single, 
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unbiased result that identifies best practices. Rather the research will be inductive in order 
to identify different barriers and facilitators, a variety of potential influencing factors, and 
consider both the simplicity and complexity of their interactions. Data collected through 
the quantitative survey will identify the degree of involvement in the diagnosis and 
management of PCOS, and explore differences between participants with more or less 
involvement. Involvement is defined by engagement in the following behaviors: 
diagnostic evaluation, treatment, and screening for complications of PCOS. This will 
produce more questions that will be answered with both subjective and objective data 
from providers in the study sample. This explains a pragmatic epistemology, which seeks 
to obtain objective and subjective points of view, and supports the use of mixed methods 
research (Creswell, 2013). 
Research Design 
A mixed-methods sequential explanatory study design that focused on provider 
behaviors, knowledge, attitudes and beliefs was carried out to answer the following 
research questions: (1) What are the practice behaviors of pediatric primary care 
providers in the identification, diagnosis and management of PCOS in adolescents? 
(quantitative inquiry) 
(2) What factors, both modifiable and non-modifiable, influence practice 
behaviors of pediatric providers to address PCOS in a primary care setting? (quantitative 
inquiry) 
(3) How do pediatric primary care providers experience barriers and facilitators in 
the identification, diagnosis and management of PCOS among adolescents, and how can 
they be addressed in order to optimize care? (qualitative inquiry) 
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First, a survey was developed and administered to pedPCPs to answer research 
questions 1 & 2. Survey development is further discussed below under research activities 
for the quantitative study. Results from the quantitative survey and the conceptual 
framework informed the development of interview questions used in the follow-up 
qualitative arm. The qualitative arm involved semi-structured interviews with individual 
pedPCPs who participated in the quantitative arm and agreed to be contacted for the 
second phase of this research. The purpose of the qualitative research was to better 
inform the results of the quantitative survey and explore nuances related to barriers and 
facilitators for pedPCPs related to the diagnosis and management of PCOS from their 
individual perspectives. A visual representation of the study design is represented below 
in Figure 3 Study Design.  








































Study Population and Setting: Inclusion/Exclusion Criteria 
The population for this research included primary care providers who treat 
adolescent patients 12-17 years of age in a primary care across Maryland, Virginia and 
the District of Columbia, capturing urban, suburban and rural areas. Providers include 
physicians, physician assistants (PA), and nurse practitioners (NPs). Eligibility was 
determined based on three questions at the start of the survey: (1) Are you a licensed 
physician (MD or DO), physician assistant (PA) or nurse practitioner (NP)? (2) Do you 
practices in an outpatient primary care practice in the District of Columbia, Maryland or 
Virginia? (3) Does your patient population include adolescent (<18 years of age) 
females?  
A definition of primary care practice was not provided and participants 
determined whether or not they considered their practice to be primary care. Due to 
variations in health care access across regions, often times settings such as urgent and 
gynecology practice are considered primary care. Therefore, the type of primary care 
practices extended beyond pediatric and family medicine practices in this study 
population. Further discussion regarding recruitment and sampling is discussed below 
under each arm, quantitative and qualitative, of this dissertation research.  
Quantitative Study 
The quantitative arm of this research addresses aims 1 & 2 and accompanying 
research questions: 
Aim 1. Identify current practice behaviors among pediatric primary care providers 
in the identification, diagnosis and management of PCOS in adolescents. RQ1: What are 
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the practice behaviors of pediatric primary care providers in the identification, diagnosis 
and management of PCOS in adolescents? 
Aim 2. Evaluate the factors (provider knowledge, practice characteristics, and 
provider attitudes and beliefs) that influence practice behaviors to address PCOS in a 
pediatric primary care setting. RQ 2: What factors, both modifiable and non-modifiable, 
influence practice behaviors of pediatric providers to address PCOS in a primary care 
setting? 
Survey Development  
The first activity of this dissertation research was to develop a survey instrument 
(Appendix A) for the quantitative arm. Survey development was carried out in three 
steps: (1) adaptation of an existing survey instrument to fit a pedPCP population and 
adolescent-specific PCOS practice guidelines; (2) incorporation of questions relevant to 
the conceptual framework regarding attitudes and beliefs; (3) cognitive validity 
interviews to finalize the survey instrument.  
Step 1: Questions related to provider knowledge and behavior were based upon 
published research that measured knowledge gaps in diagnosing and managing PCOS 
among an international community of gynecologists and reproductive endocrinologists 
(Dokras et al., 2017). The survey published by Dokras et al. (2017) was adapted to fit the 
study population of pedPCPs. Specific questions about provider knowledge and practice 
behaviors were adjusted to align with adolescent-specific guidance based on the 
International Consortium of Paediatric Endocrinology (ICPE) 2017 consensus statement 
that is endorsed by the Pediatric Endocrine Society (Ibanez et al., 2017b). 
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 Step 2: Questions related to constructs within the Health Belief Model (Glanz et 
al., 2015) and Theory of Planned Behavior (Cochrane et al., 2007), which inform the 
conceptual framework for this research (Figure 2), were created to explore pedPCPs 
attitude and beliefs regarding PCOS in their own patient population.  
Step 3: Cognitive interviewing was carried out to refine the survey instrument and 
verify clarity and understanding of the questions in the survey prior to distribution. Eight 
providers completed cognitive validity interviews over a one month period. Of the 
participants, two were specialty providers (gynecologist and pediatric endocrinologist), 
two primary care physicians (one in pediatrics, one family medicine), two physician 
assistants (family medicine), and two nurse practitioners (one in pediatrics, one family 
medicine).  
The specialty providers with expertise in PCOS helped to ensure accuracy of the 
questions, statements and answer choices. The remaining six participants were pedPCPs 
who all reported having adolescent patients in their practice, with or without PCOS, and 
were identified through the researcher’s professional network. Variations of practice 
regions (urban, suburban and rural areas) were considered to ensure that participants were 
not a homogenous group from similar practice community.  
The process of cognitive interviewing involved asking participants to read the 
survey items aloud and share their thoughts and interpretations of the questions with the 
researcher (Drennan, 2003). Confirming that the survey questions are well understood 
from the provider perspective guided modifications to the survey instrument to ensure 
that meaningful data was generated. In addition, feedback was sought related to the 
length of the survey and succinctness of the questions.  
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The resulting survey instrument grouped items into three main categories: (1) 
Provider and practice characteristics; (2) Individual provider practice behaviors that relate 
to the diagnosis and management of PCOS among adolescents; (3) Provider attitudes and 
beliefs. Most of the questions in the first two categories presented multiple choice options 
where participants either select the answer that best applied to them or their practice, or to 
select all that apply as was appropriate to the inquiry. E.g. What treatment do you 
prescribe/recommend? (check all that apply). Few questions asked providers to write in 
specific percentages to describe their patient population in terms of insurance payer mix, 
ethnicity and racial diversity. Table 4 Variables for Provider and Practice 
Characteristics and Provider Behaviors, list the variables obtained from questions in 
categories 1 and 2. Participants were able to write in answers when “other” was an 
option. Survey items regarding attitude and beliefs asked participants to measure their 
level of agreement with each statement in the scale, Table 5 Provider Attitude and Beliefs 
Scale, using a 5-point Likert scale. Statements were grouped together to corresponded 











Table 4  
Variables for Provider and Practice Characteristics and Provider Behaviors 
Provider 
characteristics Practice characteristics 
 
Main Provider Behaviors 
 
Provider type (MD, DO, 
PA, NP) 
 






Practice specialty (E.g., 
pediatric, adolescent, 
family medicine, internal 
medicine) 
 
Practice type and setting 
 
Practice location (DC, MD, VA) 
 
Region of practice (urban, 
suburban, rural) 
 




  Insurance status 
 









  PCOS diagnostic evaluation 
 
Management 
  Treatment of PCOS 
 





Table 5  
Provider Attitude and Beliefs Scale 
Item/statement Related construct 
 
PCOS is a condition that specifically impacts my adolescent 
patient population. 
PCOS is an important condition to identify among adolescent 
patients.  
PCOS is associated with significant health complications for 
adolescents.  
PCOS is associated with mental health complications of anxiety 





There is benefit to patient health outcomes if PCOS is addressed in 
adolescents. 
Practice guidelines for the diagnosis and management of PCOS 
are supported by evidence based medicine. 
I have the ability to accurately diagnosis PCOS in adolescents. 
I have the ability to effectively manage PCOS in adolescents. 
I have the support needed in my practice to diagnosis and manage 
PCOS in adolescents.  
I have the support needed in my community to diagnosis and 





Learning more about PCOS would change my practice behaviors.  
Resources are available to me to learn more about the diagnosis 
and management of PCOS in adolescents.  
 
 
Cues to action 
 
My colleagues in primary care practice are actively involved in the 
diagnosis and management of PCOS in adolescents. 





I would like to improve my practice behaviors in addressing 
PCOS among adolescents in my practice.  
I intend to change my practice behaviors in addressing PCOS 





 Three months after the survey launch, changes were made to four survey items to 
increase rate of survey completion. First, questions related to provider ethnicity and race 
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included an answer choice “prefer not to answer” (items #6 & 7 under Provider 
characteristics section). Second, a survey items (#5 under Practice characteristics 
section) that asked participants to write in the percentage of their patients in various ages 
groups was changed to ask participants to select a range of the percentage of their patient 
populations between the ages of 12-17 years of age. The intent of this question was to 
have data to compare whether or not the number of adolescents in a practice influences 
provider behavior in addressing PCOS among adolescents. Third, a survey item (#6 under 
Practice characteristics section) that asked participants to write in the percentage of the 
various insurance payers, was changed to ask participants to identify what percentage of 
their patient population is either uninsured or covered by public insurance. The intent of 
this question was to identify practices that serve a high uninsured or underinsured 
population to investigate any potential disparities in access to care. The motivation 
behind the aforementioned changes was to make these questions less burdensome to 
answer, but still preserved the original intent and allowed for collection of meaningful 
data. No data were lost due to these adjustments as data previously collected was 
collapsed into the modified categories. See detail provided below under “Sampling and 
Recruitment” that further explains the catalyst for these changes related to low survey 
response after the initial distribution of the survey.   
Sampling and Recruitment 
The initial study sample utilized convenience sampling of pedPCPs from the 
District of Columbia and states of Maryland and Virginia via professional membership 
organizations. Convenience sampling is often used when the population of interest is 
readily available (Portney & Watkins, 2015). Assumptions were made at the start of this 
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research that emails sent via member listservs of professional organizations within the 
professional network of the researchers (dissertation student and advisors) would generate 
significant responses. It was recognized and acknowledged when designing this study that 
there would be limitations in verifying the total number of members who received the 
survey to calculate response rate; however, it was determined that this was an effective 
strategy to reach and recruit a diverse group of participants. The study by Dokras et al. 
(2017), which this dissertation research survey is based on, used a similar sampling 
strategy and distributed the survey online to the member listserv for the American 
College of Obstetrics and Gynecology and the American Society of Reproductive 
Medicine. No compensation was provided for participation in the online survey. 
Eleven state chapters of professional associations for pediatricians, family 
medicine physicians, physician assistants and nurse practitioners in Maryland, Virginia 
and the District of Columbia were contacted with a request to distribute the survey 
instrument to their members. Communication was via email from the dissertation 
research student to the executive administrative staff and/or member(s) of the association 
board of directors. Two organizations distributed the survey to their member listserv via a 
unique directed email. Three organizations distributed the survey via an announcement 
within an electronic newsletter sent to member listserv. Five organizations reported 
organizational policies that prohibited the distribution of the survey to their membership. 
One organization reported that they would seek approval from their Board of Directors, but 
did not follow up with a decision despite repeated email follow-up. Of the five 
organizations that did distribute the survey, only two were willing/able to send a second 
distribution/reminder about the survey. 
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Associations who distributed the survey were asked to provide an approximate 
number of members who the survey link was sent to in order to estimate a survey 
response rate. All associations declined to provide an estimate number of their 
membership. It is important to note that even with an approximate number of members, it 
would not accurately reflect those providers who were eligible to participate.  
Twenty-one respondents participated in the survey within the first three months. 
Of these 21 respondents, 17 were eligible as per the inclusion/exclusion criteria, 13 
completed the entire survey, and 8 provided contact information to be contacted for 
follow-up qualitative interviews. While a large percentage of participants (8/13, 61.5%) 
who completed the survey volunteered to participate in phase II of this research, over 
twenty-percent of those who met inclusion criteria did not completed the entire survey 
(4/17, 23.5%). 
A review of the survey items identified a common area where eligible participants 
discontinued the survey. This was the point where participants were asked to write in the 
percentage of the various payers for, and the ethnic and racial makeup of, their patient 
population. Furthermore, it was discovered that questions related to provider ethnicity and 
racial identity did not allow participants to bypass this question, by providing a “prefer not 
to answer” option. 
  Three months following initial survey launch, an IRB addendum was submitted to 
request a change from convenience sampling to snowball sampling and to make few 
changes to the aforementioned survey items. These changes were requested as a strategy to 
increase survey participation. Snowball sampling is a method used to engage hard to reach 
populations (Valerio et al., 2016). There are several reasons why participants for this study 
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were considered a difficult to engage population. First, the target population was clinicians 
with busy clinical practice schedules. Second, several of the professional organizations 
contacted for survey distribution reported organizational policies that prohibited the 
distribution of outside research to their membership. Third, providers who do not have a 
significant interest in the topic or a connection to the research are likely less motivated to 
participate. This study aimed to recruit a diverse sampling of provider types, among a 
variety of practice settings and locations, with varying involvement in addressing PCOS.  
Following IRB approval of the addendum, snowball sampling allowed the 
dissertation research student to contact organizations where there was a professional 
connection to colleagues to request participation and/or to forward the survey invitation and 
link to other colleagues via email. Some contacts also sent survey information within 
alumni groups or professional organizations via social media pages on Facebook and 
LinkedIn. Organizations contacted included clinics, medical groups and alumni 
organizations. These institutions represent a variety of settings, urban, rural and suburban, 
across Maryland, Virginia and the District of Columbia, keeping with the original intent to 
recruit a diverse group of pediatric primary care providers.  
Overall, snowball sampling increase study participation to 78 participants. The 
survey was open from September 16, 2019 thru June 30, 2020. Survey response rate is 
unable to be calculated as snowballing sampling further reduced the ability to document the 





IRB approved language was provided for an introductory email to potential participants 
about the research, along with a link to the survey administered via REDCap. Once a 
participant opened the link, they were taken to the Study Information Sheet that 
addressed the study purpose, voluntary nature of the research, estimated duration to 
complete the survey, anonymity (unless they volunteer to provide contact information at 
the conclusion of the survey), potential risks, benefits and alternatives. If respondents 
continued, they advanced to the inclusion/exclusion criteria. Inclusion criteria for 
participation in the survey included: licensed and practicing as a physician (MD or DO), 
PA or NP in the District of Columbia, Maryland or Virginia; practice in an outpatient 
primary care setting; and adolescents (12-17 years of age) included in patient population. 
If participants did not satisfy inclusion criteria, the survey closed. Participants who met 
inclusion criteria continued on to the survey instrument. Completion of the survey 
indicated consent. No compensation was provided for participation in the online survey. 
Data Analytic Plan 
The conceptual framework for this research underpins the study hypothesis and 
provide a guide for data analysis. The overarching study hypothesis is that practice 
behaviors among pedPCPs in the identification, diagnosis and management of PCOS are 
influenced by multiple factors to include knowledge, attitudes, beliefs and non-
modifiable practice characteristics such as geographical region and makeup of patient 
population. The conceptual framework, derived from the TPB and HBM, supports that 
knowledge, attitude and beliefs influence practice behaviors in the diagnosing and 
management of PCOS. Additionally, external factors, which in this research relate to 
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practice characteristics, influence not only provider behavior, but can also have a direct 
impact on knowledge, attitudes and beliefs.  
Descriptive analyses were conducted using IBM SPSS statistical software version 
26 to describe provider behaviors, knowledge, attitude/beliefs and practice 
characteristics. Next, correlational analyses, with either independent t-tests, analysis of 
variance (ANOVA) or Chi square analysis as appropriate, were conducted to evaluate 
associations among each factor (knowledge, attitudes/beliefs, practice characteristics) and 
provider behaviors in diagnosis and management of PCOS.  
Aim 1. Analysis  
 Provider practice behaviors in addressing PCOS are the first key part for 
investigation in this research. The survey instrument queried provider practice behaviors 
across three phases or categories to address PCOS:  identification, diagnosis and 
management (treatment and screening for complications). Throughout the survey, 
participants selected whether or not they engaged in various behaviors within their 
practices. Survey items either inquired about engagement in a specific behavior (0= no; 
1= yes), or ask providers to “select all that apply” when presenting several options for 
items such as diagnostic tests or treatment. Responses were recorded as nominal data, 
which was analyzed to report frequencies for each behavior. Additionally, where 
appropriate, sums of specific behaviors in each category were calculate to use in data 
analysis for Aim 2. /RQ2, to compare differences in practice behaviors across items 
related to knowledge, attitudes/beliefs and provider/practice characteristics. Table 6 
Provider Behavior, provides a list of the behaviors queried in the survey as it relates to 
one of the three categories to address PCOS (identification, diagnosis and management), 
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the type of responses and data collected, and indicates were sums were calculated to 
create continuous data related to a specific behavior.   
 Additionally, provider demographic characteristics, collected as categorical data, 
are described using descriptive statistics. Frequency counts of provider type (MD, PA or 
NP), gender, age, ethnicity, race, practice specialty (pediatrics, family medicine, etc.), 
and years in practice provide information about the diversity of the study population.  











Visit type for inquiry of menstrual regularity 
 




Patients with diagnosis of PCOS 
 
Yes/No/dichotomous 
Selection of diagnostic tests Select all that apply/nominal 
Sum score of diagnostic test selection* Sum score/continuous  






Whether or not provider treats PCOS 
 
Yes/No, dichotomous  
Treatment goals Select all that apply/nominal 
Treatment selection  Select all that apply/nominal 
Referral/ specialist consultation Yes/No, dichotomous 
Screening for complications of PCOS Yes/No, dichotomous 
 Selection of screening tests Select all that apply/nominal 
Sum score of screening test selection* 
 
Sum score/continuous 
*Designates data that were transformed into a sum score. 
Aim 2. Analysis  
 Research question #2, more specifically addressed the study hypothesis by 
evaluating the factors that influence practice behaviors and conducting correlational 
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analysis to determine if there are strong associations among any specific factor(s) and 
practice behaviors. First, descriptive statistics, reporting frequencies, were used to 
analyze factors of knowledge and provider/practice characteristics. The indicator for 
knowledge was familiarity with any diagnostic criteria for PCOS (yes/no), and then more 
specifically, for Pediatric Endocrine Society (PES) adolescent-specific diagnostic 
guidelines, which providers selected from list of six different diagnostic criteria with the 
option to select all that apply. Provider response is recorded as a dichotomous value (1 if 
selected; 0 if not selected).  
 Practice characteristics considered for analysis in Aim 2 include: pediatric versus 
family medicine focus, practice setting, practice location, practice region, percent of 
adolescent in patient population, percent of total patient population uninsured or 
public/Medicaid insured, and ethnic and racial make-up of patient population. Either 
independent t-tests, analysis of variance (ANOVA) or Chi square analysis was used as 
appropriate for the data. Independent t-test was most appropriate for comparison related 
to knowledge as familiarity of PES guidelines (1=yes, 0=no) is a dichotomous value and 
diagnostic practice scores as continuous data (Portney & Watkins, 2015). ANOVA is 
most appropriate when comparing behaviors of diagnostic practice scores and 
management/screening score (continuous data) to provider/practice characteristics 
(categorical data with two or more levels) (Portney & Watkins, 2015). Chi square 
analysis is most appropriate to compare behaviors of management/treatment (yes=1, 
no=1) as dichotomous data with provider/practice characteristics (categorical data with 
two or more levels) (Portney & Watkins, 2015). 
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 Factors of provider attitudes and beliefs were analyzed by determining level of 
agreement, on a five-point Likert Scale, with 16 items informed by constructs from the 
conceptual framework for this research. Statements and related constructs from the 
framework are listed in Table 5 Provider Attitude and Beliefs Scale. Cronbach’s alpha 
reliability estimates was calculated to determine internal consistency of the overall scale 
(16 items). Cronbach’s alpha is an appropriate statistical method to use for these items 
related to attitudes and beliefs as it is known to be an estimate of the reliability of a 
psychometric test (Portney & Watkins, 2015). Next, provider agreement with each 
statement was reported descriptively with mean item scores, standard deviation and 
range. The three highest and three lowest mean item scores for level of agreement were 
identified.  
 Multiple independent sample t-test were carried out to with scale and subscale 
scores to compare means between groups of providers with high vs. low diagnostic 
practice scores, providers who treat vs. do not treat, and providers who screen for 
complications vs. those who not screen. Independent sample t-test is an appropriate test 
to compare means between groups where the variable for provider behaviors are 
represented as categorical data (Portney & Watkins, 2015).  
The quantitative component of this research provided extensive information about 
pedPCP’s practice behaviors, filing a gap in the literature regarding the diagnosis and 
management of adolescents with PCOS in a primary care setting. Comparing behaviors 
across multiple variables will help to identify areas to target future interventions and 
reveal potential disparities. Collectively, the information obtained from analysis of the 
quantitative data helped to informed qualitative inquiry that seeks to understand barriers 
 
 69 
and facilitators to the identification, diagnosis and management of adolescents with 
PCOS in a primary care setting. 
Qualitative Study 
The qualitative arm of this research addresses aim #3 and accompanying research 
questions. Aim 3. Understand barriers and facilitators to the identification, diagnosis and 
management of PCOS among adolescents in a primary care setting in order to inform 
future interventions to influence practice behaviors. RQ 3: How do pediatric primary care 
providers experience barriers and facilitators in the identification, diagnosis and 
management of PCOS among adolescents? RQ 4: How can barriers and facilitators be 
addressed in order to optimize care for adolescents with PCOS?  
Qualitative Research Activities 
Following the collection of data from the quantitative phase of this research, a 
smaller sample of pedPCPs were contacted for semi-structured qualitative interviews to 
better understand the context and conditions related to the responses captured in the 
provider survey. Semi-structured interviews are a main tool in qualitative research that 
allows the researcher to illustrate how participants make meaning, understand meaning 
within context and identify unanticipated consequences (Patton, 2015). Qualitative 
research in this mixed-methods study is necessary to obtain a complete and nuanced 
understanding of current practice behaviors and barriers and facilitators to change 
behaviors among primary care providers.  
An interview guide (Appendix B) was developed based on the conceptual 
framework for this research and the results of the quantitative survey. First, questions 
were developed that aligned with key constructs within the Theory of Planned Behavior 
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(TPB) and the Health Belief Model (HBM). Specifically, this included questions related 
to: knowledge about guidelines and current practice behaviors; attitudes and beliefs about 
PCOS in adolescents; intention and motivation to change; and inquiry about external 
factors that influence practice. Questions were them modified and refined based on 
results from the from the survey results. As interesting findings emerged from the survey 
data that either supported or rejected the study hypothesis around pedPCPs knowledge 
and practice behaviors, the qualitative interview allowed for follow up to gain a more 
nuanced perspective. Additionally, individual participant survey data was available for 
reviewed prior to the interviews, which allowed the interviewer to address outliers and 
seek additional information to explain variations within the sample.  
Interview questions followed guiding principles of interview questions: ask 
question that are open-ended and require a descriptive answer; ask questions that are 
clear; communicate clear transitions in the interview guide when changing topics or 
ideas; allow time for follow-up to probe unexpected responses (Patton, 2015). Interviews 
were scheduled from June 18 – August 24, 2020. A total of twenty interviews were 
completed.  
Sampling and Recruitment 
The study population was a purposeful sample of pedPCPs in Virginia, Maryland, 
and the District of Columbia who completed the quantitative survey and agreed to be 
contacted to participate in the qualitative phase of this study. Survey respondents 
provided limited contact information at the conclusion of the on-line survey, which asked 
if they were willing to be contacted at a later date for the follow up phase of the research. 
Providing their contact information was completely voluntary and was not a required 
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field on the survey.  
 Inclusion criteria for participation in the qualitative phase of this research 
included: completion of the on-line survey (and therefore meeting the initial inclusion 
criteria of a physician, PA or NP in primary care practice); verbal fluency in English; 
having a valid email address; and have access to a computer or phone.  
Exclusion criteria include providers who did not complete the survey 
disseminated prior to this study; practice in a specialty vs. primary care oriented setting 
(E.g. endocrinology); providers who do not currently practice/see patients in Virginia, 
Maryland or the District of Columbia, even if they hold a medical license in those 
jurisdiction; and providers who do not have access to a reliable phone line or computer 
with Wi-Fi to participate in the interviews. 
Prior to initiation of this study, the literature was reviewed for exemplars of 
qualitative interviews with health care providers to estimate an ideal sample size based on 
previous research. Guidance on a reasonable number of participants was sought rather 
than suggesting theoretical saturation in order to ensure diversity in the sample 
population. There are limited examples of qualitative research with health care providers 
that include physicians, but a study of palliative care health care professionals involved in 
pediatric palliative care from 2015 utilized a sample size of 17 (Lotz et al., 2015). The 
palliative care study relates to this dissertation research as it aimed to inform future 
interventions for support and education of health care professionals (Lotz et al., 2015). 
 This dissertation study recruited twenty-seven survey participants who indicated 
that they were willing to be contacted for follow up. All twenty-seven pedPCPs were sent 
emails between June thru August 2020 to request an interview. Two emailed the 
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researcher indicating that they no longer wished to participate in the interviews, twenty 
scheduled and completed interviews, and five had no response. Participants with no 
response were contacted a total of three times between June-August 2020.  
Participants received a small incentive ($25 gift card to Target) in appreciation for 
their time. The gift cards were sent via mail. A tracking sheet was maintained and 
participants were contacted via email to alert them when the gift cards were mailed. 
Participants were asked to reply if they had not received the gift cards within one week of 
mail date. No email response indicated that the gift cards was received. 
Procedure 
Participants who provided their contact information for follow up were contacted 
via email with a request to schedule an individual interview. The email was approved by 
IRB, as well as the Study Information Sheet attached to the email. IRB determined this 
study to be minimal risk; therefore, a Study Information Sheet was used in place of 
signed Informed Consent. Participants were able to schedule interviewers via a link to a 
Google calendar associated with the researcher’s email, which displayed available 
appointments. An email was generated to the researcher once the interview was 
scheduled. At that time a follow up email was sent to inquire if the participant preferred 
an interview meeting via phone or Zoom videoconference. This method allowed 
individuals to participate from distant areas without having to make travel a limiting 
factor in recruiting for this phase of the study. If phone preference, the participant was 
asked to provide a phone number for the researcher to call at the scheduled date/time. If 
videoconference was preferred, participants were emailed an on-line meeting link unique 
to their individual interview.  
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At the start of each interview, the Study Information Sheet was reviewed in detail 
regarding the purpose of the research, the voluntary nature of the study and that the 
interviews would be recorded for purposes of transcription. The participate was asked if 
they had any questions or required clarification before the interview began. Interviews 
were limited to 30 minutes in length.  
Interview recordings were then transcribed by a transcription service. For the 
interviews carried out via videoconference, only the audio recording was saved and 
shared for transcription. Once transcribing was complete, the researcher reviewed each 
transcript while listening to the recording to verify each transcript. The verified transcript 
was sent to each participant via email, allowing them the opportunity to clarify any 
information they provided. This strategy, called member checking, helps the researcher to 
ensure accuracy of the data (Creswell, 2013). Participants were not obligated to review 
the transcription document. A specific date, ten days from the time the transcription was 
emailed, was provided by which changes should be received. No response from the 
participant indicated that they did not have any additional comments for clarification. 
Only one participant replied that there were a few terms that they thought were 
“incorrect”, but that it did not change the meaning of the interview and they did not 
provide any specific annotations for correction.  
Data Analysis 
 First, seven transcripts were coded manually, using opening coding in the first 
coding cycle to identify barriers, facilitators and ways to address practice behaviors, 
attitudes and beliefs. These seven transcripts were purposively selected to ensure the 
diversity of the sample was represented to maximize potential for new codes in the initial 
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coding process. Selection considered provider type, practice focus and setting, provider 
engagement in diagnostic and management of PCOS, and provider behavior evaluation 
and intention to change as per their response on the attitude/beliefs survey items. The 
researcher collaborated with a peer reviewer to check for agreement on the initial codes 
generated from the first cycle of coding for barriers, facilitators and ways to address 
practice gaps.  
 A second cycle of manual coding used descriptive coding (Saldana, 2016) to 
describe the barriers, facilitators and ways to address that were identified in the first cycle 
of coding. The first two cycles of coding utilized an inductive approach to allow concepts 
to be developed from the raw data. A third cycle of coding took a deductive coding 
approach to consider the concepts within the conceptual framework for this research. 
While there was no predefined code book, considering the unique constructs from the 
TBP and HBM ensured that there were no outliers in the qualitative data that were not 
captured in the codes that emerged from the inductive coding process. The third cycle of 
coding resulted in refinement of codes and subcodes, and development of categories that 
considered both the initial results of open coding and the guiding framework. Subcodes 
were maintained under some of the general codes in order to provide more nuanced 
analysis and preserve input from the participant that was specific and unique (Saldana, 
2016). 
 At the completion of the manual coding a codebook was developed based on 
themes identified (Appendix B). The peer reviewer, who participated in the first cycle of 
coding, reviewed codes and categories with the researcher for agreement on a codebook 
to be used for coding remaining transcripts. The finalized codebook was entered into 
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NVivo 12 (Release 1.3) qualitative data analysis software to code the remaining 
transcripts. Thematic analysis was then applied to generate themes that best represent 
thoughts and experience shared by the participant/interviewee as guided by the frequency 
of categories and codes (Saldana, 2016). Figure 4 Study Schema provides a visual 
summary of the study activities, procedures, and outputs.  





Internal validity is obtained by using survey instruments based on existing 
literature and established theoretical models/frameworks. Completion of cognitive 
validity interviews prior to distribution of the survey further contributes to rigor of the 






















































of practice settings and geographical locations. Sampling was not limited to a specific 
group of providers as population validity is a threat to external validity.  
Values of trustworthiness considered for accuracy of qualitative findings include 
credibility, dependability, transferability, and confirmability (Lincoln & Guba, 1985). 
Credibility is addressed by utilizing evidence from previous qualitative research and 
publications on qualitative research to guide qualitative methods (Shenton, 2004). As 
stated above under activities in the qualitative description of the study, guiding principles 
from experts in qualitative research (Patton, 2015) informed the development of the 
interview guide. Additionally strategies for credibility that were used in this dissertation 
research include: 
 - Triangulation of data (Shenton, 2004) - Quantitative data in this mixed-methods 
study supports results that emerge from the thematic analysis of the qualitative 
interviews, as well as qualitative data helps to better explain quantitative findings.  
 - Frequent debriefing session - the researcher for this dissertation received 
guidance and mentorship via frequent debriefing sessions (Shenton, 2004) with the 
PI/dissertation chair and a committee member, with qualitative research expertise, as the 
qualitative research was carried out.  
 - Member checks – member checks were carried out by asking participants to 
review final transcripts of the interview dialogue (Shenton, 2004). Participants had the 
opportunity to provide feedback to ensure that the type transcript match the words and 
ideas they intended to convey (Shenton, 2004).  
 - Peer scrutiny – the dissertation research student worked with a peer reviewer to 
provide feedback during the qualitative research process and to verify codes, categories, 
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final codebook and emerging themes from the qualitative data (Shenton, 2004). 
 - Examination of previous research findings (Shenton, 2004)  
- Dependability relates to the reliability of the work (Shenton, 2004). In this study, 
dependability was addressed by detailing the process of how the qualitative research was 
carried out, such that a reader has a guide to replicate this study (Shenton, 2004). In 
addition, ensuring alignment of the methods with the research questions support 
dependability. This was addressed by having researchers, from the dissertation 
committee, review the alignment (Figure 5 Maxwell’s Alignment and process of the 
research (Creswell, 2013; Maxwell, 2013)). 
-Transferability is addressed by providing detailed information of the existing 
evidence that supports this research and thick, rich descriptions of the phenomenon (the 
experience of pedPCPs in addressing PCOS) being study (Lincoln & Guba, 1985). This 
will be addressed by providing descriptions and memos during the process of qualitative 
data collection and analysis.  
-Confirmability is addressed by detailing the process of data collection, analysis 
and interpretation, and taking time to reflect, and document reflection, on how the 
researcher’s background may have influenced the findings (Patton, 2015; Shenton, 2004).  
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Figure 5  
Maxwell’s Alignment 
 
Protection of Human Subjects 
 Research protocols for IRB review were submitted separately for each 
phase, quantitative and qualitative, of this study. 
Quantitative Research 
Children’s National and the George Washington University Institutional Review 
Board provided approval for this study (Pro00012251). The survey research was 
determined exempt under DHHS regulatory category 2. Children’s National was the IRB 
of record, and George Washington University IRB provided concurrence. Participation in 
the study was voluntary and risk to subjects was minimal. Providers did not experience 
any adverse events if they decline participation. Alternative to study participation was 
non-completion of the survey. No names were collected and no identifying information 











































contact information to participate in the qualitative phase of this research. For 
participants who provided contact information, only the research team has access to their 
contact information and link with the study data in a secure password protected folder. 
Only aggregate data is analyzed without naming any individuals or providing potentially 
identifying information, such as naming the institutions where they practice. Participants 
did not and will not receive any direct benefits. Potential benefit is that knowledge gained 
from this study will inform future interventions to modified practice behaviors to 
optimize the role of the primary care provider in the identification, diagnosis and 
management of PCOS among adolescents. No compensation was provided. 
IRB approval was not applied to the cognitive validity interviews that preceded 
survey distribution and data collection. The purpose of the cognitive validity interviews 
was for survey development and personal data was not collected. Providers simply read 
the survey questions out loud and providing feedback on clarity of the question to the 
researcher. As per federal regulations 45CFR46.101(f), this part of the research activities 
did not meet the definition of “about whom”. 
Qualitative Research 
The IRB of record for this research is Children’s National IRB, which provided an 
expedited review and determined the qualitative study to be no more than minimal risk 
(Pro#00013265). A Reliance Agreement was required with George Washington 
University Committee on Human Research, Institutional Review Board in order to 
designated GWU as an external site. The request for a Reliance Agreement was 
submitted and approved using the SMART IRB.   
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For the qualitative semi-structured interviews, a Study Information Sheet was 
provided to all participants and the following key elements were highlighted prior to the 
interview: voluntary nature of the research; study purpose; duration and research 
procedures; risks, benefits and alternatives. Risk to study subjects was minimal. 
Participation in the interviews was completely voluntary, but there is a minimal risk of 
loss of confidentiality since information related to the identity of the participant is known 
to the researcher and their information can be linked with their survey responses. In order 
to reduce potential risk associated with loss of confidentiality, the researcher has 
followed routine precautions to protect participant privacy, including password protection 
and encryption of electronic data files and de-identification of interview transcripts. The 
link between participants with their survey responses is only known to the researcher and 
destroyed after completion of the analysis. Participants had the opportunity decline to 
participate at any time, even if the interview had already started, with no risk of adverse 
events. Alternative to study participation was not participating in the qualitative 
interviews. 
Participants did not receive any direct benefit from participating in this research. 
Potential indirect benefit is that knowledge gained from this study will inform future 
interventions to modified practice behaviors to optimize the role of the primary care 
provider in the identification, diagnosis and management of PCOS among adolescents. 
$25 Target gift cards were provided to interview participants in appreciation for their 
time.  
Beneficence throughout the entirety of this research was considered and addressed 
by reducing risk to individuals through anonymity of the surveys and taking measures to 
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maintain privacy and confidentiality in the interviews. This included keeping 
documentation linking participants contact information with the study and their survey 
responses in a password protected file on Dropbox, only accessed by the researcher.  
Interviews were conducted either via phone or Zoom videoconferencing with unique 
password protected meeting links. Participants were informed that recordings of 
interviews would be used for thematic analysis only and were destroyed after 
transcription was verified. Transcripts have been stored in a password protected computer 
drive and do not contain any name or other identifiers of the interviewee. Only members 








CHAPTER 4: RESULTS 
 
 
 An on-line survey to identify practice behaviors and evaluate factors that are 
associated with behaviors among pediatric primary care providers (pedPCPs) in the 
identification, diagnosis and management of PCOS in adolescents was distributed to 
pedPCPs in the District of Columbia, Maryland and Virginia. Seventy-eight (78) 
providers responded to the survey invitation by opening the link and reviewing the study 
information sheet. Seventy-four (74) respondents completed inclusion/exclusion criteria; 
12 were not eligible to participate. Of the remaining 62 participants, 10 had incomplete 
responses that could not be analyzed, resulting in 52 completed survey responses that 
were available for analysis.  
 Follow-up individual interviews were conducted via phone or videoconferencing 
to better understand barriers and facilitators to addressing PCOS among adolescents in a 
primary care setting. Twenty-seven participants volunteered to be contacted for 
interviews and provided contact information. Twenty interviews were completed. This 







The majority of participants were PAs (n=29/52, 55.8%), with physicians (MDs) 
representing 23.1% (n=12/52) of the sample, and NPs 21.1% (11/52). Responses for 
areas of practice included: general pediatric (n=15), adolescents medicine (n=3), internal 
medicine (n=6), family medicine (n=22), urgent care (n=1), health department 
reproductive health clinic (n=1), general gynecology (n=3), and primary care (n=1). 
Table 7 Provider Demographics and Characteristics, presents provider demographics 
and individual characteristics. Individual characteristics include: practice specialty and 



















Table 7  












 n % n % n % n % 
Gender         
   Female 7 13.5 26 50 9 17.3 42 80.8 
   Male 5 9.6 3 5.8 2 3.8 10 19.2 
Age         
   20-39 years 7 13.5 23 44.2 4 7.7 34 65.4 
   39-59 years 5 9.6 6 11.5 7 13.5 18 34.6 
Ethnicity         
  Hispanic/Latino 0 0 1 1.9 0 0 1 1.9 
  Not Hispanic/Latino 12 23.2 27 51.9 11 21.2 50 96.2 
  Prefer not to answer 0 0 1 1.9 0 0 1 1.9 
Race         
   White 7 13.5 24 46.2 6 11.5 37 71.2 
   Black 4 7.7 1 1.9 3 5.8 8 15.4 
   Asian 1 1.9 0 0 0 0 1 1.9 
   Two or more races 0 0 4 7.7 2 3.8 6 11.5 
Specialty         
   General pediatrics 10 19.2 4 7.7 1 1.9 15 28.8 
   Adolescent medicine 0 0 0 0 3 5.8 3 5.8 
    Internal medicine 1 1.9 4 7.7 1 1.9 6 11.5 
    Family medicine 1 1.9 15 28.8 6 11.5 22 42.3 
    Other 0 0 6* 11.5 0 0 6 11.5 
Years in Practice         
   1-10 years 7 13.5 21 40.4 8 15.4 36 69.2 
   11-20 years 1 1.9 5 9.6 3 5.8 9 17.3 
   >20 years 4 7.7 3 5.8 0 0 7 13.5 
*Other PA specialties included: urgent care (n=1), health department reproductive health clinic 
(n=1), GYN (n=3), and one designated as “primary care” (n=1) 
 
Practice Characteristics 
 Practice characteristics include: practice location (District of Columbia, Maryland 
or Virginia), practice region, practice focus and setting, and patient characteristics of 
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insurance status, ethnic and racial groups, and percent of adolescents within patient 
population.  
 Practice Location and Region. Practice locations (DC, MD and VA) were 
distributed across urban, suburban and rural areas, with three participants stating their 
practice was divided between two different regions; Figure 6 Practice Location and 
Region. 
Figure 6  
Practice Location and Region 
 
 Practice Setting and Patient Population. Practice setting includes both practice 
focus (pediatric vs. family medicine) and type of practice setting such as private or group 

























pediatric focused practice or family medicine focused practice. Practice specialties in 
internal medicine, primary care, health department clinic, urgent care or general 
gynecology have a family medicine perspective with populations that include both 
adolescents and adults, versus pediatric practice focus with adolescents and younger 
patients. 
Original categories for type of practice setting in the survey were collapsed into 
the following categories: solo private practice (single-physician owned) (n=3); group 
practice (either owned by physician group, corporation or hospital system) (n=28); an 
outpatient clinic that is affiliated with an academic medical center (n=6); public or 
community health clinic (including health department clinic and a school-based clinic 
that is part of a Federally Qualified Health Center (FQHC) (n=9); and urgent care clinic 
(n=6). (Of note, this is different than the single provider who indicated “urgent care” as a 
specialty as noted in Table 7 Provider Demographics and Characteristics. There is not a 
medical specialty for “urgent care”. In this study, urgent care is a setting where providers 
have a family medicine focus.) 
Inquiry to discern between public and private insurance payer mix asked 
participants if less than or greater than 50% of their patient population had 
Medicaid/public insurance or were uninsured. Twenty-four of fifty-two participants 
(46.2%) responded that >50% of their patients were either uninsured or Medicaid 
beneficiaries; and 28/52 (53.8%) had less than 50% of their patient population in this 
insurance payer group.   
Next, participants wrote in estimated percentages for categories of ethnicity and 
race represented in their patient population. Ethnicity and race data was collapsed into 
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categories designating whether minority populations of interest in this study, Hispanic 
and Black/African American, accounted for 50% or greater of the patient population. 
Collapsed data into categorical values allowed later analysis to explore disparities, 
previously reported in the literature, in the context of this research regarding provider 
diagnostic or management behaviors. Other races reported by providers and the average 
reported among the sample included: Asian 6.6%, Native American 0.6%, Pacific 
Islander 0.6%, more than two races 9.9% and other 6.7%. For “other” participants wrote 
in Middle Eastern, Indian, and Hispanic as a race. Due to small percentages among a 
small dataset, categorical values were not assigned for additional race data beyond White 
and Black/African American.  
Finally, the majority of the providers (n=38/52, 73.1%) reported that adolescents 
make up less than 25% of their patient population and 25% of the participants (n=13/52,) 
reported that adolescents make up greater than 25% percent of their practice population. 














Table 8  


























 n % n % n % n % n % n % 
Practice focus 
     Pediatric  0 0 10 35.7 5 83.3 3 33.3 0 0 18 34.6 
     Family Med 3 100 18 64.3 1 16.7 6 66.7 6 100 34 65.4 
 
% Patients Uninsured or Public Insurance 
          ≤ 25% 2 66.7 13 46.4 1 16.7 2 22.2 2 33.3 20 38.5 
         26-50% 0 0 5 17.9 0 0 0 0 3 50 8 15.4 
         >50% 1 33.4 10 35.7 5 83.3 7 77.8 1 16.6 24 46.2 
 
% Patient Population Hispanic** 
       <50% 3 100 26 92.9 4 66.7 7 77.8 4 66.7 44 84.6 
        ≥ 50% 0 0 1 3.6 2 33.3 2 22.2 1 16.7 6 11.5 
 
% Patient Population Black/African American* 
       <50% 2 66.7 21 75 3 50 8 88.9 6 100 40 76.9 
       ≥ 50% 1 33.4 6 21.4 3 50 1 11.1 0 0 11 21.2 
 
% Adolescent Patients* 
      <10% 2 66.7 11 39.2 0 0 2 22.2 1 16.6 16 32.7 
        11-25% 0 0 10 35.7 2 33.3 6 66.7 4 66.7 22 42.3 
       >25% 1 33.4 7 25 4 66.7 1 11.1 0 0 13 25 
*One missing value 
**Two missing values 
 
Research Question #1: What are the practice behaviors of pediatric primary care 
providers in the identification, diagnosis and management of PCOS in adolescents? 
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Behavior: Identification of PCOS  
 Fifty-two (52) complete survey responses were available for analysis related to 
behaviors to identify PCOS. The survey first asked providers to identify at which visit 
type they inquired about menstrual irregularities in adolescent patients. Since menstrual 
irregularities is one of the main criteria for diagnosing PCOS in adolescents, inquiring 
about menses is a key behavior to identify patients who may be at risk. Survey 
respondents were able to select all that apply to indicate when they inquiry about menses, 
and also had the option of “I never inquire about menstrual irregularities.  
 Figure 7 Encounters When Providers Inquire About Menses highlights the type of 
visits where providers inquire about menstrual irregularities and the percentage of 
respondents indicating this behavior. No participants indicated that they “never inquire 
about menstrual irregularities”. Respondents who choose “other”, wrote in that they 
inquire about menses for appointments related to abdominal pain, vaginal discharge, 
vaginal bleeding, sexual transmitted infection and birth control appointments.  
  Next, providers were asked whether or not menstrual irregularities among 
adolescents is a frequent finding in their practice that would potentially require further 
follow. Twenty-six out of fifty-two respondents (50%) estimated that 11-25% of their 
adolescent patient population have menstrual irregularities; 8/52 (15.4%) respondents 
estimated <10%; 14/52 (26.9%) estimated 26-50%; 3/52 (5.8%) estimated >50%; and one 









Figure 7  
Encounters When Providers Inquire About Menses 
   
 
Behavior: Diagnosis of PCOS in Adolescents 
All participants were asked if they had patients with a diagnosis of PCOS. 
Participants who indicated that they had patients with a diagnosis of PCOS branched into 
specific questions about their practice behaviors for the diagnosis and management of 
PCOS. Eight of fifty-two respondents (15.4%) stated that they did not have adolescent 
patients with a diagnosis of PCOS. These 8 participants were then directed to another part 





























was collected regarding practice behaviors. Reasons stated for not having adolescents 
with a diagnosis of PCOS included: lack of patients who meet diagnostic criteria (n=4); 
lack of knowledge needed to diagnosis PCOS (n=1); lack of confidence (has knowledge, 
but not comfortable) to diagnosis PCOS (n=3).  
For the remainder of items regarding practice behaviors, survey responses from 
the subset of 44 providers who have patients with PCOS were available for analysis. 
Table 9 Estimate Number of Patients with PCOS Annually, represents provider estimates 
of the number of adolescent patients with PCOS seen annually.   
Table 9  





focused practice Total 
Number of patients n % n % n % 
< 25 10 22.7 26 59.1 36 81.8 
25-50 3 6.8 3 6.8 6 13.6 
>75 1 2.3 1 2.3 2 4.5 
 
Behavior of providers who have adolescents with PCOS (n=44) was first analyzed 
for their selection of laboratory and/or imaging tests for PCOS diagnostic evaluation. The 
selection of diagnostic tests is important as PCOS is a diagnosis of exclusion without 
specific tests to make a definitive diagnosis. Additionally, in contrast to other PCOS 
diagnostic criteria that are applicable to the adult population, routine use of 
ultrasonography to identify polycystic ovarian morphology is discouraged in the PES 
adolescent specific guidelines. The survey presented laboratory test options that are 
recommended in adolescent-specific guidelines to document biochemical 
hyperandrogenism (free and total testosterone) and to rule out other conditions that can 
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also be associated with the clinical manifestations of PCOS. Providers were able to select 
all that applied. Eight respondents stated that they did not carry out evaluations for PCOS 
in their practice. All responses are shown in Figure 8 Diagnostic Tests Selected, which 
indicates the percentage of respondents that utilize each laboratory test or procedure.  
Figure 8  
Diagnostic Tests Selected 
      
 Finally, providers were asked if they made the diagnosis of PCOS within two 
years of menarche. Adolescent specific diagnostic criteria recommend that the diagnosis 
of PCOS not be made within two years of menarche as irregular menses (necessary for 
the diagnosis of PCOS) can be a normal part of pubertal development. Nine providers did 
not answer this question, 22 providers stated that they did not diagnosis adolescent 
























adolescent patients with PCOS within two year of menarche, and 6 stated that they did 
not make the diagnosis of PCOS.  
A sum score for behavior in diagnosing PCOS (diagnostic practice score) was 
calculated to identify providers who have high vs. low engagement in carrying out 
adequate diagnostic evaluations as per PES endorsed adolescent-specific diagnostic 
guidelines. Analysis focused on nine specific behaviors that are outlined in the PES 
guidelines as key for diagnostic evaluations. Key behaviors to diagnose PCOS are listed 
in Table 10 Key Behaviors to Diagnose PCOS. In the survey instrument, participants 
selected all behaviors that they engaged in with 1=Yes and 0=No. Sum of the 
dichotomous data for each behavior resulted in a score, labelled as diagnostic practice 
score, for each participant. Since no provider stated that they never inquire about 
menstrual irregularities, score ranged from 1-9. A summary of the distribution of the 
practice score is represented in Figure 9 Diagnostic Practice Scores and Table 11 
Distribution of Practice Scores. 
Table 10  
Key Behaviors to Diagnose PCOS 
Clinical evaluation 
1. Evaluation of menstrual irregularity (inquiry about menstrual irregularities at any visit). 
2. Irregular periods must be persistent two years after menarche prior to making a 












Abbreviations: Thyroid Stimulating Hormone (TSH); 17 Hydroxy-Progesterone (17-
OHP); Dehydroepiandrosterone Sulfate (DHEAS); Follicle Stimulating Hormone (FSH); 
Luteinzing Hormone (LH). 
 
Figure 9  
Diagnostic Practice Scores 
 
Table 11  
Distribution of Practice Scores 
N Mean Median SD Min Max Variance Skewness 
44 5.55 6.00 2.74 1 9 7.51 -.421 
 
 With a median of 6, score of 6 and above was the range set of what is considered 
to be a high practice score, reflecting optimal participation in behaviors to evaluate a 
patient for a diagnosis of PCOS. Twenty-six out of forty-four participants (59.1%) had a 






























practice score between 1-5 (labelled as low practice score). Eight of the forty-four 
participants (18.2%) had a maximum score of 9. Despite optimal practice scores, 2/8 
respondents with high diagnostic practice scores reported that they do not make the 
diagnosis of PCOS.  
Behavior: Management of PCOS in Adolescents 
 Management of PCOS includes treatment and screening for complications of 
PCOS. 
Treatment  
Providers were first asked if they engaged in treatment of PCOS. Twenty-nine out of 
forty-four providers (65.9%) indicated that they treat PCOS and 15/44 (34.1%) indicated 
that they do not engage in the treatment of PCOS. Figure 10 Provider Identified 
Treatment Goals, represents treatment goals from the provider perspective, and Figure 11 
Provider Treatment Selection, depicts provider selection of treatment. Most providers 
(≥50%) noted that normalizing BMI, regulating menses and improving markers of 
cardiometabolic health were treatment goals in addressing PCOS in adolescents. Sixty-
six percent of providers recommend lifestyle modifications as a mainstay of 
treatment/management of PCOS; and 50% or more are prescribing hormonal 
contraception and/or metformin. Most of the providers (23/44, 52.3%) stated that they 







Figure 10  







































Figure 11  
Provider Treatment Selection 
 
 
Screening for Complications  
 Screening for complications of PCOS is an important component of the 
management of PCOS. PCOS is associated with long-term complications to include 
obesity, insulin resistance, T2DM, depression and anxiety. Thirty of the forty-four 
providers (68.2%) stated that they screen for complications of PCOS, while 14/44 
(31.8%) reported no screening. Figure 12 Screening for Complications of PCOS 
represents specific complications that providers indicated they carry out screening for as 
























all that apply. Data were not collected to inquiry about methods or frequency of screening 
(E.g. monthly versus annual screening).  
Figure 12  
Screening for Complications of PCOS 
  
  
All of the above complications are recommended for screening in adolescents 
with PCOS (Ibanez et al., 2017). A screening practice score, with one point given for 
each complication/condition screened for, was calculated to identify providers who have 
high vs. low engagement in carrying out recommend screening to use in further analyses. 
Thirteen of forty-four providers (29.5%) have a maximum score of 7, and 14/44 (31.8%) 
a minimum score of 0, which represents the 14 providers who stated that they did not 
























Practice Scores reports the mean and distribution of screening practice scores and Figure 
13 Screening Practice Scores the frequency of screening practice scores.  
Table 12  
Distribution of Screening Practice Scores  
n Mean Median SD Min Max Variance Skewness 
44 4.20 6.00 2.99 0 7 8.96 -.632 
 
Figure 13  
Screening Practice Scores 
 
 
 Table 13 Frequency Table Practice Behaviors summarizes all provider behaviors 



























Table 13  


























 n % n % n % n % n % n % 
Practice Focus 
  Pediatric 1 2.3 13 29.5 5 11.1 9 20.5 4 9.1 10 22.7 
 
  Family Medicine 17 38.6 13 29.5 10 22.7 20 45.5 10 22.7 20 45.5 
 
Practice Setting 
  Solo 2 4.5 0 0 1 2.3 1 2.3 1 2.3 1 2.3 
  Group 7 15.9 16 36.3 6 13.6 17 38.6 4 9.1 19 43.2 
  Academic Med 1 2.3 5 11.1 2 4.5 4 9.1 4 9.1 2 4.5 
  Public/Comm. 3 6.8 5 11.1 1 2.3 7 15.9 2 4.5 6 13.6 
  Urgent Care 5 11.1 0 0 5 11.1 0 0 5 11.1 0 0 
 
Practice Region 
  Urban 6 13.6 9 20.5 5 11.1 10 22.7 5 11.1 10 22.7 
  Suburban 10 22.7 8 18.2 6 13.6 12 27.3 6 13.6 12 27.3 
  Rural 1 2.3 7 15.9 2 4.5 6 13.6 1 2.3 7 15.9 
  Practice between 
more than one 
region 1 2.3 2 4.5 2 4.5 1 2.3 2 4.5 1 2.3 
 
Percent Uninsured or Medicaid Patients 
 
   ≤ 25% 8 44.4 10 38.5 7 46.7 11 37.9 4 28.6 14 46.7 
   26-50% 3 16.7 4 15.4 3 20 4 13.8 2 14.3 5 16.7 
   >50% 7 38.9 12 46.2 5 33.3 14 48.3 8 57.1 11 36.7 
 
Percent Patient Population Hispanic 
 
  <50% 15 88.2 22 88 12 85.7 25 89.3 11 78.6 26 92.9 
  ≥ 50% 2 11.8 3 12 2 14.3 3 10.7 3 21.4 2 7.1 
 
Percent Patient Population Black/African American 
 
  <50% 17 94.4 18 72 14 93.3 21 75 12 85.7 23 79.3 
  ≥ 50% 1 5.6 7 28 1 6.7 7 25 2 14.3 6 20.7 
 
% Adolescent Patients 
  <10% 9 52.9 6 23.1 4 28.6 11 37.9 3 23.1 12 40 
 11-25% 8 47.1 10 38.5 8 57.1 10 34.5 7 53.8 11 36.7 
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>25% 0 0 10 38.5 2 14.3 8 27.6 3 23.1 7 23.3 
 
Referral to Specialty Care 
 Providers who reported having patients with PCOS (n=44) were also asked about 
referral to specialty care for consultation in diagnosing or treating PCOS. Most (38/44, 
86.4%) reported referring for specialty care, including referral for multi-disciplinary care 
such as nutrition and behavioral health services. Specific specialty referrals include: 
endocrinologist (n=21), gynecologist (n=28), dietician/nutritional counseling (n=5), 
behavioral health specialists (n=4), adolescent medicine provider (n=4) and/or 
pediatrician (n=1). Providers who did not refer, indicated that they were “confident in 
their own ability to diagnose and treat most cases of PCOS” (n=6). None of the providers 
selected “lack of specialty resources in my community” as a reason for not referring.  
Knowledge Seeking Behaviors 
 Providers were also asked if they engaged in any professional activities, such as 
continuing medical education (CME), on the topic of PCOS within the past year, and if 
they are interested in learning more about PCOS in adolescents. Table 14 Continuing 
Education Activities, represents provider responses regarding continuing education 
activities. Frequency data is represented within the subgroups of those providers who 
reported having adolescent patients with a diagnosis of PCOS and those who do not have 
patients with a diagnosis of PCOS. There is one missing value under “desire to learn 
more about PCOS in adolescents” in the patients with PCOS subgroup. Activities that 
providers reported engaging in within the past year include: reading journal articles 
(n=4), online CME (n=4), and attending in-person lecture (n=3). Format for future 
activities that respondents stated they would prefer to participate in included: reading 
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journal articles, podcast, online CME/webinar, in-person conference lecture, and/or on-
site training/in-service activity.  
Table 14  









 Aim 1 Key Points  
• All participants (n=52) report inquiring about menses. However, when they 
inquire, at what type of visit, varies. 19.2% (n=10/52) of the providers stated that 
they inquire about menstrual irregularities at all encounters, regardless of the 
reason for the visit.  
• 84.6% (n=44 out of 52) of the providers in the sample (n=52) report having 
adolescent patients with a diagnosis of PCOS. 
• Of the subset of providers (n=44) with patients with a diagnosis of PCOS, 81.8% 
(n=36) reported carrying out some or all of the diagnostic evaluations for PCOS 





Patient with PCOS 
(n=44) 
No patients with 
PCOS (n=8) 
n % n % 
 
Participation in professional activity 
on topic of PCOS in  
the past year 
 
Yes 6 13.6 0 0 
No 38 86.4 8 100 
Desire to learn more about PCOS in 
adolescents 
 
Yes 34 77.3 8 100 
No 9 20.5 0 0 
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• Of the subset of providers (n=44) with patients with a diagnosis of PCOS, 29/44 
(66%) reported engaging in some form of treatment for PCOS.  
• Of the subset of providers (n=44) with patients with a diagnosis of PCOS, 30/44 
(68.2%) reported screening for some complications associated with PCOS such as 
T2DM.  
 
Research Question #2 
What factors, both modifiable and non-modifiable, influence practice behaviors of 
pediatric providers to address PCOS in a primary care setting? 
 Hypothesis: Practice behaviors among pedPCPs in the identification, diagnosis and 
management of PCOS are influenced by multiple factors to include knowledge, non-
modifiable practice characteristics such as geographical region, and attitudes/beliefs.  
 Sub-hypotheses include:  
• PedPCPs will report low knowledge of adolescent specific guidelines for the 
diagnosis and management of PCOS supported by the Pediatric Endocrine 
Society. 
• Investigation into differences between provider behaviors may reveal potential 
disparities in how PCOS is being addressed among different settings and 
geographical regions. 
 Further analysis of quantitative survey data explored potential associations of 
knowledge, practice characteristics, and provider attitude/beliefs with provider behaviors. 
Results are presented below in respective sections of:  provider knowledge, provider 




 Specific knowledge explored in this study related to knowledge of pediatric-
specific diagnosis criteria. This knowledge is vital to identify and diagnosis PCOS in 
adolescents, and prevent missed or over-diagnosis. All providers in this study (n=52) 
were queried as to whether or not they are aware of diagnostic criteria for PCOS. If they 
responded yes, they were asked to select which criteria they are familiar with. Table 15 
Knowledge of Diagnostic Criteria notes number and percentages of providers who report 
knowledge of any diagnostic criteria and PES adolescent-specific criteria compared 
between groups of providers who have patients with PCOS and those who do not. Figure 
15 Knowledge of Diagnostic Criteria, represents the specific diagnostic criteria that 
providers indicated familiarity. 
Table 15  
Knowledge of Diagnostic Criteria 


















Are you aware of diagnostic criteria 
for PCOS? 
Patient with PCOS 
(n=44) 
No patients with 
PCOS (n=8) 
n % n % 
Yes 31 70.5 2 25 
No 13 29.5 6 75 
Familiar with PES criteria? 
    
Yes 8 18.2 0 0 
No 36 81.8 8 100 
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Figure 14  
Knowledge of Diagnostic Criteria 
 
*Other criteria included the following write-in responses: “combination of all stated (n=1)”, and 
“I don’t know them by name.” (n=1) 
 
 Further analysis of the subgroup of 44 providers who have patients with PCOS 
was carried out to test if knowledge is a factor that influences behavior. First, an 
independent sample t-test was performed to compare the means of diagnosis practice 
score (range1-9) between providers who indicated knowledge of any PCOS diagnostic 
criteria versus those who indicated no knowledge of any PCOS diagnostic criteria. The 
group with knowledge of any PCOS criteria (31/44) had a mean diagnostic practice score 
of 5.94 (SD= 2.61). By comparison, the no knowledge group (13/44) had a mean 
diagnostic score of 4.62 (SD= 2.93). For the t-test, assumption of homogeneity of 
variance was tested and satisfied via Levine’s F test, F(42) = .880, p= .354. The 






















= 1.478, p=.147. Diagnostic practice scores were not different between providers with or 
without knowledge of any diagnostic criteria.  
 Second, an independent sample t-test was performed to compare the means of 
diagnostic practice score (range 1-9) between providers who indicated knowledge of PES 
endorsed adolescent-specific diagnostic criteria for PCOS versus those who indicated no 
knowledge of PES endorsed diagnostic criteria. The group with knowledge of PES 
criteria (8/44) had a diagnostic practice score M= 5.88 (SD= 3.36). By comparison, the 
no knowledge group (n=36) had a diagnostic score M=5.47 (SD= 2.64). For the t-test, 
assumption of homogeneity of variance was tested and satisfied via Levine’s F test, F(42) 
= .58, p= .449. The independent sample t-test did not demonstrate a statistically 
significant effect, t (42) = .37, p=.712. Thus, knowledge of PES endorsed adolescent-
specific diagnostic criteria was not associated with a difference in practice behaviors 
related to diagnosis of PCOS.  
 Statistical analysis was not performed to measure differences in whether or not a 
provider treated PCOS or screening scores based on knowledge of adolescent-specific 
PCOS diagnostic guidelines. This is because the question in the survey was specifically 
inquired about guidelines as it related to diagnosis and not management.   
Practice Characteristics 
 Descriptive statistics were used to describe practice behaviors across variables of 
practice characteristics for the subset of providers (n=44) who report having patients with 
a diagnosis of PCOS. Frequency data for behaviors related to the diagnosis and 
management of PCOS is reported in Table 13 Frequency Table Practice Behavior. Next, 
analysis of variance (ANOVA) was performed to explore the relationship between 
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practice characteristics and practice behaviors. Specific provider characteristics 
considered as independent variables included: pediatric versus family medicine focus, 
practice setting, practice region, percent of adolescent patients in practice population, 
percent of adolescent patients who are uninsured or public/Medicaid insured, percent of 
adolescent in patients who are Hispanic, and percent of adolescent in patients who are 
Black/African American.  
Analysis of Diagnostic Behaviors  
 ANOVA was performed to compare diagnostic practice scores (continuous data) 
to variables for the aforementioned practice characteristics (categorical data with two or 
more levels). Statistically significant difference in the mean for diagnostic practice scores 
was identified for characteristics of practice focus, practice setting, percentage of 
adolescents in practice, and percentage of adolescent patient population identified as 
Black/African American. Table 16 Analysis of Variance for Diagnostic Practice Score 
and Practice Characteristics, displays the results for the findings in the analysis, and 
Table 17 ANOVA Post Hoc Tests. Post hoc tests were not performed for less than three 










Table 16  
Analysis of Variance for Diagnostic Practice Score and Practice Characteristics 
Characteristic  n 
Mean  





































(3.26-7.24) 2.375 .840 
Urgent care 5 
 
1.20 







































































<25% 18 5.33 
(4.05-6.62) 






















(4.79-6.62) 2.747 .452 F(1,40) 
.292 .592 
≥ 50% 5 
 
5.00 





















* Homogeneity of variance was violated for analysis; results based on Welch ANOVA. Results of 
Games-Howell Post hoc test in Table 17. SD=Standard Deviation; SE=Standard Error 
 
Table 17  
ANOVA Post Hoc Tests 
  Mean 
difference SE Sig 95% CI 
Practice 
Setting      
 
Urgent Care* Solo -3.30 .539 .146 -10.78-4.18 
 Group -5.191 .572 .000 -6.87- -3.51 
 Academic -5.467 .742 .002 -8.29- -2.64 
 Public 
Health/Comm. -4.050 .863 .011 -7.05- -1.05 
      
% population 
adolescent*      











* Homogeneity of variance was violated for analysis; results based on Welch ANOVA and 




 Comparison of means of diagnostic practice score between areas of practice focus 
(pediatric vs. family medicine) demonstrated statistical difference. F(1,42)=12.228, 
p=.001. Pediatric focused practice had a statistically significant higher mean value for 
diagnostic practice score (M=7.43, SD=1.828) compared to family medicine focused 
practice (M=4.67, SD=2.670).  
 Comparison of means of diagnostic practice score between practice settings 
demonstrated statistical difference in the urgent care setting. F(4,6.9)=30.151, p<.001. 
Homogeneity of variance was violated with this analysis; therefore, results are based on 
Welch ANOVA. Post hoc testing with Games-Howell analysis revealed that urgent care 
settings had a statistically significant lower mean value for diagnostic practice score 
(M=1.20, SD=.447) compared to public/community health center (M=5.25, SD=2.375), 
group practice (M=6.39, SD=2.572) and academic medical center affiliated clinic 
(M=6.67, SD=1.751). There was not a significant difference between urgent care and solo 
practice (M=4.50, SD=.707). 
 There was a significant difference in diagnostic practice scores among the three 
groups representing different percentage of adolescent patients in the practice population, 
F(2,26.2) = 19.484, p<.001. Homogeneity of variance was violated with this analysis; 
therefore, results are based on Welch ANOVA. Post hoc testing with Games-Howell 
analysis revealed difference between providers reporting adolescent patients as <10% 
(M=4.60, SD=2.38) and 11-25% (M=5.0, SD=2.72) having lower diagnostic practice 
scores than providers reporting adolescent patients as >25% (M=8.30, SD=1.06).  
 Comparison of means of diagnostic practice score between percent of 
Black/African American patients in population (< 50% vs. ≥ 50%) demonstrated 
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statistical difference. F(1,41)=4.882, p=.033. Providers who reported that Black/African 
Americans made-up ≥ 50% of their adolescent patient population had a statistically 
significant higher mean value for diagnostic practice score (M=7.38, SD=2.20) compared 
to providers who reported < 50% of their patient population were Black/African 
American (M=5.09, SD=2.73).  
Analysis of Treatment Behaviors  
 Analysis to determine if there was an association between practice characteristics 
and behaviors was not conducted given limitations in the small sample size and the fact 
that treatment was only measured as a dichotomous value (1 = treats PCOS, 0 = does not 
treat). ANOVA was not an appropriate test for comparing treatment behavior among 
groups, as treatment behaviors were only measured as dichotomous data that was unable 
to be converted into a continuous value to measure mean differences. Chi square analysis 
was proposed in original data analysis; however, the small population size violates the 
rule that no more than 20% of the cells can have an expected value <5. Fisher’s Exact test 
is not appropriate as an alternative due to multiple levels within the factor variables 
representing practice characteristics.  
Analysis of Behaviors to Screen for Complications of PCOS   
 ANOVA was performed to compare screening practice scores (continuous data) 
to practice characteristics (categorical data with two or more levels) list in Table 13 
Frequency Table Practice Behavior. No statistically significant differences were found in 
screening practice scores across the key practice characteristics included in the analyses: 
pediatric vs. family medicine focus, practice setting, practice region, percent patient 
population uninsured or Medicaid, percent patient population Hispanic, percent patient 
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population Black/African American, and percent patient population made up of 
adolescents.  
Provider Attitudes and Beliefs 
 A psychometric scale, Table 5 Provider Attitude and Beliefs Scale, in Chapter 3 
Methods, was developed to capture provider’s attitudes and beliefs about PCOS in 
adolescents. The scale contains 16 items and respondents were asked to rate their level of 
agreement with each item based on a 5-point Likert Scale. Item development was guided 
by the conceptual framework for this research, which includes the Theory of Planned 
Behavior (TPB) and Health Beliefs Model (HBM). Items were grouped to corresponded 
with specific constructs of the framework: Threat Perception, Behavior Evaluation, Cues 
to Action, Subjective Norms and Intention to Change Behavior. 
Inventory of items for attitudes and beliefs was first evaluated with Cronbach’s 
alpha reliability estimate to determine internal consistency of the overall scale of 16 
items. The attitudes and belief scale was presented to all participants in the survey, n=52. 
Four items had one missing value, for a total of four missing value across the entire scale, 
resulting in 99.5% of the data valid for this analysis. One reverse code variable was 
created for item #14: PCOS is mostly diagnosed and managed by specialists to align with 
positively keyed items related to primary care providers addressing PCOS. Cronbach 
alpha of the entire 16 item scale was .795. Internal consistency is a reflection of the 
correlation among the 16 items. Cronbach alpha index ranges from 0.00-1.00. Values 
approaching 0.9 are considered high, with ideal values between 0.7-0.9 (Portney & 
Watkins, 2015). A moderate correlation within this range is supported by the notion that 
if a correlation is too high, the items are likely redundant (Portney & Watkins, 2015). 
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Table 18 presents the Psychometrics Properties for the Attitude and Belief Scale and 
Subscales. Table 19 Attitude and Belief Scale Analysis, presents the average score for 
each item and highlights items with the highest and lowest mean item score. 
 
 114 
Table 18  
Psychometric Properties for Attitude and Beliefs Scale and Subscale (n=52) 
Scale Mean item score SD Range 
Cronbach’s 
alpha 
     Attitude and Beliefs 3.74 .45 2.88-4.75 .795 
Subscales     
     Threat Perception 4.23 .52 3-5 .771 
     Behavior Evaluation 3.64 .72 2.17-5 .792 
     Cues to Action 3.88 .65 2.5-5 .031 
     Subjective Norms 2.72 .88 1-4.5 .553 




Table 19  
Attitude and Belief Scale Analysis (n=52) 
Item Range Mean SD 
Threat Perception    
  








PCOS is an important condition to identify among adolescent patients. 
 
3-5 4.45 .577 
 PCOS is associated with significant health complications for 
adolescents.  
 
3-5 4.29+ .667 
PCOS is associated with mental health complications of anxiety and 
depression in adolescents. 
 
3-5 4.08+ .763 
Behavior Evaluation    
 








Practice guidelines for the diagnosis and management of PCOS are 
supported by evidence based medicine. 
 
2-5 4.06 .669 
I have the ability to accurately diagnosis PCOS in adolescents. 
 
1-5 3.31 1.076 
I have the ability to effectively manage PCOS in adolescents. 
 
1-5 3.06^ 1.139 
I have the support needed in my practice to diagnosis and manage 
PCOS in adolescents. 
 
1-5 3.33 1.178 
I have the specialty support needed in my community to diagnosis and 
manage PCOS in adolescents.  
 
1-5 3.75 1.082 
Cues to Action    
 








Resources are available to learn more about the diagnosis and 








Subjective Norms    
 
My colleagues in primary care practice are actively involved in the 








PCOS is mostly diagnosed and managed by specialists. * 
 
1-5 2.54^ 1.019 




I would like to improve my practice behaviors in addressing PCOS 








I intend to change my practice behaviors in addressing PCOS among 
adolescents in my practice. 
 
1-5 3.79 .977 
+Three highest mean item scores 
^ Three lowest mean item scores 
*Item reverse coded 
 
 The independent t-test was used to compare total item scores for the entire scale 
and subscales within each category of practice behaviors for the subset of 44 participants 
who have patients with PCOS. Although all 52 respondents completed the survey, data 
for practice behaviors is only available for the 44 respondents who reported having 
patients with a diagnosis of PCOS in their practice. The specific behaviors (independent 
variables) for comparison of scale and subscale total mean scores (dependent variables) 














Table 20  

















Attitude and Belief scale sum score (16 items)  
Treat Perception subscale sum score (4 items) 
Behavior Evaluation subscale sum score (6 items) 
Subjective Norms subscale sum score (2 items) 





Yes No Attitude and Belief scale sum score (16 items)  
Treat Perception subscale sum score (4 items) 
Behavior Evaluation subscale sum score (6 items) 
Subjective Norms subscale sum score (2 items) 




Yes No Attitude and Belief scale sum score (16 items)  
Treat Perception subscale sum score (4 items) 
Behavior Evaluation subscale sum score (6 items) 
Subjective Norms subscale sum score (2 items) 
Intention to Change subscale sum score (2 items) 
 
 Identification as a behavior was not considered as a separate independent variable, 
as the indicator used for identification, inquiry about menstrual regularity, is one of the 
components of the diagnostic evaluation included in diagnostic behavior measurements. 
Cues to action subscale was not included as dependent variables for this analysis due to 
the low Cronbach alpha score (.031), indicating poor internal consistency as a subscale 
(UCLA, 2020). 
 See Tables 21-23 for results. Each test below met the assumption for equal 





Table 21  
Comparison of Attitudes/Beliefs Scale/Subscale Scores with Diagnostic Behaviors 










Scale  M SD M SD t statistic p value 
 






















































































Table 22  
Comparison of Attitudes/Beliefs Scale/Subscale Scores With Treatment Behaviors 























































































Table 23  
Comparison of Attitudes/Beliefs Scale/Subscale Scores With Screening Behaviors 





















































































 Higher scores for Behavior Evaluation subscale, is the only attitude/belief 
measure that demonstrated a statistically significant difference in total mean score for 
behaviors related to the diagnosis of PCOS. Higher scores for the entire attitude belief 
scale, behavior evaluation subscale and subjective norms subscale demonstrated a 
statistically significant difference in total mean score with positive (yes vs. no) provider 
engagement in treating PCOS in adolescents.  
Aim 2 Key Points 
• 15.4% (8/52) respondents indicate knowledge of the adolescent-specific 
guidelines for the diagnosis and management of PCOS in adolescents endorsed by 
the Pediatric Endocrine Society.  
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• Providers who practice in a pediatric focused practice have statistically significant 
higher diagnostic practice score for addressing PCOS in adolescents.  
• Providers from urgent care settings demonstrated statistically significant lower 
diagnostic practice behaviors compared providers from other practice settings.  
• Providers who reported that adolescents make up >25% of their patient population 
demonstrate statistically significant higher diagnostic practice behaviors 
compared to other practices with <25% of adolescents in their patient population.  
• Providers who reported that Black/African American patients make up ≥ 50% of 
the adolescent patients in their practice had statistically significant higher 
diagnostic practice behaviors compared to other providers with <50% Black/ 
African American adolescent patient population.  
• There are no significant differences between clinics that have high versus low 
uninsured or public/Medicaid insured patient populations in diagnostic or 
screening behaviors to address PCOS in adolescent patients. 
• There are no significant differences between clinics that have high versus low 
Hispanic populations in diagnostic or screening behaviors to address PCOS in 
adolescent patients. 
• PedPCPs with high diagnostic practice scores reported higher mean scores for the 
Behavior Evaluation subscale. 
• PedPCPs who treat adolescent patients with PCOS reported higher mean scores 







Research Question #3 
How do pediatric primary care providers experience barriers and facilitators in the 
identification, diagnosis and management of PCOS among adolescents, and how can they 
be addressed in order to optimize care?  
 
Participant Characteristics  
Twenty-seven pediatric primary care providers (pedPCPs) who completed the 
quantitative survey expressed interest in participating in follow up individual semi-
structured interviews. All 27 participants were contacted via email to schedule a 30-
minute interview via phone or via secure Zoom video conferencing. Twenty participants 
responded, scheduled and completed an interview; 2 indicated via email that they were no 
longer available for an interview; 5 did not respond to three requests sent via email over a 
three-month period. Most of the interview participants were PAs (n=14); 2 were 
physicians (MDs) and 4 were NPs from pediatric or family medicine focused practices in 
a variety of settings. Table 24 Provider Demographics and Practice Characteristics of 
Interview Participants, displays provider demographics and practice characteristics for 




Table 24  
Provider Demographics and Provider Characteristics of Interview Participants (n=20) 
 
Variable # % Variable # % 
Provider type  Years in practice  
MD 2 10    1- 10 years 14 70 
PA 14 70   11-20 years 5 25 
NP 4  20   > 20 years 1 5 
    
Provider gender  Practice location  
Female 17 85    District of Columbia 4 20 
Male 3 15    Maryland 6 30 
     Virginia 10 50 
Age    
20-29 years 5 25 Practice practice region  
30-39 years 9 45 Urban 5 25 
40-49 years 3 15 Suburban 8 40 
50-59 years 3 15 Rural 4 20 
  Divided between more than one 3 15 
Ethnicity    
Not Hispanic 
 
19 95   
Prefer not to answer 
 
1 5 Percent of adolescents in patient 
population 
 
Race   <10% 4 20 
Black 3 15 11-25% 10 50 
White 12 60 26-50% 5 25 
Asian 1  5 >75% 1 5 
Two or more races 5 25   
  Percent uninsured/public insurance   
Practice focus     ≤25% 7 35 
Pediatric 7 35    26-50% 5 25 
Family Medicine 13 65    >50% 8 40 






Participant Behaviors and Attitudes/Beliefs 
 In the survey, seventeen of the twenty participants reported having patients with a 
diagnosis of PCOS. Data related to their current behaviors in addressing PCOS is 
provided in Table 25 Interview Participant Knowledge and Behaviors. Mean item score 
for all twenty interview participants’ responses to attitude/belief scale and subscales for 
threat perception, behavior evaluation, and intention to change are displayed in Table 26 
Interview Participants Attitude and Beliefs. These scores are similar to the overall sample 
(Table 18 Psychometric Properties for Attitude and Beliefs Scale and Subscale (n=52)), 
where mean items scores for the entire scale, threat perception subscale, behavior 




Table 25  
Interview Participant Knowledge and Behaviors  
 
Knowledge or Behavior # 
Have adolescent patients with diagnosis of 
PCOS (n=20) 
 
    Yes 17 
    No 3 
  
Awareness of PCOS diagnostic guidelines 
(n=20) 
 
   Awareness of any diagnostic criteria 
         Yes              




   Awareness of PES guidelines  
         Yes 
          No 
5 
15 
Diagnostic Practice Scores (n=17)  
High (≥6) 9 
Low (<6) 8 
  
Providers who treat PCOS (n=17)  
    Yes 11 
    No 6 
  
Screen for complications of PCOS (n=17)  
     Yes 12 
     No 5 










Table 26  
Interview Participants Attitude and Beliefs 
 
 Mean SD Min Max 
 Mean item score for attitude and belief scale 3.75 .48 3.13 4.75 
 Mean item score for threat perception subscale       4.31 .52 3.50 5.00 
 Mean item score for behavior evaluation subscale 3.52 .83 2.17 5.00 




Seven interviews were completed via Zoom and 13 via phone. Average interview 
length for all participants was 21.8 minutes, with a range of 11.6 minutes to 33.7 minutes. 
Interview length varied among providers who did not have patients with PCOS or did not 
engage in diagnosis or treatment, versus providers who had adolescent patients with 
PCOS and were actively engaged in diagnosis and/or treatment. Participants who 
reported that they do not have patients with a diagnosis of PCOS (n=3) or do not engage 
in any behaviors to diagnose or treat PCOS (n=3) had shorter mean interview duration of 
16.3 minutes (range= 11.6-21.7) as compared to a mean interview duration of 24.1 
minutes (range =13-33.7) among 14 participants who reported engagement in diagnosis 
or treatment of PCOS.  
Thematic Analysis 
 Three overarching themes emerged related to barriers and facilitators in the 
identification, diagnosis and management of PCOS among adolescents. The themes 
connect seven categories of descriptive codes for barriers, facilitators and ways to address 
barriers (Figure 15 Categories and Overarching Themes). Each theme is presented below 
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with supporting evidence from applicable categories and codes. Qualitative data 
informing “ways to address” identified barriers is discussed as it relates to each theme. 
Appendix B. reflects all the categories and codes that informed three overarching themes 
and identifies them as barriers or facilitators.  
Figure 15  
Categories and Overarching Themes 
 
Theme #1 
Delay in identification and hesitancy to establish the diagnosis of PCOS in 
adolescents without specialty input. Establishing a diagnosis of PCOS requires both 
recognition of clinical manifestations of PCOS and knowledge of appropriate diagnostic 
laboratory evaluations. All participants discussed an understanding of the clinical signs of 

























practice. Many pedPCPs discussed ordering laboratory evaluations for diagnosing PCOS 
once clinical manifestations have been identified; however, most rely on specialists to 
establish the diagnosis. Reliance on specialists requires patient referrals, which may delay 
diagnosis if there is limited access to specialty care within respective practice 
communities. Code categories related to theme #1 include: Establishing the diagnosis, 
Access to Specialty Care, and Ways to Address. 
Establishing the Diagnosis 
Participants discussed barriers and facilitators to establishing a diagnosis. Barriers 
include delay in identifying clinical manifestations of PCOS, confusion about diagnostic 
guidelines, concern with missing other endocrine disorder, and concern of threat to 
adolescent well-being by labelling them with a diagnosis of PCOS.  
Delay in Identification. PedPCPs identified the following barriers that result in a 
delay in identification: under recognition of clinical manifestations of PCOS, normalizing 
irregular menses, or symptoms are masked by other medications, such as contraception 
use.   
“I think it’s very under-recognized. I feel like that people don’t really put  that 
 high on the differential if people are coming in with these complaints, maybe 
 overweight, maybe depressed, maybe irregular cycles, that kind of thing, people 
 don’t put that at the top of their differential typically.” (ID32, NP, family, S) 
 
“As providers we’re not always the best at asking about last menstrual cycle 
 when people come in for acute things or it could be something like… I always tell 
 my staff ‘that’s a vital sign too you know.’“(ID19, PA, family, S) 
 
“Would definitely say I’m sure we don’t really do that enough [to diagnosis 
 PCOS]. And part of it if we don’t ask and they don’t want to bring up the periods 
 or their vague or we just think it’s just your period being abnormal because 
 you’re a teenager then it probably doesn’t get addressed quite as often as  it 
 should because obviously some of them have PCOS and we probably don’t 




“…I think there’s kind of like a delay in workups sometimes. I wish we looked  
 earlier  for, or tested more people I guess I would say because I feel like once 
 you see like someone comes in with hirsutism and they’re having menstrual 
 irregularities and they’re over weight that becomes oh maybe it’s this and we can 
 work it up. But when you have that patient who’s just a little bit overweight and 
 they’ve got some acne and their menstrual periods are regular but they’re already 
 on birth control or they have Nexplanon and they just think it’s that. I do think 
 that we could test for it more  because I do think it is more common then.” (ID29, 
 PA, family, R) 
  
“I think we normalize an irregular menstrual period or we normalize a little 
 bit of overweight when they’re still young; eleven, twelve, thirteen but then 
 by the time they’re sixteen and it’s more of a significant issue it’s already fostered 
 itself for a while so making it a part of that regular conversation that we have 
 with kids a little earlier.” ID25, PA, peds, R)  
 
Confusion with Diagnostic Guidelines. PedPCPs reported confusion with 
diagnostic guidelines and/or lack of confidence with their knowledge of the appropriate 
diagnostic evaluations.  
“I do think every physician will probably tell you like a different lab  
 workup that they do initially and would definitely be like I have to look that up. 
 Every time, I get confused; I’m not sure which one.” (ID69, MD, pediatrics, 
 urban) 
 
“I think it’s kind of difficult, and this could just be myself that I haven’t really 
 found the best resources, adolescents versus adults I think it’s kind of hard 
 to find distinguishing  factors to do that.” (ID29, PA, family med, rural) 
 
Concern with Missing Other Endocrine Disorders. Some providers also 
expressed concerns with misdiagnosis or overlooking other similar conditions. PCOS is a 
diagnosis of exclusion and requires ruling out other disorders. PedPCPs indicated a 
preference to obtain specialty input to ensure that they do not miss another diagnosis as 
the underlying cause for a patient’s symptoms.  
“I think anything with endocrinology feels a little bit like oh we’re already 
 getting into something a little scary or a little like nebulous and a little confusing 
 I think that part of it is not wanting to miss other things that can mimic PCOS and 
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 just not having that kind comfort and so feeling like they should see a specialist 
 whether it’s adolescent or endocrinology first. I think that feels like a barrier.” 
 (ID69, MD, pediatrics, urban) 
 
Harms of Labeling. Many pedPCPs expressed concern about the consequences 
of a diagnosis of PCOS on adolescent well-being.  
“So, I kind of have mixed feelings about it. I think from an overall health   
 aspect it’s really important but I also think that the diagnosis comes with a  
 psychological  component that I worry that my adolescent patients don’t   
 handle  as well as if they were older so I think that’s always a tough   
 conversation.” (ID29, PA, family, R) 
 
“…from a mental health standpoint of placing this in their mind that there  
 can be  something wrong when it may not be an actual diagnosis”. (ID31) 
 
Most interview participants discussed utilizing point of care tools, such as 
UpToDate, to obtain guidance for carrying out diagnostic evaluation for PCOS. Point of 
care resources serve as facilitators to carry out diagnostic evaluations for providers who 
may have limited experience with or uncertainties about appropriate laboratory tests.  
Point of Care Resources. 
“So I really I go to UpToDate which has the guidelines from I think it’s   
 the adolescent  health, no maybe it’s the endocrinology guidelines.” (ID69,  
 MD, pediatrics, urban) 
 
“So typically I’ll get, and usually I have to, because I don’t do this I would  
 say it’s not something that I’ve seen every single day usually I do have to   
 look at UpToDate.” (ID47, MD, pediatrics, suburban) 
 
Access to Specialty Care 
 Reliance on expert guidance during the diagnostic evaluation for PCOS can delay 
or support pedPCPs in establishing a diagnosis depending on access to specialty care in 
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their community. Factors that impact access to specialty care include: specialty provider 
shortages as a barrier and close proximity to specialty practices or larger health systems 
as a facilitator.  
Specialty Provider Shortages.  
“There are only 2 endocrine physicians in town. Takes 9-12 months for a   
 new patient appointment.” (ID15, PA, family medicine, suburban) 
 
“We don’t have Peds endo in the county so it’s within the health system   
 locally but they would have to drive for that out of county...” (ID16, PA,   
 family  medicine, suburban) 
 
Proximity to Specialists. 
“The big hospital systems are here and then we do have some outpatient   
 whether it be endocrinology or OBGYN, there’s a lot of private practices   
 too. And I feel like most of the practices are larger and so I think that they  
 [patients] are  able to get in easier than perhaps some other places.”   
 (ID50, PA, pediatrics, suburban and urban) 
 
“I think a lot of the doctors have affiliations with [large academic medical  
 center in urban area] and [a suburban clinic] so a lot of the physicians   
 will work amongst the two institutions so it becomes a lot more convenient  
 in terms of referrals for them [patients] to go there versus a lot of times   
 having to go to main campus.” (ID47, MD, pediatrics, suburban) 
  
Ways to Address 
Most pedPCPs discussed utilizing point of care resources, such as UpToDate, to 
guide diagnostic evaluations. Many pedPCPs identified a need for improving content of 
and access to point of care resources and/or establishing practice protocols to serve as a 
guide for diagnostic evaluation. Providing opportunities for provider education/training 
was also recognized for pedPCPs to gain a better understanding of adolescent-specific 
guidelines and distinguishing the diagnosis of PCOS in adolescents from adults. Table 28 
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Ways to Address provides qualitative data for applicable codes that align with providers’ 
suggestions for addressing barriers related to theme #1: Education and Training and Point 
of Care Protocols. 
 
Theme #2 
Divergent experiences managing adolescent PCOS in a primary care setting 
shaped by differences in provider interactions and practice structure and policies. 
Provider interactions with other providers, access to specialty care, and practice 
structure/organizational policies are key factors that impact whether a provider 
experiences barriers or facilitators in the management of adolescents with PCOS. Figure 
16 Divergent Experiences in the Management of PCOS highlights the specific barriers 
and facilitators that drive the divergent experiences of pedPCPs in managing PCOS 
among adolescents. Code categories related to theme #2 include: Provider Interaction, 












Figure 16  
Divergent Experiences in the Management of PCOS
 
 
Provider Interactions  
Collaboration and communication, internally between practice colleagues and 
externally with gynecologist, endocrinologists and other experts, become very important 
to manage PCOS in the adolescent patient. Many pedPCPs highlighted the importance of 
guidance from senior providers and/or collaboration with their peers to guide 
management. Some providers also highlighted established relationships between their 
primary care practice and specialty practices within their community that allowed for 
direct specialists to provider interaction. Table 27 Barriers and Facilitators to 
Management highlights some of the key data related to guidance from senior providers, 
collaboration with peers and collaboration with specialists.  






















Access to specialists influences whether or not pedPCPs rely on specialists to 
manage PCOS or if they have the opportunity for collaboration. Participants who 
reported a significant presence of specialists within their community are able to easily 
refer patients for management or obtain guidance with management recommendations. In 
contrast, some pedPCPs reported not only a shortage of specialists in their community, 
limiting the opportunity for referrals, but also specialists who may not be comfortable 
managing PCOS in adolescents. PedPCPs shared that specialists will send the patient 
back to the primary care clinic with little to no guidance for management.  
Additionally, many pedPCPs discussed limited options for multi-disciplinary 
management of PCOS. Lifestyle modifications is a mainstay of management and 
guidelines recommend a multi-disciplinary management approach. Very few pedPCPs in 
this research reported engagement of a multi-disciplinary team except for unique practice 
structures (to be discussed under Practice Structure and Policies) where support services 
for multi-disciplinary care are built into their practice setting. Most pedPCPs reported 
limiting factors to engage an inter-professional team, such as nutritionists and behavior 
health professionals, in the management of PCOS. Barriers included both shortage of 
nutrition or behavior health services and lack of health insurance coverage for nutrition 
counseling or behavior health care. Table 27 Barriers and Facilitators to Management 
highlights some of the key data related to specialty provider shortages, limited options for 
multidisciplinary care and proximity to specialty care. 
Practice Structure and Organizational Policies  
 Practice settings vary, and the concept of primary care has broad application 
beyond traditional pediatric or family practice settings. Structure and policies unique to 
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each practice may support or limit the opportunity for primary care providers to 
management adolescents with PCOS.  
First, patient exposure and types of patient visits can be a barrier or a facilitator to 
managing PCOS in adolescents. As adolescent health needs vary, some pedPCPs will 
have limited exposure as adolescents return for fewer well-child visits or more exposure 
if their primary care practice is more oriented to adolescent health. Some pedPCPs shared 
that they have a unique focus in their practice, such as primary care for teenage mothers, 
which would shift their focus from addressing conditions such as PCOS.  
Second, practice policies that frame provider roles and set standards for patient 
care can be restrictive to providers engaging in and building experience in managing 
PCOS in adolescents. For example, some pedPCPs report policies that do not allow PAs 
or NPs to have their own patient panel, thereby limiting their follow up to prescribe and 
manage interventions to address PCOS. Other providers reported a practice setting that is 
split between urgent care and primary care and practice policies determine when they can 
engage in long-term management versus having to refer.  
Lastly, some pedPCPs describe programs in their practice setting that increase 
primary care capacity to address PCOS. In this study, these were providers who practice 
in health care safety net programs such as health department clinics, Federally Qualified 
Health Centers (FQHCs) and Medicaid clinics. Despite being located in a low resource 
setting with limited access to specialty care and uninsured or underinsured patient 
populations, special programs, such as school based health clinics managed by an FQHC, 
are facilitators to managing PCOS among adolescents. Table 27 Barriers and Facilitators 
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to Management highlights some of the key data related to patient exposure, restrictive 
practice policies and health care safety net programs.  
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Table 27  
Barriers and Facilitators to Management 
 Barriers Facilitators  
 Specialty Provider Shortages 
“In my area, some of the GYN 
don’t like to manage PCOS 
they would rather that a 
primary care or an 
endocrinologist manage that. 
…they refer back to the 
primary”. (ID 19, PA,family,S) 
 
  “And then we also live quite a 
distance from specialty care so 
most of our pediatric specialty 
care can be, or some of it can 
be up to an hour’s drive. And 
then in those instances we try 
to keep those families in house. 
So we do have some other 
providers in our offices that 
are a little more comfortable 
and provide more GYN 
services it’s just sometimes 
we’ll lean on them internally to 
get some help for those 
families.” (ID25, PA, peds, R) 
 
Limited Options for 
Multidisciplinary Care 
“It is 3-6 months for a mental 
health appointment in the 
community. I have never 
considered a mental health 
appointment for PCOS. I would 
like to use nutrition services, 
but those are not easy to 
access. There is only one 
nutritionist at the hospital, 
other than private pay nutrition 
services”. (ID15, PA, family,S) 
 
“I do not generally refer to 
nutritionists or dietitians; I 
Guidance from Senior 
Providers 
“…there’s one of the other 
physicians that I work with, 
she does much more with 
women’s. So she had created 
a little flow chart of 
management.” (ID29, PA, 
family, R) 
 
“Yeah I think I learned a lot 
in my own, in the practice that 
I’m in because we have 
providers who have been 
there for thirty years and, you 
know, our program tends to 
stay on top of, you know, 
latest research and we try to 
implement or at least 
communicate what’s new, and 
so there’s always someone 
that you can bounce a case off 
of or discuss with.” (ID42, 
NP, pediatrics, U) 
 
Collaboration with Peers 
“…when I started, the other 
PA and I did not really know 
a lot about PCOS, but 
working together we kind of 
did a little of our own 
research and kind of bounced 
ideas off of each other and I 
think we got a little bit better 




“…because of us having 
pretty decent relationships 






















would like to, but, not just for 
PCOS, I find that a lot of 
patients aren’t able, you know, 
their insurance does not cover 
it”. (ID07,PA, family, R) 
manage a little bit more of 
our complex conditions at 
least to an extent. We manage 
a lot of conditions with either 
consultation by phone with 
the specialists or even just 
consultation with some of the 
providers here that have been 
working in the area since the 
eighties I believe is the 
earliest.” (ID50, PA, peds, 
R&U) 
 
 Proximity to Specialists 
“…we reach out to the local 
hospital systems, they both 
have endocrinology, so they 
can kind of take over things 
once we’ve done that initial 
evaluation.  Or in some cases 
they’ll say “hey do you mind 
starting an oral 
contraceptive?”  Or “I feel 
like this patient would benefit 
from metformin.” And we 
might do that and then hand 
off that from there.” (ID50, 








 Patient Exposure 
“I think we’re really focused 
on contraception with those 
teens [teen moms] it’s like a 
focus so a lot of them are on 
contraception so evaluating 
their menstrual cycles is a little 
bit difficult. So I don’t think it’s 
common to be thinking about 
or talking about PCOS”. 
(ID69, MD, peds, U) 
 
Restrictive Practice Policies 
“PAs and NPs do not have 
their own panel of patients. 
[This is]one of the reasons that 
I do not see a lot of adolescents 
and adolescents with PCOS. 
PAs and NPs will get moved 
around. Ideally I would have I 
follow up with patients who I 
have ordered a diagnostic work 
up for or started treatment. I 
feel that it [PCOS] is under 
diagnosed, due to limitations 
as above in both the practice 
setting I am in”. (ID15, PA, 
Fam, S) 
 
“The practice that I mainly 
work in is urgent care. 
Percentage wise overall the 
company does twenty-eight 
percent of primary care. And 
really [we] would be a first 
line to detect any potential 
diagnosis of a hormone 
imbalance and the potential for 
PCOS. But right now how our 
protocol is set up is if it’s a 
suspected PCOS we would do 
those three labs and then 
refer.” (ID31, PA, family, U) 
Patient Exposure 
“I think at our clinic we see a 
lot of teens and I think people 
are more comfortable dealing 
with teen adolescent issues 
but in general I know 
pediatricians tend to like, you 
know, the ones who like teens 
are doing adolescent health, 
and so, in general. There are 
a number of us who really do 
like working with adolescents 
and dealing with adolescent 
life issues”. (ID69, MD, peds, 
U) 
 
Healthcare Safety Net 
Programs 
“Fortunately we can follow 
our kids through our school 
based health center so we 
have that continuity care with 
them. I think that with a lot of 
our chronic conditions 
including just obesity in itself 
we have a much better way of 
managing it when we use our 
school based health centers 
within our own FQHC for our 
kids that we provide primary 
care to just because it is more 
individualized, it’s more one-
on-one. They have more 
access to providers than they 
would just a regular clinic”. 


























Ways to Address  
Many pedPCPs highlighted a need to have further collaboration and guidance 
from specialists in order to improve their comfort level and capacity to address PCOS 
among adolescents. This includes both establishing a partnership for collaboration and 
engaging experts to provide training for pedPCPs and clinical staff.  
Some pedPCPs shared that a change in practice policy is needed in order to 
change their practice situation in which policies restrict them from having patient follow 
up and continuity of care. Recognizing however that these changes may not be feasible, 
pedPCPs offered suggestions for other ways that practice organizations can provide 
support to increase their capacity to manage PCOS among adolescents. Specifically, 
providers made recommendation for improving follow up by flagging patients in the 
EMR. If the initial provider who saw the patient for PCOS is not able to follow up with 
that patient, at least a system to flag patients can alert another member of the clinic staff. 
Table 28 Ways to Address provides qualitative data for applicable codes that align with 
providers’ suggestions for addressing barriers related to theme #2: Improve Practice 
Support, Education/training and Collaboration with Specialists. 
Theme #3 
Behavior evaluation and parent/caregiver influence.  
PedPCP’s comfort with treatment options for PCOS and perception of benefit 
may serve as a barrier or facilitator in the management of PCOS. Additionally, pedPCPs 
discussed patient factors that they experience as either a barrier or facilitator to 
management. Code categories related to theme #3 include: Provider Behavior Evaluation, 
Provider Perception of Patient Factors, and Ways to Address.  
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Behavior Evaluation  
 Some providers reported limitations in their own comfort level with treatment 
options for POCS. Other providers reported confidence with prescribing various 
treatments and perception of benefit. 
 Provider Discomfort with Treatment Options. 
 
 “I’m not sure from a management perspective that a lot of providers are really 
 comfortable with the management of it. I think we’re comfortable with talking 
 about it, we’re comfortable with addressing it and pointing out features or things 
 that we notice  that may lead us to be suspicious. But I think once it becomes more 
 of a management of it  or we get close to a diagnosis then I think a lot of us feel 
 more comfortable to refer. I know it a be a lot easier if we could feel a little 
 more comfortable managing it ourselves.”(ID25, PA, peds, R) 
 
 “I think it is an area where pediatricians don’t feel that much comfort. I think it 
 would be great to feel more empowered to more easily diagnose and treat it”. 
 (ID69, MD, peds, U) 
 
 “And I think that’s more of a reluctance to prescribe medications off label in a 
 younger population if it’s not really implicated”. (ID16, PA, family, S) 
 
  
 Provider Confidence with Treatment. 
 
 “Oh, and the people actually do really well and the Metformin along with diet 
 changes just helps people control those cravings better. They have less fatigue 
 and brain fog and just to start feeling overall better.” (ID01, PA, family, S) 
 
 “But for a lot people their concern is this irregular menstrual cycle and so one 
 thing that’s easy to start with is just like this [contraception] will help make your 
 menses more regular and so they’re more predictable and so you’re kind of like, 
 people feel reassured  when they’re having a monthly menstrual cycle.” (ID69, 
 MD, peds, U) 
 
 “And then I would say just the response of patients or the concerns that they have 
 I think  is the biggest thing. I try to make sure that I’m addressing their concerns 
 and not just mine and so I try to listen to not only the teenagers but their parents 
 and brothers and sisters, relatives that are there for them. I try and listen to what 
 their concerns were, how they’d like to manage things differently.” (ID50, PA, 





Provider Perception of Patient Factors  
 Participants recognized patient factors that may be barriers or facilitators to 
addressing PCOS among adolescents. Adolescent health is unique as providers consider 
the balance of empowering adolescents to have control of their health and 
parent/caregiver influence.    
 Parent/Caregiver Influence. 
 
 “The disadvantage is parent involvement in this age group and the insertion of 
 their opinion on their child.” (ID15, PA, family, S) 
 
 “So I think there’s sometimes a hesitancy to talk about it because there really 
 isn’t a  solution or the family at least doesn’t see there is one.” (ID25, PA, peds 
 R) 
 
 “Yeah I would think, yeah, yeah, birth control first parents it’s a really hard thing 
 because they’re like ‘I don’t want my daughter to be promiscuous on birth 
 control. That’s not something we’re ready for at this time.”(ID19, PA, family, S) 
 
 “I think parents just really associate Metformin with saying my child has diabetes 
 so I find that they tend to be, or parents have personal experience of being on it.” 
 (ID47, MD, peds, S) 
 
 
PedPCPs recognize facilitators to addressing PCOS when an adolescent is 
motivated to address symptoms of PCOS. Providers shared that this is often when they 
experience undesirable characteristics of PCOS such as facial hair growth.  
 Patient Health Seeking Behavior.  
 
 “I’d say probably the biggest complaint that we have is girls who come in usually 
 with facial hair growth that they’re concerned about. But sometimes we also just 
 get late teens who girls, who have menstrual irregularities or amenorrhea and 
 then you have  more of a metabolic syndrome kind of picture but I would probably 
 say hirsutism is probably the biggest presenting symptom. Hirsutism is probably 
 the biggest thing that  prompts the lab work and so that’s something that I find 
 that girls are very self-conscious about and very much want to work up and get 




 “Most patients are willing to try it because again if they’re overweight,   
 maybe they have some other abnormal labs whether it’s cholesterol or   
 something like that that they are willing to try something to see if it makes   
 a difference in their, just how they feel energy wise. Or if the weight loss is  
 a goal that they have sometimes they’re willing to try that  just for that   
 possible weight loss that Metformin can have. And I always tell them that   
 my goal in seeing them is ‘if we can make you happy and healthy now   
 you’ll be happy and healthy later’ and so they tend to understand that   
 and are okay with putting in the work.” (ID50, PA, peds, S&U) 
 
 
Finally, pedPCPs discussed challenges in addressing complex topics surrounding 
PCOS with adolescent patients. As adolescent patients approach adulthood, pedPCPs 
recognize the need to counsel patients about long-term health risks associated with 
PCOS. However, pedPCPs discussed challenges in how to communicate these complex 
topics, and the need to tailor them for age-appropriate communication.  
 Addressing Complex Topics.  
 
 “Disadvantages are just the hard topics that we have to go through. The   
 weight  piece is always a struggle.” (ID25, PA, peds, R) 
 
 “Disadvantages is in how you do it [counsel patient] going back to the   
 fertility thing and the weight thing, you don’t want to freak them out for   
 lack of a proper term and or freak out the family. You don’t want it to   
 be something that they’re going to obsess about, oh  I’m not going to be   
 able to have a kid in ten years or I’m going to be obese in ten years.   
 Try not to give them, making sure they have a positive outlook, letting   
 them know that there are some risks or there can be some long-term   
 effects but that it’s not definitely going to happen.”(ID71, PA, family, S) 
 
 “I think that a lot of girls when you talk to them about it, the only thing   
 they know about it when they Google it really quick is that they’re    
 not going to be able to get pregnant someday, which is just not true at all   
 because we’ve got so many great management options for that and   
 many women with PCOS don’t even have a problem getting    
 pregnant. So I think that that is maybe one of the biggest downfalls of   
 information that is available to patients. And I don’t want twelve to   
 eighteen-year old girls worrying about that for in the future.” (ID01,   




 “I’ve also been finding anecdotally in a lot of the teenagers with irregular 
 periods with or without a diagnosis with PCOS seem to believe that they cannot 
 get pregnant now, like in the moment. And so this was a number of patients. I’m 
 not sure how they got that into their head and so I try and do some counseling 
 related to that and address the education and medication and physiologic kind of 
 needs of from PCOS.” (ID40, NP, peds, U) 
 
Ways to Address  
 PedPCPs identified a need for more education/training and increased patient visit 
duration. Recognizing that increasing provider time with patients may not be feasible, 
some providers suggested greater engagement of clinical staff to more effectively address 
PCOS in primary care practice. Clinical staff can help with identifying adolescents at risk 
for PCOS, ensuring follow up with diagnostic evaluations, helps with patient and 
parent/caregiver education and counseling in managing PCOS, and ensure follow up with 
referrals if specialty or multi-disciplinary consultation is requested.  
Finally, some pedPCPs recognized their own limitation in communication 
complex topics around PCOS with adolescents and their parents or caregivers. Providers 
suggested training that is specific to communicating complex and sensitive topics and 
resources that are appropriate for adolescents of different ages. Table 28 Ways to Address 
provides qualitative data for applicable codes that align with providers’ suggestions for 
addressing barriers related to theme #3: Improve Practice Support, Provider 




Table 28  
Ways to Address 
Code: Improve Practice Support 
 
     Subcode: Change in practice policies 
 
   “Change in practice culture and policy. It is never going to change.” (ID15), PA, FM, S   
 
“I think something to show[to practice leaderships] the benefits of it, why it’s [addressing 
PCOS in primary care setting] important just something that I could bring to the table when 
we have our provider meetings and stuff to say “you know hey we should probably look into 
managing this a little bit better when we see it,” that would be helpful.” (ID 73), PA, family, 
R&S 
 
     Subcode:  Increase Patient Visit Duration  
 
“In my ideal world I would have an hour time to talk to the teen and the parent about PCOS 
and be able to, you know, listen and educate and make sure they understood what they heard.” 
(ID42), NP, peds, U 
 
     Subcode: Engagement of Clinical Staff  
 
“…potentially having one of our providers or nurses or someone be a point person for that.  
Because I know we have point people for depression and suicidality and we have someone who 
really focuses on Autism screening and developmental delays. And so if we could have 
someone who almost kept us accountable for that I think that would be helpful.” (ID50), PA, 
peds, S&U 
 
     Subcode: Process for Patient Follow-up 
 
“One, I think that there could be a better way of flagging any patient at risk. So any time 
anything like acne or irregular period or obesity comes up that that would be some way to flag 




“I sort of would love to just have, have like an educational professional development session 
from an adolescent doctor or an endocrinologist of like this is what I do and make sure that it 
aligns with what I do or feel more empowered...”  (ID69), MD, peds, U 
 
 “I think some sort of training, yeah I think a training. And my supervising physician has also 
mentioned that if she could go through a training, like at Children’s or something that would 




Code: Point of Care Protocols 
 
“I think it would be nice to have just more just almost like an algorithm that people are 
following just more regularly in the community I think.” (ID47), MD, peds, S 
 
“It really is just implementing a more specific flow sheet.” (ID31), PA, family, U 
 
Code: Collaboration with Specialists 
 
“I guess what I would change [pause] is being a little bit quicker to treat and at the same time 
what I would love to do is just feel more confident and have, and that requires just some more 
knowledge and guidelines from the experts.” (ID69), MD, peds, U 
 
Code: Resources for Provider-Patient/Caregiver Communication 
 
“… just learning about how to have that conversation with them; even better in the young 
population.” (ID07), PA, family, R 
 
 
NP=Nurse Practitioner; MD= Medical Doctor; PA=Physician Assistant; peds=pediatric practice focus; 





 Main barriers to addressing PCOS among adolescents in a primary care setting are 
related to uncertainties in diagnosis, lack comfort with treatment options, and provider 
perception of challenges communicating complex topics to adolescent patients. Main 
facilitators include provider collaboration and specialty guidance. Interview participants 
identified five main actions or interventions that would address barriers and/or support 
facilitators already in place: Improve practice support; education or in-service training for 
providers and clinical staff; develop/improve point of care resources; develop a pathway 
for provider-specialist collaboration and communication; and develop provider training 
on communicating complex topics to adolescent patients with PCOS.   
All interview participants recognized the importance of addressing PCOS in the 
adolescent population, despite barriers or limitations that pedPCPs may experience in 
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their own practice. Additionally, some participants indicated their belief that pedPCPs are 
on the front-line for identification, diagnosis and management of PCOS.  
 
 “I think it’s really misdiagnosed, underdiagnosed and affects quality of life 
 dramatically. I think we can be more on the frontline instead of getting 
 specialists involved.” (ID31,  PA, family, U) 
 
 “I think it’s actually pretty critical that it’s addressed in adolescents only because 
 of the possible complications that can occur later on it. And that’s usually where 
 patients are picked up and addressed and by then sometimes it’s actually well 
 passed the time they needed to have an intervention and then you get into higher 
 costs and it just makes more sense to really address it in the adolescent age.” 
 (ID36, PA, family, U) 
 
 “Well I think that if those patients get missed they get set up for a lot of sequela 
 that might be very difficult to treat later on. And I think it’s important for these 
 kids to get diagnosed from a behavioral health standpoint because with all of 
 the things that are happening to their bodies, you know the excess hair 
 growth, the weight. Kids can be rather cruel so I think the faster we get to 
 diagnosis and treatment I think the better off they are.” (ID57, NP, family, 
 S&R) 
 
 “Well it’s a syndrome of a lot of things. So, first of all menstrual irregularities 
 can be  really difficult on an adolescent girl. If she’s let’s say not sure when she’s 
 going to get her menses or it’s very irregular, she doesn’t know that can just 
 psychologically take a toll on her. And then acne and hirsutism obviously  will 
 take a toll on how they feel about themselves and of course  obesity. And then with 
 obesity and metabolic syndrome everything else that comes along with that I think 
 this whole syndrome is important to address. And then of course the infertility, 
 in the future.” (ID54, PA, peds, S). 
 
 
Mixed Methods Results 
 
 Results from the qualitative study explain some key findings from the survey 
research in this sequential explanatory mixed-methods study design. The primary 
objective of this research was to identify practice behaviors of pedPCPs, and explain 
factors that influence pedPCP behaviors through the lens of a barriers to practice 
framework. Understanding how barriers and facilitators shape practice behaviors of 
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pedPCPs in this research, contributes knowledge to better understand the role of the 
pedPCP and target areas for future learning or behavior change interventions to optimize 
care of adolescents with PCOS. An overview of mixed-methods results is presented in 
Table 29 Mixed Methods Results. 
Table 29  
Mixed Methods Results 
Quantitative Results  
(Aims 1&2) 
 
Qualitative Results (Aim 3) 
 
 
Integration of Results  
 
 
All participants (n=52) reported 
inquiring about menstrual 
irregularities, but only 21.2% 
inquire at all encounters regardless 





PedPCPs discussed unrecognition of 
symptoms of PCOS. Inquiry about 
menses is not addressed at every visit. 
Concern that providers “normalize” 
irregular menses in adolescents. 
Qualitative codes: Under recognition 
of symptoms; treatment masking 
symptoms; normalizing symptoms. 
 
PedPCP are not regularly 
inquiring about menses. 
There may be knowledge 
gap in understanding 
when irregular menses is 
considered as part of the 
normal physiology of 
puberty versus when to 
consider abnormal. 
84.6% of the pedPCPs in the 
sample (n=52) report having 
adolescent patients with diagnosis 
of PCOS. Of the subset of 44 
providers, 81.8% (n=36) indicated 
that they carry out some or all 
diagnostic evaluations for PCOS in 
their adolescent patients. However, 
selection of diagnostic test varied 
and the most commonly selected 
tests did not align with key 
laboratory evaluation needed to 
diagnose PCOS and to rule out 




PedPCPs reported confusion about 
diagnostic guidelines, concern with 
missing other endocrine disorders and 
harms of labelling an adolescent with 
PCOS if they are uncertain about the 
diagnosis. Most rely on specialist to 
establish the diagnosis. Qualitative 
codes: Confusion about diagnostic 
guidelines, concern with missing 












Limited knowledge of 
adolescent-specific 
criteria is a potential 
barrier to diagnosis. 
Collaboration with and/or 
guidance from senior 
providers, peers and 
specialists help facilitate 
the diagnostic process 
even when there is lack of 
awareness of guidelines. 
PedPCPs also reference 
online point of care 
resources with the 
expectation that they 
include up to date 
evidence-based guidance. 
 
Few respondents (8 out 52; 15.4%) 
indicate knowledge of ICPE 2017 
internal consensus statement, 
supported by the Pediatric 
Endocrine Society (PES). There 
was no difference in diagnostic 
behavior scores between pedPCPs 
PedPCPs reported utilizing point of 
care resources, such as UpToDate 
inform practice. 
Qualitative codes: Point of Care 
Resources. 
 
Some providers also discussed 
receiving guidance from more 
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Quantitative Results  
(Aims 1&2) 
 
Qualitative Results (Aim 3) 
 
 
Integration of Results  
 
 
who do or do not have knowledge 
of PES guidelines. 
 
 
experienced providers in the practice, 
collaboration with peers, or 
collaboration with specialists who 
have an established relationship with 
the practice. Qualitative codes: 
Proximity to specialists, guidance 
from senior providers, peer 











Providers who practice in a 
pediatric focused practice have 
significantly higher diagnostic 
practice score for addressing PCOS 
in adolescents than providers with a 
family medicine focused practice. 
 
Providers who reported that 
adolescents make up >25% of their 
patient population demonstrate 
significantly higher diagnostic 
practice behaviors compared to 
other practices with <25% of 







These two findings from the 
quantitative research are likely 
related. Of the participants in the 
qualitative study, those who practiced 
in pediatric focused practice had a 
significant focus on adolescent 
patients versus a general pediatric 









Patient exposure to a 
higher population of 
adolescents likely impacts 
pedPCP experience in 
building knowledge and 
skill to address PCOS. 
Consider appropriate 
intervention approaches 
for practices that have 
less exposure to 
adolescent patients. 
Identify opportunities for 
case based learning that 
will have a greater impact 






PedPCPs in urgent care settings 
demonstrated significantly lower 
diagnostic practice behaviors 







PedPCPs in urgent care reported 
restrictive practice policies that do not 
allow them to carry out diagnosis or 
participate in the management of 
PCOS. Regardless of their knowledge 
or motivation to address PCOS, they 
are limited by their practice policies. 





Providers who practice in 
non-traditional settings 
should not be overlooked 
when implementing 




policies may be a 
significant barrier to 
behavior change. 
 
There were no significant 
differences in diagnostic or 
screening behaviors for pedPCPs 
who reported a higher percentage of 
Non-traditional practice settings of 
community/public health clinics 
highlighted unique structures and/or 







Quantitative Results  
(Aims 1&2) 
 
Qualitative Results (Aim 3) 
 
 
Integration of Results  
 
 
uninsured or Medicaid patients, or 
with a higher percentage of ethnic 
minority populations (Hispanic). 
However, pedPCPs who reported 
Black/African American population 
of ≥ 50%, had a significantly higher 
diagnostic practice score compared 
to pedPCPs with <50% 





expand capacity for addressing the 
complexity of PCOS in adolescents. 
For examples, community health 
clinics have partnerships between 
public health entities to ensure that 
uninsured and underinsured 
populations have access to multiple 
treatment options. Another example is 
school-based health clinic where 
having daily access to patients allows 
for continuity of care, especially 
when considering complex aspects of 
treatment such as counseling on 
lifestyle modifications. Qualitative 
codes: healthcare safety net programs, 
patient exposure. 
safety-net programs may 
explain why the 
quantitative data did not 
reveal evidence of 
potential disparities in 
how PCOS was addressed 
among low income 
populations or in minority 
groups. Further research 
should investigate care 
delivery models and 
team-based structure 
within safety-net 




The most common treatment 
selected by pedPCPs participants 
aligns with adolescent-specific 
guidelines that recommend life-
style modifications as the main stay 
of treatment, with the addition of 
hormonal contraception or 
metformin, depending on an 
individual patient’s clinical 
presentation (Ibanez et al., 2017). 
Only 34% of participants did not 






There was a divergent theme in the 
qualitative research regarding pedPCP 
comfort level and confidence in the 
treatment options to manage PCOS. 
For example, some pedPCPs report 
comfort with OCP to treat irregular 
menses, but are not comfort with 
metformin, while other report the 
opposite. Qualitative codes: provider 
discomfort with treatment, provider 






PedPCPs have varying 
comfort levels in treating 
PCOS. Results from this 
research demonstrates 
that pedPCPs have 
awareness of metabolic 
complications of PCOS, 
but may be less 
comfortable with utilizing 
medication such as 
metformin. Since PCOS 
is an endocrine disorder 




specific to addressing the 
metabolic complications 
of PCOS in adolescents. 
 
PedPCPs with high diagnostic 
practice scores and who treat 
PCOS, have higher mean scores for 
the behavior evaluation subscale. 
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Quantitative Results  
(Aims 1&2) 
 
Qualitative Results (Aim 3) 
 
 
Integration of Results  
 
 
Over half of pedPCPs participants 
reported that they refer to specialty 
providers. PedPCPs mostly reported 
to referring to gynecology (64%), 
with 48% referring to 
endocrinology. Fewer providers 
referred to nutritionists (11.4%) or 
behavioral health specialists (9.1%) 
to address diet modifications or 













In the qualitative research, several 
providers discussed initiating 
treatment while also referring to 
specialists, and some reported 
provider-to-provider phone 
consultations to assist in treatment 
selection.  
 
Other providers discussed barriers 
due to limited access to specialty 
providers. Limitation in access was 
due to both proximity to specialty 
care, and to specialty providers who 
do not management adolescent 
patients with PCOS.  
 
PedPCPs also discussed limited 
options for multidisciplinary care, 
which explains why a low percentage 
of survey participants selected 
referrals to nutritionist or behavioral 
health specialists.  
Qualitative codes: specialty provider 
shortages, limited options for 
multidisciplinary care, proximity to 
specialists, collaboration with 
specialists.  
Future interventions need 
to address access to care 
issues and engage a 
multi-disciplinary group 


















A majority of the pedPCPs 
indicated that they screen for 
complications of PCOS. Over 
50% of pedPCPs indicated that 
they screen for all complications 
recommended in the adolescent-
specific guidelines 
(hyperlipidemia, obesity, T2DM, 
hypertension, depression and 
anxiety). Only 32% of pedPCPs 





PedPCP recognize long-term 
complications associated with 
PCOS, but those who do not carry 
out screening for complications 
report restrictive practice policies 
that do not allow adequate follow 
up to test and/or screen for 
complication. Qualitative code: 








In general, pedPCPs are 
aware of long-term 
complications of PCOS 
and are engaged in 
screening. Those who 
do not engage have 
barriers related to 
practice policies that 
dictate what a provider 
practice. 
Future interventions 
should reinforce the 
role of the primary care 
provider to screen for 
complications of 
PCOS. 
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Quantitative Results  
(Aims 1&2) 
 
Qualitative Results (Aim 3) 
 
 
Integration of Results  
 
 
Over 80% of the survey 
participants (42 out of 52) 
identified an interest to improve 
knowledge and skill regarding 
PCOS in adolescents. When 
queried about interest in 
continuing education on PCOS, 
participants endorsed interest in: 
reading journal articles, podcast, 
online CME/webinar, in-person 
conference lecture, and/or on-
site training/in-service activity. 
 
Mean items score for items in 
the Intention to Change subscale 
(within the attitude beliefs scale) 
were: 4.13 for “I would like to 
improve my practice behaviors” 
and 3.79 for “I intend to change 
my practice behaviors.”  
 
 
PedPCPs indicated a desire to 
improve practice behaviors in 
addressing PCOS. PedPCPs 
proposed specific interventions to 
include: designating an office 
PCOS champion; developing 
practice protocols; and carrying 
out training programs for 
clinicians and staff. Qualitative 
code: Ways to Address 
 
The difference in mean items score 
for “like to improve” vs. “intend to 
change” may be explained by 
barriers of restrictive practice 
policies. One participant, who 
reported being in a setting with 
restrictive policies, stated that in 
order to change practice behavior, 
practice culture and policy would 
need to change, but stated “It is 
never going to happen”.  
Future interventions for 
learning should include 
clinic staff beyond just 
providers, provide 
practical tools to be 
used in practice, and 
establish a foundation 
to improve practice 
support so as to impact 
practice level behavior 
change. 
 
There may be a 
discrepancy between 
provider motivation to 
change and intention to 
change if providers 
encounter barriers that 
they perceive are 
difficult to overcome, 
such as restrictive 
practice policies. 
 
 Additionally, the quantitative findings, and the participants from the survey who 
volunteered to be a part of qualitative interviews, likely informed the qualitative findings 
in several ways. First, the majority of interview participants were from a family medicine 
focused practice (n=13/20, 65%) and had been in practice for ≤ 10 years (n=14/20, 70%) 
(see Table 24 Provider Demographics and Provider Characteristics of Interview 
Participants). Less practice experience and broad focus in family medicine may explain 
why pedPCPs may seek specialty input in establishing the diagnosis of PCOS.  
 Second, practice settings of interview participants varied, with 8/20 (40%) 
practicing in non-traditional practice settings. PedPCPs discussed significant variations in 
practice policies among these practice settings, with providers in urgent care settings, 
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which made up 20% (n=4/20) of the interview participants, highlighting the most 
restrictive practice policies and protocols. This helps explain difference in interview 
duration, where those providers who had less involvement in diagnosis and management 
had shorter interview durations, and divergence in the qualitative themes.  
 Lastly, despite difference in practice settings, structure and policies, most 
interview participants agreed or strongly agreed with statements for provider attitude and 
beliefs related to threat perception and intention to change. This highlights a motivated 
group of interview participants, which likely explains the depth of insight offered by 
providers related to their own confidence and perspective on patient factors as they desire 






CHAPTER 5: DISCUSSION 
 
Introduction 
The aim of this chapter is to discuss the major findings, limitations, and 
translational application of this dissertation research. Major findings are discussed in the 
context of the dissertation’s guiding conceptual framework for identifying and addressing 
barriers to optimal care and current literature in the field. Figure 17 Barriers and 
Facilitators to Addressing PCOS Among Adolescents in Primary Care highlights the 
barriers and facilitators identified in this research within the conceptual framework that 
informed study aims and research questions.  
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Figure 17  
Barriers and Facilitators to Address PCOS Among Adolescents in a Primary Care 
Setting 
 
This chapter explains barriers and facilitators presented in Figure 17 Barriers and 
Facilitators to Address PCOS Among Adolescents in a Primary Care Setting, and 
highlights the contributions of this dissertation to advancing knowledge about the role of 
the pedPCP in identifying and treating PCOS, application of adolescent-specific 
guidelines in practice, and practical evidence to inform future interventions to optimize 
care of the adolescent patient with PCOS. 
Major Findings of the Dissertation 
This is the first known research in the United States that systematically evaluated 
practice behaviors among pedPCPs in the diagnosis and management of adolescents with 


























primary care setting in DC, MD, or VA. Over half of the pedPCPs in the study sample 
addressed some aspect of PCOS in adolescent patients, including identification, 
diagnosis, and treatment, despite few reporting awareness of adolescent-specific 
guidelines. Level of engagement within each of these behaviors varied among pedPCPs. 
Differences in provider confidence, collaboration with colleagues and/or specialists, 
practice structure and policies, and pedPCPs’ perception of patient factors explain some 
variations observed across different types of practices. Overall, pedPCPs believe it is 
important to address PCOS in adolescents and that there is benefit to improving health 
outcomes early in the course of this chronic condition. Most pedPCPs in this study 
indicated motivation to change practice behaviors and desire to participate in future 
educational activities to better inform their practice. Figure 17 Barriers and Facilitators 
to Address PCOS Among Adolescents in a Primary Care Setting, highlights where 
barriers and facilitators identified in this research may interconnect to influence behaviors 
and behavior change. The findings of this research highlight several opportunities for 
implementing knowledge translation interventions and provide a direction for the type of 
interventions that will impact behavior change.  
Behavior, Knowledge, and the Role of the PedPCP 
In the only known study focused on pedPCPs’ behaviors addressing PCOS, this 
dissertation research identified that a majority of respondents carry out some or all 
diagnostic evaluations, or participate in the management of PCOS in adolescents.  
However, not all reported behaviors align with current guidance and very few pedPCPs 
reported knowledge of adolescent-specific guidelines for the diagnosis and management 
of PCOS. Only 8 out of the total sample of 52 pedPCPs (15.4%) reported awareness of 
 
 157 
adolescent-specific PCOS diagnostic guidelines. Forty-four pedPCPs (44/52, 84,6%) 
stated that they have adolescent patients with a diagnosis of PCOS. Thirty-six (36/44, 
81.8%) of this sub-set of 44 pedPCPs stated that they carried out some or all of the 
diagnostic evaluation for PCOS; 29/44 (66%) stated that they actively treat PCOS; and 
30/44 (68%) screen for complications of PCOS. The most common laboratory tests 
selected by pedPCPs for PCOS diagnostic evaluation included thyroid functions tests 
(84%), FSH (68%), LH (64%), free testosterone (55%), and ultrasonography (52%). Less 
than 50% of the sample selected additional tests that are important to rule out other 
endocrine disorders listed in the guidelines as PCOS is a diagnosis of exclusion (Ibanez et 
al., 2017). Qualitative results also revealed pedPCPs uncertainty about selection of 
diagnostic tests and concern with missing another endocrine disorder. For example, one 
participant highlighted: “I think anything with endocrinology feels a little bit like oh 
we’re already getting into something a little scary or a little like nebulous and a little 
confusing I think that part of it is not wanting to miss other things that can mimic PCOS 
(ID69). Additionally, over half of the participants selected ultrasonography as part of the 
diagnostic evaluation for PCOS, which is discouraged in adolescent-specific PCOS 
diagnostic guidelines (Ibanez et al., 2017). 
The most common treatment selected by pedPCPs in this dissertation research 
were lifestyle modifications (66%), hormonal contraception (61%), and metformin 
(50%); 55% reported that they refer to specialist. Over 60% of the pedPCPs identified 
that they screen for the following complications of PCOS: hyperlipidemia (68%), obesity 
(66%), T2DM (64%), hypertension (61%), depression (73%), anxiety (73%). This 
demonstrates better alignment with guidelines, which promote lifestyle modifications, 
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hormonal contraception and metformin as the most common treatment recommendations 
(Ibanez et al., 2017). Over 60% of the pedPCPs indicated that they participate in all 
screening considerations recommended in the guidelines (Ibanez et al., 2017). 
Extant survey research regarding specialty provider practice behaviors to address 
PCOS also shows significant heterogeinty in diagnostic evaluations for PCOS and related 
management, and limited awareness of current diagnostic guidelines (Bonny et al, 2012; 
Conway et al., 2014; Dhesi et al., 2016; Dokras et al., 2017). It is important to note that 
the aforementioned research focused on different provider populations, largely specialty 
providers addressing adults with PCOS (Conway et al., 2014; Dhesi et al., 2016; Dokras 
et al., 2017); with the exception of one study, which targeted specialists in pediatric and 
adolescent gynecology (Bonny et al., 2012). Recognition of similarities and differences 
of major findings from specialty provider studies and this dissertation research is helpful 
to discern the role of a pediatric primary care provider from that of specialty providers, 
identify knowledge gaps among different providers, and provide direction for future 
interventions.  
Research by Bonny et al. (2012), with specialty providers who treat adolescents 
with PCOS identified oral contraception and lifestyle modifications as the most 
commonly selected treatment, and less than 30% reported prescribing metformin. This 
contrasts the finding in this dissertation research where half of the respondents selected 
metformin as a commonly selected treatment. This may be explained by the fact that the 
Bonny et al. (2012) study mostly included gynecologists, who may not be as familiar 
with addressing the metabolic complications of PCOS, as is suggested by a study by 
Dhesi and colleagues (2016). A survey study of American College of Obstetricians and 
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Gynecology fellows in 2016, demonstrated that most GYN providers were not 
comfortable with addressing the metabolic complications of PCOS and referred patients 
back to primary care to manage treatments such as metformin (Dhesi et al., 2016). This 
highlights a potentially important role for the primary care provider in managing the 
metabolic complications of PCOS.  
Survey research by Dokras et al. (2017) queried specialty provider (gynecologists 
and reproductive endocrinologists) knowledge related to potential complications for 
PCOS. Specialty providers were aware of all complications of PCOS measured in this 
dissertation survey, except anxiety. Less than half of the specialty providers were aware 
of the association between PCOS and anxiety symptoms (Dokras et al., 2017), whereas in 
this dissertation study 73% of pedPCPs reported screening for anxiety among adolescent 
patients with PCOS. This may be a reflection of standard of care in primary care practice 
to routinely assess mental health and unique concerns in adolescents. 
Finally, a study by McShane and colleagues conducted a chart review for women 
age 12-21 years of age to determine provider behaviors in obtaining a menstrual history 
at annual wellness exams. The researchers compared menstrual histories taken by 
adolescent medicine, pediatric, and family medicine practices. Pediatric and family 
medicine practices demonstrated significant deficiencies in taking a complete menstrual 
history compared to adolescent medicine practices, which were over 6 times more likely 
to take a complete menstrual history (McShane et al., 2018). There were no differences 
between pediatric and family medicine practices (McShane et al., 2018). This dissertation 
research also revealed a potential deficiency in obtaining an adequate menstrual history 
as not all pedPCPs reported inquiring about menses during annual visits 81% (n=42/52), 
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and only 19.2% (n=10/52) of the participants reported inquiring about menses at all 
encounters, regardless of the reason for the visit. Participants were not queried for the 
details that they collected when inquiring about menstrual irregularities, however the 
qualitative research provided further insight on this potential deficiency. Specifically, the 
qualitative results captured pedPCPs’ concern that symptoms related to menstrual 
irregularities are often under recognized or “normalized” by pedPCPs. The study by 
McShane and colleagues (2018) did not have a study aim specific to PCOS, but does 
support evidence of a practice deficiency among pediatric and family medicine providers 
to identify irregular menses in adolescents. Identification of irregular menses is a key 
criterion to diagnosis PCOS; if pedPCPS are not obtaining menstrual histories, this 
presents a barrier to identification and diagnosis of PCOS.  
In summary, pedPCPs are engaged in addressing some aspect of diagnosis and 
management of PCOS among adolescents. Despite low awareness of adolescent-specific 
guidelines, most of the pedPCPs in this study report management behaviors that align 
with adolescent-specific guidelines. In contrast, behaviors to identify and diagnose PCOS 
had less alignment with adolescent-specific PCOS diagnostic criteria. Over half of the 
pedPCPs refer to a gynecologist or endocrinologist to contribute to the management of 
PCOS, but there is evidence of a unique and important role of the pedPCPs where 
specialty providers may have gaps in knowledge, including prescribing metformin to 
manage metabolic complications and routinely screening for mental health complications 
associated with PCOS. Future interventions should consider improving knowledge 
around obtaining a menstrual history and adolescent-specific PCOS diagnostic criteria, 
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and supporting the role of the pedPCPs to address metabolic and mental health 
complications of PCOS. 
Behavior and Attitude/Beliefs  
PedPCPs perceive that PCOS is a threat to adolescent health and there is benefit 
to treatment, but report low confidence in their ability to diagnose or treat PCOS. Results 
from both the quantitative and qualitative data suggest pedPCPs believe in the importance 
of addressing PCOS in adolescents, but also highlight lack of confidence in establishing a 
diagnosis of PCOS and limited comfort with treatment options as barriers to addressing 
PCOS in a primary care setting. Knowledge gaps, as discussed in the previous section, 
can contribute to lack of confidence and discomfort with treatment options. However, the 
conceptual framework for this dissertation posits that lack of confidence is an important 
the attitudinal factor to be consider separately for its influence on behavior in the 
knowledge to action process and can also be influenced by other factors beyond 
knowledge. (Cochrane et al., 2007). 
Qualitative data highlighted specific areas where there is low provider confidence. 
In terms of diagnosis, factors associated with low confidence include: confusion about 
diagnostic guidelines, concern with missing other endocrine disorders and concerns of 
labeling an adolescent with a diagnosis of PCOS. The only other known qualitative study 
focused on clinicians’ perspective in addressing PCOS demonstrated similar findings: a 
diverse group of providers (specialists and generalists) reported uncertainties about 
diagnostic criteria and caution with labeling as barriers to establishing a diagnosis (Copp 
et al., 2019). This study was carried out in Australia and providers primarily treated adult 
patients. Despite a different target population from this dissertation research, many of the 
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findings and themes that emerged from the Copp et al. (2019) qualitative research are 
similar to and reinforce the findings of this research.  
Provider confidence with treatment options also varied as some pedPCPs in the 
qualitative interviews stated they were comfortable with prescribing hormonal 
contraception treatment but not metformin; for other providers, it was the opposite. Some 
pedPCPs were not comfortable with or confident in their ability to prescribe any 
treatment for PCOS, and some were confident with all treatment options.  
Provider confidence with treatment may also be impacted by parent/caregiver 
hesitation. During the qualitative interviews, several providers indicated that some 
parents are resistant to treatment with hormonal contraception due to concern that it will 
promote sexual promiscuity. Other pedPCPs reported that parents are hesitant to have 
their child start metformin as they associate metformin with diabetes, or personally 
experienced side effects when taking metformin.  
PedPCPs’ confidence may also be impacted by challenges in addressing sensitive 
topics with adolescents regarding reproductive health and potential complications 
affecting fertility. Providers expressed difficulty balancing age-appropriate education 
about reproductive health risks, not wanting to overly concern adolescent patients about 
their future fertility, with the need to ensure that if they were sexually active they were 
utilizing contraception and not assuming that they could not get pregnant because they 
have PCOS. Several studies have shown that adolescents with PCOS are concerned about 
their future fertility and that this can have a negative impact on quality of life (Hahn et 
al., 2005; Kudesia et al., 2017; Trent et al., 2003). In contrast, some research has found 
that adolescents with PCOS who are sexually active have a low baseline rate of 
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contraception use (Malcolm et al.; 2015). During the qualitative interviews, pedPCPs 
indicated a need for resources to help facilitate patient and parent/caregiver education, 
which may impact their confidence in discussing and/or prescribing hormonal 
contraception.  
Understanding attitudes and beliefs of pedPCPs in addressing PCOS provides new 
knowledge to target future interventions. This is the first known research to evaluate 
pedPCP attitudes and beliefs regarding PCOS. Belief that PCOS is important to address 
in adolescents and perceived benefit of treatment indicates that pedPCPs may have higher 
levels of motivation to change behaviors. Future interventions should focus on 
opportunities to increase provider confidence and comfort with diagnostic guidelines and 
treatment options, and providing resources for evidence-based patient and 
parent/caregiver education.  
Behavior and External Factors: Practice Characteristics 
Qualitative results informed salient factors that influence pedPCPs’ behaviors to 
diagnose and manage PCOS in adolescent patients, including access to specialty care, 
provider interactions, and practice structure and organizational policies. These findings 
align with the Barriers to Adherence to Practice Guidelines Framework (Cochrane et 
al.,2007), which identifies rigidity of practice protocols, lack of peer influences, 
discrepancies in organizational structure as professional and system/process barriers to 
implement evidence into practice.  
Access to Specialty Care 
Access to specialty care impacts whether or not providers are able to obtain expert 
guidance in diagnosing and managing PCOS. This refers not only to having a specialty 
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practice within close proximity to the primary care practice, but also whether or not the 
specialty providers themselves are comfortable with addressing PCOS among 
adolescents. During qualitative interviews, some pedPCPs discussed referring patients to 
gynecologists who did not contribute to the management plan and referred the patient 
back to pedPCPs for management without making any recommendations. Previous 
research with specialty providers demonstrates significant knowledge gaps and variability 
in practice behaviors among specialty providers in both diagnosis and management of 
PCOS in both adolescent and adult patients (Bonny et al., 2012; Dokras et al., 2017).  
In contrast, pedPCPs who are in close proximity to specialists or are within the 
same health system report gaining easier access to specialists. Some participants 
highlighted that even when a patient is not able to be seen in a timely manner, specialists 
will provide guidance on diagnosis or initiating management. In the qualitative study, 
many of the providers in pediatric-focused practices reported having ease of access to 
specialty providers, which may explain why pedPCPs in pediatric practices had higher 
diagnostic practice scores as compared to pedPCPs in family medicine focused practices. 
In this dissertation study, access to specialty care also considered access to a 
multi-disciplinary team of health care professionals to address lifestyle modifications 
and/or mental health complications of PCOS. A majority of pedPCPs indicates that they 
recommend lifestyle modifications for the treatment of PCOS (66%) and 73% screen 
adolescent patients with PCOS for complications of depression and anxiety. However, 
only 9.1% and 11.4% of the pedPCPs in this dissertation study reported referring to a 
behavioral health specialist or a nutritionist, respectively. During the qualitative 
interviews participants shared that there are limited options for multidisciplinary care in 
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their community. Some reported that there is a shortage of behavioral health specialists, 
and that visits to a nutritionist often will not be covered with a diagnosis of PCOS.  
In summary, access to specialty care is not only limited by provider shortages, but 
also deficiencies in practice behaviors and/or discomfort among specialty providers to 
addressing PCOS in adolescence and lack of options for multidisciplinary care. Future 
interventions should target areas where pedPCPs can fill gaps in care such as increasing 
knowledge and confidence to address metabolic complications of PCOS. Additionally, 
future interventions should empower clinical staff (such as nurses, community health 
workers, clinical pharmacists, patients and caregivers) to obtain specialty training to offer 
evidence-based programs for nutrition counseling, motivational interviewing and peer 
support groups. An example from the literature includes a best practice toolkit that was 
developed to address a deficiency in support for families of children with disability and 
complex medical needs (Schippke, et al., 2017). In this example, best practices were 
synthesized so that communities with limited resources for caregiver support could 
develop and provide effective evidence-based peer support programs.  
Provider Interactions  
Qualitative findings showed that interactions with more experienced 
providers/attending physicians with knowledge and experience in addressing PCOS, or 
information sharing between peers, is a facilitator to the management of PCOS in a 
primary care setting. A few providers also discussed having established practice 
relationships with specialists who either have helped with building practice protocols or 
offer provider-to-provider phone consultations.  
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Meaningful provider interactions also included peer-to-peer interactions. PedPCPs 
in the qualitative interviews discussed carrying out self-directed learning to acquire new 
knowledge about PCOS along with a peer, or sharing knowledge among peers after 
attending conferences. This relates to the construct in the conceptual framework of 
subjective norms, which posits that provider behaviors are influenced by the behavior of 
other peers (Cochrane et al., 2007).  
Findings related to provider interaction were not evident in the quantitative 
research findings, but the qualitative research indicated that such interactions are a major 
facilitator to pedPCPs engaging in the diagnosis and/or management of PCOS. Future 
interventions should consider opportunities to connect pedPCPs to other more 
experienced providers or specialists. A model for connection between primary care 
providers and specialists that has been well researched for effectiveness and impact on 
patient outcomes is the Extension for Community Healthcare Outcomes (ECHO) model. 
The ECHO model is a professional development module of education that utilizes 
videoconferencing to connect leaners to specialists across distance and various settings 
(Cuttriss, 2020).  
Practice Structure and Policies  
An unexpected finding in this dissertation research is the variety of practice 
settings that providers identified as primary care. Several pedPCPs who participated in 
this study were not from traditional pediatric or family medicine practice settings, but still 
care for adolescent patients. Non-traditional practice settings include urgent care 
practices, school-based clinics, and community or public health clinics. PedPCPs in 
urgent care settings reported strict practice policies that prohibited them from carrying 
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out diagnostic evaluations, providing treating, or screening for complications of PCOS in 
their urgent care setting. Despite identifying patients who presented to the urgent care 
with complaints related to PCOS, strict practice protocols required all diagnostic 
evaluation and/or management of PCOS to be referred to specialty practice. Several of 
these providers identified an additional barrier of limited access to specialty providers, 
demonstrating that multiple external factors serve as barriers.  
Providers in more traditional settings also shared similar barriers related to 
practice structure and policies limiting patient exposure and opportunities for patient 
follow up. Specifically, some pedPCPs reported a patient medical home model in which 
practice policy did not allow for non-physician providers (PAs and NPs) to have their 
own patient panel. This limited their follow up to gain experience in diagnosing and 
managing PCOS, and also potentially resulted in patients being lost to follow up if they 
did not have continuity of care with the same provider. PAs and NPs in this type of 
practice setting also indicated limited provider-to-provider interaction, demonstrating 
again that the interplay between multiple practice characteristics may be influencing 
pedPCP behaviors. 
Dissimilarly, pedPCPs in public health and community health settings reported 
organization structures and policies related to healthcare safety-net programs that 
increased the capacity of otherwise low-resource settings to address multiple aspects of 
managing PCOS. The facilitator of safety net programs may explain why there was a lack 
of association across different practice demographics and patient populations with quality 
of provider behaviors.  
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Restrictive practice policies limit provider-patient exposure and the opportunity to 
build experience and expertise in addressing PCOS. Some of these policies are found in 
nontraditional settings, but are also found in traditional settings where policies delineate 
roles between physician and non-physician providers. Influencing practice policies may 
be difficult, but caution should be taken to not overlook pedPCPs in these settings. 
Improving provider knowledge and skill outside of practice may allow pedPCPs to bring 
new knowledge to their practice setting and be a catalyst for change.   
Behaviors and External Factors: Patient Factors 
Providers acknowledged challenges in addressing complex and sensitive topics 
related to PCOS with adolescent patients. This was mostly related to addressing weight 
and also engaging in discussion around how PCOS may impact future fertility. These 
conversations need to be tailored for different age groups and adolescent maturity levels, 
balanced with parent/caregiver hesitation that may be associated with cultural beliefs and 
social norms. Many pedPCPs shared during the qualitative interviews that they did not 
feel confident in their ability to have difficult conversations with adolescents and their 
parents/caregivers, nor did they have enough resources or patient education tools to 
reference.  
This finding is similar to a theme that emerged from qualitative research by Copp 
and colleagues (2019). Although Copp et al.’s (2019) research investigated provider 
perspective on diagnosis PCOS, and not barriers to practice, a theme related to tailoring 
care and communication for patients with PCOS parallels this this research finding. 
Clinicians in this study (Copp et al., 2019) emphasized the need for patient-centered 
communications. This dissertation research builds on this finding and offers evidence that 
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providers identify significant challenges in providing patient-centered communication 
and highlights this as a barrier to be addressed in future interventions.  
Other patient factors included parent/caregiver influence and that parent/caregiver 
hesitation or misunderstanding about certain treatment options may limit pedPCPs’ 
ability to adequately address PCOS in an adolescent patient. Furthermore, adolescents 
often have limited control over modifications to diet and physical activity if it is not a 
change embraced by the entire family. Even when an adolescent is motivated to change 
their behavior and exhibit health seeking behaviors, they may have limited ability to carry 
out these changes due to their dependency on their parent/caregiver. PedPCPs in the 
qualitative interviews also discussed families who normalize some of the complications 
associated with PCOS such as obesity or diabetes, as these conditions are prevalent in 
society. Future research should seek to capture patient and parent/caregiver perspective in 
order to develop evidence-based patient-centered education resources.  
Study Limitations 
Primary limitations of this dissertation research are related to sample size and 
sampling method for the quantitative survey research. After 9 months of recruiting 
efforts, 78 responses were received, with 52 eligible and completed surveys available for 
analysis. This modest study population resulted in limitations for quantitative data 
analyses. Specifically, multivariable logistic regression was not able to be performed to 
determine which factors, if any, related to practice characteristics affected the likelihood 
of pedPCPs engaging in the treatment of PCOS in adolescents. This limited the ability of 
this research to use covariates to identify modifiable factors associated with the diagnosis 
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and management of PCOS among adolescents patients in a primary care setting. As a 
result, the study results were unable to fully address research question #2.  
The initial sampling method for the survey research was convenience sampling 
via email to professional membership associations listservs, followed by snowball 
sampling after an IRB-approved addendum to address low survey responses. It was 
acknowledged in the study design that these sampling methods would not allow 
verification of the total number of members who received the survey to calculate response 
rate. Membership associations were not willing to provide data to indicate the number of 
members on their listservs. Furthermore, not all members would have been eligible for the 
study as the membership associations served a diverse group of providers to include both 
unrelated specialties and primary care providers. Snowball sampling further reduced the 
ability to track the number of eligible providers who would have received the survey link. 
Adapted snowball sampling was an appropriate method to recruit a difficult to reach 
population of primary care providers, but it increased the difficulty of calculating the 
survey response rate. However, snowball sampling captured a diverse population of 
practice providers who care for adolescents in both traditional and nontraditional settings. 
Having providers included in this study from nontraditional settings presented new 
considerations for the future direction of this research that may not have otherwise been 
discovered.  
The advantages of the recruitment strategy utilized for this dissertation research 
are clear. In order to capture a diverse group of primary care providers, several different 
membership organizations that capture a broad group of providers needed to be targeted. 
The target area was limited to DC, MD, and VA so that the student researcher could 
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collect information relative to the community where they practice and provide a 
foundation for future work to implement interventions mapped to barriers within a local 
region. Previous survey research in this field recruited study participants via specialty 
organizations. While this resulted in a large study sample, the population is a more 
homogeneous group of providers who were distributed over a wider region, limiting 
opportunities to implement future targeted interventions. Additionally, this dissertation 
research included PAs and NPs as providers, versus referenced research that only 
targeted physician behaviors. Including non-physician providers is reflective of modern 
medical practice and provides practical information to inform future interventions.  
Given the difficulty in recruitment, it is possible that the data reflect selection 
bias. Providers who were more knowledgeable about PCOS may have been more likely 
to participate in this research. The email sent with the link to invite providers to 
participate named PCOS as the point of interest in this study. It is possible that only 
providers who were interested in the topic were willing to take the time to participate in 
the survey. This may explain why all participants in this research reported high 
agreement with the statements that PCOS is important to address in adolescents and high 
motivation to change their behaviors.  
Lastly, the survey instrument used for the quantitative arm of this research was 
created specifically for this study. While the survey is based on previous survey research, 
it is not a validated instrument to assess provider knowledge, behaviors, or 
attitude/beliefs. The instrument was piloted and refined through cognitive validity 
interviews, but it was not validated through a more rigorous process. The attitude and 
beliefs scale is new as it was developed for this research and informed by the conceptual 
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framework proposed for this research. Factor analysis to validate the scale was outside 
the scope of this research. The survey instrument should be used in larger, more diverse 
samples and linked with objective indicators of practice data in future research.  
Despite difficulties in recruiting participants for the survey research and 
limitations with low sampling, the majority of survey participants (27/52) did volunteer 
to be contacted for the follow up qualitative interviews. This allowed for a relatively 
large qualitative study population. With 20 pedPCPS who participated in follow-up 
interviews, rich qualitative data was obtained to not only explain some of the gaps in the 
quantitative research, but provide a more nuanced understanding of pedPCPs’ experience 
in addressing PCOS. Additionally, diversity in the qualitative study population, with 40% 
of the participants practicing in non-traditional primary care settings, likely contributed to 
the divergence of themes. This allowed for the emergence of new knowledge that may be 
applicable to a wider variety of medical practices. Qualitative data provided meaningful 
insight regarding provider attitude/beliefs and influence of external factors related to 
practice characteristics and patient factors that have not previously been reported for this 
population in this field.  
Recommendations/Directions for Translational Research 
Two intervention strategies are proposed to address barriers identified in this research and 
optimize the role of the primary care provider to address PCOS among adolescents: (1) 
implementation of the ECHO platform to disseminate knowledge, increase access to 
specialists, and improve provider confidence to drive individual behavior change and (2) 
development and implementation of a PCOS Practice Toolkit to drive practice level 
change. These interventions are supported by the literature and learning theories that best 
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align with the barriers and facilitators identified in this dissertation research. 
Additionally, there is alignment with research participant’s input for recommended action 
to address barriers in their practice (Table 28 Ways to Address). Figure 18 Intervention 
Mapping highlights the proposed intervention, barriers linked to the intervention, and 
influence on behavior change.  
Figure 18  
Intervention Mapping 
 
This dissertation research has established the important role of the primary care 
provider to address PCOS among adolescents. Previous research studies highlight 
significant gaps among specialty provider knowledge in addressing PCOS in both adult 
and adolescent populations (Bonny et al., 2012; Conway et al., 2014; Dhesi et al., 2016; 
Dokras et al., 2017). Recognizing similarities and differences between past study findings 




































address aspects of PCOS that may not otherwise be managed by gynecologists and/or 
may be difficult to refer to endocrinologists due to provider shortages. Gaps in 
knowledge among specialty providers are grouped around metabolic and mental health 
complications of PCOS (Bonny et al., 2012; Conway et al., 2014; Dhesi et al., 2016; 
Dokras et al., 2017); these two areas present significant concerns for long-term health and 
are appropriate to be addressed in a primary care setting. Therefore, the proposed 
interventions should be focused on establishing accurate diagnosis of PCOS among 
adolescents in order to identify those at risk for long-term health complications and 
management of metabolic and mental health conditions associated with PCOS. 
Additionally, previous research has recognized a gap in understanding optimal models of 
multidisciplinary care to address the complexity of PCOS in adolescents (Bonny et al., 
2012; Conway et al., 2014; Dhesi et al., 2016; Dokras et al., 2017). Future interventions 
should include opportunities for interprofessional learning and collect data to inform 
optimal models of care. Finally, the proposed intervention should link to the practice 
barriers identified in the research (Straus et al., 2013). Key barriers identified in this 
dissertation research that will be the focus of the proposed intervention include: lack of 
knowledge, lack of pedPCPs confidence, limited access to specialty care, and rigid 
practice policies.  
ECHO Model 
The ECHO model is a professional development module of education that utilizes 
videoconferencing to connect leaners to specialists across distance and various settings 
(Cuttriss, 2020). Several studies have demonstrated the effectiveness of the ECHO model 
as an effective continuing professional development tool to improve provider knowledge, 
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skill, confidence, and ultimately patient outcomes (Cuttriss, 2020, Zhou 2016, Arora, 
2017, Stephens 2019; Furlan 2018). Similar to the population of interest for this 
dissertation, the ECHO model has been supported in addressing diabetes in a pediatric 
primary care setting where primary care providers needed to take on a more advanced 
role in care delivery due to limited access to endocrine specialists (Cuttriss 2020). The 
ECHO intervention links to the following barriers and facilitators identified in this 
dissertation research: knowledge gap, lack of provider confidence, lack of access to 
specialty care, and lack of opportunity for provider interaction. 
The ECHO model engages providers/learners frequently over a designated period 
of time to deliver the intervention via a videoconferencing platform. The specific 
structure includes a brief lecture by an expert and case consultation that will take place 
between a primary care provider and endocrine specialist. The brief lecture provides the 
opportunity to disseminate knowledge regarding adolescent-specific PCOS guidelines. 
Case consultation allows for provider collaboration and addresses barriers related to 
access to specialty care.  
The ECHO model aligns with adult learning theories that state that individuals 
have better learning outcomes and are motivated to change their behavior when they are 
exposed to a problem-based learning activity (Grol, 2013). ECHO would allow pedPCPs 
to bring actual patient cases to discuss and receive guidance from specialty providers. 
The ECHO model is effective to reach higher learning objectives and has proven impact 
on provider behaviors. In fact, research on the ECHO model has demonstrated 
effectiveness in increasing clinical capacity (Stephens 2019) and changes in practice 
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behavior that have impacted both patient- and community-level health outcomes (Zhou 
2016).  
Specific objectives for the proposed ECHO activity include: (1) increase pedPCP 
knowledge of adolescent-specific guidelines for the diagnosis and management of PCOS; 
(2) apply adolescent-specific guidelines for the diagnosis and management of PCOS to 
primary care practice; (3) improve pedPCP confidence in establishing the diagnosis of 
PCOS and managing treatment of PCOS; (4) support collaboration among a 
multidisciplinary team to manage PCOS in adolescents; (5) improve pedPCP capacity to 
manage PCOS in areas with limited access to specialty care; and (6) improve adolescent 
patient PCOS outcomes.  
Development and Implementation of PCOS Toolkit 
Experience and expertise gained by providers and clinical staff who participate in 
an ECHO intervention could be scaled up to develop a PCOS practice toolkit as a second 
phase of this intervention. A PCOS practice toolkit would contain point of care resources, 
evidence-based patient education resources, and training materials to engage clinical staff 
and other healthcare professionals in collaborative practice efforts to address PCOS. 
Several resources and interventions proposed by pedPCPs as “Ways to Address” barriers 
align with the proposed content of this toolkit: adolescent-specific practice algorithms, 
patient and parent/caregiver educational resources that are age and culturally appropriate, 
and a PCOS champion handbook (to develop practice PCOS Champions). 
A PCOS practice toolkit will help to disseminate knowledge of adolescent-
specific guidelines, and address barriers to applying knowledge to practice that have been 
identified by this dissertation research. Additionally, the toolkit will address barriers that 
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may not be addressed by the ECHO intervention. Specifically, this intervention is 
mapped to address barriers related to knowledge, provider confidence, patient-provider 
communication, lack of multidisciplinary care by increasing interdisciplinary interaction, 
and limited practice structure/polices (see Figure 18 Intervention Mapping).  
Development of the toolkit would require input from content experts and 
additional research to inform its development. First, knowledge generated from this 
dissertation research provides the first step in identifying barriers, understanding context, 
and identifying the problems. These are key elements to a knowledge to action 
framework (Ward et al. 2012). Second, a mix-method evaluation design to assess 
activities of the proposed ECHO model could provide measures of effectiveness to 
address initial barriers and impact behavior change. Third, patient and caregiver 
perspective is vital. Suggested next steps for this research include phenomenology studies 
to understand how adolescents and parents/caregivers experience the diagnosis, 
management and living with PCOS. Additionally, a community-based participatory 
research model could be used to incorporate the voices of adolescents, parents/caregivers, 
and other stakeholders.  
Schippke and colleagues (2017) provide an example of a toolkit developed to 
provide support for parents of children with disability and complex medical needs. 
Development of the toolkit included focus groups and community-based participatory 
research to identify best practices in peer support programs to address an unmet need in 
clinical practice (Schippke et al., 2017). Practice toolkits have been identified as a way to 
effectively disseminate knowledge and effect change in clinical outcomes (Yamada et al., 
2015). It is vital, however, that the development of the toolkit be informed by high-
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quality evidence and targeted research to inform the content (Yamada et al., 2015), as 
suggested above regarding future research. 
It is also proposed that the PCOS toolkit will include training a practice PCOS 
Champion who will help individual practices identify and improve their own gaps in care. 
This also provides the opportunity for a dedicated staff member to become trained to 
address some of the more complex topics related to PCOS such as lifestyle interventions. 
This concept is similar to the Centers for Disease Control and Prevention diabetes 
prevention programs and champion toolkit (CDC, 2020), where healthcare professionals 
in a practice community receive specialized training to lead a lifestyle change program 
for patients at risk for developing diabetes. Another example, more closely related to 
adolescent health, is the Got Transition program (Got Transition, 2021). Got Transition is 
a federally funded national resource center aimed at helping youth and young adults 
transition from pediatric to adult care (Got Transition, 2021). Got Transition contains 
online resources for patients and parents/caregivers, and clinician education and 
resources.  
Specialty and primary care focused professional organizations could be 
approached to fund and lead this effort. PES (2017) has started to provide resources on 
their website targeting primary care providers. Specifically, a brief guide has been 
developed to inform primary care providers of the appropriate evaluation for adolescents 
with suspected PCOS (Kamboj & Indyk, 2019). Knowledge gained from this dissertation 
research can inform specialty organizations, such as PES, of the barriers and facilitators 
to optimal care of adolescents with PCOS and help focus future efforts to collaborate 




 PedPCPs can play an important role in the identification, diagnosis, and 
management of PCOS in adolescence; especially in filling gaps in care to address 
metabolic and mental health complications of PCOS. Application of a barrier assessment 
framework, combined with behavior change models, revealed several factors, beyond 
knowledge, that influence primary care provider practice in addressing PCOS among 
adolescents. Interventions to overcome practice barriers, and optimize the role of the 
pedPCP, should include continuing medical education activities that are case based and 
allow pedPCPs to collaborate with experts. Long-term interventions should include the 
development of evidence-based practice resource that can be utilized by a 
multidisciplinary healthcare team and guide practice level change. Implementation of a 
practical tool-kit that includes resources for providers and clinical staff as well as 
patient/parent educational information can address barriers related to practice policies and 
patient factors. Improving the capacity of primary care practices to diagnose and manage 
PCOS in adolescence is key to optimize care for adolescents and reduce risks of 
immediate and long-term complications of PCOS.  
 This dissertation research advances the knowledge in this field by demonstrating 
the role of the primary care provider in the diagnosis and management of PCOS among 
adolescents. The findings underscore a crucial need to not only disseminate emerging 
knowledge regarding PCOS in the adolescent patient beyond the specialty literature, but 
to also focus on primary care practice-level interventions to affect change that will 
improve patient health and long-term population-health outcomes among adolescent 
patients. This research provides new and valuable information regarding barriers and 
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facilitators to practice, across a diverse group of providers and a variety of practice 
settings that can be used to inform future research to investigate optimal models of care 
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Appendix A. Survey Instrument 
 
Pre-survey questions to capture inclusion/exclusion criteria 
1. Are you a licensed physician (MD or DO), physician assistant (PA), or nurse 
practitioner (NP)? 
2. Do you practice in an outpatient primary care practice in the District of Columbia, 
Maryland, or Virginia? 
3. Does your patient population include adolescent (12-17 years of age) females? 
The survey will only continue after the participant responds yes to each of these 
questions. If the participant respond “no” to any of these questions, they will receive a 
message that they do not met inclusion criteria to continue the survey.  
 
Provider Characteristics 






2. How many years have you been in clinical practice (include residency or 
fellowships years)? 
__ Less than 1 year 
__ 1-5 years 
__ 6-10 years 
__ 11-20 years 
__ >20 years 
3. Are you currently in a post-graduate clinical training program?   
__ No 
__ Yes   
 
If yes:  What type of training program? 
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__Physician residency program 
__Physician fellowship program 
__PA/NP residency/fellowship program 







__Rather not say 
__Other (please state) _______________ 
 
5. What is your age category? 
__20-29 years  
__30-39 years  
__40-49 years  
__50-59 years  
__> 60 years 
6. What is your ethnicity (check one)? 
__Hispanic/Latino 
__Not Hispanic/Latino 
__Prefer not to answer 
 
7. What is the race with which you most identify?   
__White  
__Black/African American  
__American Indian/Alaskan Native  
__Asian  
__Native Hawaiian/Pacific Islander  
__Two or more races 
__Prefer not to answer 
__Other (please state)__________ 
 
Practice characteristics- The next set of questions refers to your primary clinical position. 
“Primary clinical position” refers to the clinic position at which you work the most hours 
during the work week.  








2.  Which of the following best describes the type of practice setting where your 
primary clinical position is located: 
__Office-based private practice - solo 
__Office-based private practice - single specialty physician group 
__Office-based private practice- multi-specialty physician group 
__Hospital (non-government) based outpatient clinic 
__Hospital (government/military) based outpatient clinic 
__Academic medical center clinic 
__Military clinic 
__Community health center (Federally Qualified Health Center) 
__Community health or free clinic (non-federally qualified) 
__Health department clinic 
__Rural health clinic (federally certified) 
__School clinic or college health center  
__Urgent care 
__Other_________________ 
3. What is the location of your primary practice setting? 
_District of Columbia 
_Maryland 
_Virginia 
__My primary practice is divided between more than one of the above.  
     Please specify________ 
 




    ___ My primary practice is divided between more than one of the above.  
     Please specify________ 
  







6.  What percentage of adolescent patients (ages 12-17 years) in your practice are 







7.  Estimate the current percentage of your patients who are in the following ethnic 
groups. (Responses must add up to 100%) 
   __Hispanic 
   __Non-Hispanic 
   __Other (please specify________) 
8. Estimate the current percentage of your patients who are in the following racial 
groups. (Responses must add up to 100%) 
    __White alone 
    __Black/African American alone 
    __American Indian/Alaskan Native alone 
    __Asian alone 
    __Native Hawaiian/Pacific Islander alone 
    __Two or more races 
    __Other (please state)__________ 
 
Provider Practice Behaviors - The next set of questions refers to female patients you see 
in your primary clinical practice between 12-17 years of age. 
1.Estimate the number of female patients age 12-17 years old that you see in your 
practice annually?  
__<50 
__³50 
2. When do you inquire about menstrual irregularities (check all that apply)? 
__Well-patient visits  
__ If there is a complaint related to the menstrual cycle  
__If there are complaints related to metabolic abnormalities (E.g. 
obesity) 
__ All encounters regardless of complaint 
__I never inquire about menstrual irregularities 
__Other____________________ 
 










3.  Do you have patients with a diagnosis of polycystic ovary syndrome (PCOS)? 
__No (skip to part B) 
__Yes 
If yes, estimate the number of patients (age 12-17 years old) you see 





4. What tests do you order in evaluating a patient for PCOS (check all that apply)?  
__Thyroid function tests (TSH, free T4) 
__Prolactin 
__17-OH progesterone 
__dehydroepiandrosterone sulfate (DHEAS) 
---Random urine cortisol 
---24-hour urine cortisol 
__Adrenocorticotropic hormone (ACTH) 
__Follicle stimulation hormone (FSH) 




__Sex hormone-binding globin (SHBG) 
__lipid panel 
__fasting blood glucose 
__hemoglobin A1C 
__Ultrasonography (or other imaging of ovaries) 
__Other_______ 
__I do not carry out my own evaluations for PCOS in my practice (skip to 
question #6) 
 
5. Will you diagnose PCOS within two years of menarche?  ___Yes  ___No  __I 
do not diagnosis PCOS 
 
6. Are you aware of diagnostic criteria for PCOS?    ___Yes  ___No 
 
If yes, what diagnostic criteria are you familiar with? 
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__ NIH criteria (1990) 
___Rotterdam criteria (2003) 
__ __Androgen Excess Society criteria (2006) 
     __Amsterdam criteria (2012) 
   ___Endocrine Society criteria (2013) 
    __Pediatric Endocrine Society criteria (2015) 
__Other (please specify)  
 
7. Do you the treat/manage PCOS in your practice?   
         ___Yes  
           ___No  (skip to question #  10 ) 
8.What treatment do you prescribe/recommend? (check all that apply) 




__Cosmetic procedures such as laser depilation 
__Referral to specialist  
__Other_________ 
9. What are your treatment goal(s) for adolescent patients with PCOS? (check all 
that apply) 
 __Normalize BMI (weight loss) 
__Resolve facial hirsutism and/or hair loss 
__Acne control 
__Normalize menstrual cycles 
__Decrease androgen levels 
__Improve markers of cardiometabolic health 
__I don’t know 
__Other____________________________ 
10. Do you screen patients with PCOS for complications associated with PCOS?  
Yes__    
No__   (skip directly to #11) 
 
If yes, what do you screen for? (check all that apply):  
__Hyperlipidemia 
__Obesity 
 __Insulin resistance 








 Do you screen patients with PCOS for complications of PCOS 
regardless of BMI?  Yes____  No____ 
11. Do you refer to a specialist for consultation in diagnosing or treating PCOS? 
__Yes (go to question #12)  
__No (skip to question #13) 




__Behavioral Health provider 
__Adolescent medicine provider 
__Other (please be specific)__________________   
 
(then skip #13 and go to #14) 
13. Which of the following best describes the reason that you do not refer to a 
specialist? (select one that best applies) 
__Lack of specialty resources in my community 
__I feel confident in my practice to diagnosis and treat most cases of PCOS 
__Other______________ 
 
14. Do you screen adolescents with PCOS for anxiety and depression?    Yes__ No__ 
 
 If yes, what screening tool do you use? (select all that apply) 
__PHQ-2 
__PHQ-9 
__Columbia Depression Scale 
__Kutcher Adolescent Depression Scale – 6 item 
__Strengths and Difficulties Questionnaire (SDQ) 




15. In the past year, have you participated in any professional activities (e.g. CME) 
regarding PCOS in adolescents?   Yes____  No____ 
 
If yes, what was the activity: 
__ reading journal article 
__online CME 





16. Would you like to learn more about PCOS in adolescents? Yes____  No____ 
 If yes, what format/type of activity would you participate in?___________ 
 
Part B- for responses that indicate none of their patients have a diagnosis of PCOS. 
5.  Which of the following best describes why you do not have female patients 12-17 
years of age in your practice with a diagnosis of PCOS? (select one that best 
applies) 
__Lack of patients who meet diagnostic criteria 
__I do not have the knowledge needed to diagnosis PCOS 
__I have the knowledge to diagnosis PCOS, but I am still not comfortable with 
making the diagnosis 
__Other________________________ 
 
6. Are you aware of diagnostic criteria for PCOS?   Yes____  No____ 
 
If yes, what diagnostic criteria are you familiar with? 
__ NIH criteria (1990) 
___Rotterdam criteria (2003) 
__ __Androgen Excess Society criteria (2006) 
     __Amsterdam criteria (2012) 
   ___Endocrine Society criteria (2013) 
    __Pediatric Endocrine Society criteria (2015) 
__Other (please specify)  
 
7. In the past year, have you participated in any professional activities (e.g. CME) 
regarding PCOS in adolescents?  Yes____  No____ 
 
If yes, what was the activity: 
__ reading journal article 
__online CME 
__ in person CME lecture 
__other________________ 
  
8. Would you like to learn more about PCOS in adolescents? Yes____  No____ 
 
If yes, what format/type of activity would you participate in?_________________   
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Provider Attitudes and Beliefs 
Please rank your agreement with the statement below (Likert Scale for level of 
agreement):   
strongly disagree (1); disagree (2); neutral (3); agree (4); strongly agree (5) 
1. PCOS is a condition that impacts my adolescent patient population. 
2. PCOS is an important condition to identify among adolescent patients. 
3. PCOS is associated with significant health complications for adolescents.  
4. PCOS is associated with mental health complications of anxiety and depression in 
adolescents. 
5. There is benefit to patient health outcomes if PCOS is addressed in adolescents. 
6. Practice guidelines for the diagnosis and management of PCOS are supported by 
evidence based medicine. 
7. I have the ability to accurately diagnosis PCOS in adolescents. 
8. I have the ability to effectively manage PCOS in adolescents. 
9. I have the support needed in my practice to diagnosis and manage PCOS in 
adolescents. 
10. I have the specialty support needed in my community to diagnosis and manage 
PCOS in adolescents.  
11. Learning more about PCOS would change my practice behaviors.   
12. Resources are available to learn more about the diagnosis and management of 
PCOS in adolescents. 
13. My colleagues in primary care practice are actively involved in the diagnosis and 
management of PCOS in adolescents. 
14. PCOS is mostly diagnosed and managed by specialists. 
15. I would like to improve my practice behaviors in addressing PCOS among 
adolescents in my practice. 
16. I intend to change my practice behaviors in addressing PCOS among adolescents 
in my practice. 
 
A follow up phase of this study will involve individual interviews with primary 
care providers to better understand barriers and facilitators to the identification, diagnosis 
and management of PCOS among adolescents in a primary care setting. If you are willing 
to be contacted for a follow up interview, please provider your name and preferred 
contact information. Your contact information will be kept confidential and only used for 
purposes of requesting your participation in a follow up phase to this research. It will not 








1. Tell me about your practice and how you are currently addressing PCOS in the adolescent 
patient. 
 
2. Describe the typical patient for whom PCOS is on your differential diagnosis. 
• How do patients with a concern for or symptom of PCOS access care? 
 
3. Tell me about your standard diagnostic work up for PCOS.  
• What tests? 
• What is the process? 
• What informs the diagnostic tests you select? 
 
4. How do you treat/manage PCOS in an adolescent patient in your practice? 
• What is the process? 
• What informs your management plan? 
• How do patients and their parents/caregivers respond to treatment/management? 
 
5. How do you address potential long term complications of PCOS with your adolescent 
patients? 
• How do patients respond to this? 
 
6. What specialists do you engage with to address PCOS and what is that process? 
• How do you think this works for patients? 
• What other disciplines do you engage beyond clinical specialist (i.e. 
 dieticians/nutritionists, psychologists, alternative medicine professionals, etc. – if 
other disciplines are not mentioned as specialists) 
 
Attitude/beliefs 
7. How important is it that PCOS is addressed in adolescents? Why? 
8. What are advantages and disadvantages to addressing PCOS in adolescents? 
 
Intention/Motivation to change 
9. How would you like to change your current practice in regard to addressing PCOS? 
• What would you need to change your practice? 
 
External factors 
10. How are your colleagues in your community addressing PCOS? 
 
11. What factors, outside of your practice setting, influence how you address PCOS? 
 How do these factors influence you? 
Other 
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Appendix D. Qualitative Codebook 
Category: Establishing the Diagnosis (Definition: Confusion and/or lack of knowledge about 
guidelines, delay in recognition of key clinical manifestations of PCOS and concern about 
missing a diagnosis as barriers to diagnosis. For facilitators, participants report utilizing point 
of care resources, although there still may be ambiguity.) 
Code: Delay in Identification  
    Subcode: Under recognition of symptoms (Providers do not inquiry about symptoms, and/or 
overlook or normalize symptoms.) 
I really, I think it’s very under recognized. I feel like that people don’t really put that 
high on the differential if people are coming in with these complaints, maybe 
overweight, maybe depressed, maybe irregular cycles, that kind of thing, people 




I feel that a lot of time, menstrual cycle questions are often overlooked. For example, 
if an adolescent is there for a sports physical, menstrual cycle is not normally a point 





As providers, we’re not always the best at asking about last menstrual cycle when 
people come in for acute things or it could be something like… I always tell my staff 




I just think it doesn’t get addressed. I think it doesn’t come up. I think it gets missed a 




I think sometimes we have kiddos who are starting with symptoms of PCOS and even 
starting menstrual periods as early as eleven and so not waiting until they’re sixteen 
and a little older to make those identifications. I feel like sometimes those kids could 
have been identified a little sooner... (ID25) 
PA, 
peds,R 
  Subcode: Treatment masking symptoms (Treatment used to manage other conditions and/or 
patients utilizing cosmetic treatments mask signs/symptoms of PCOS) 
We’re really focused on contraception with those teens [teen moms] it’s like a focus 
so a lot of them are on contraception so evaluating their menstrual cycles is a little 
bit difficult. So I don’t think it’s common to be thinking about or talking about PCOS. 
(ID69) 
 
I do find that people who are over sixteen have been having this for years like they’re 
used to having some of this stuff, the excess facial hair, the acne and so they don’t 
necessarily bring it up and that’s when you’re asking about hirsutism they’ll like “oh 





…I think there’s kind of like a delay in workups sometimes. I wish we looked earlier 




someone comes in with hirsutism and they’re having menstrual irregularities and 
they’re over weight that becomes oh maybe it’s this and we can work it up. But when 
you have that patient who’s just a little bit overweight and they’ve got some acne and 
their menstrual periods are regular but they’re already on birth control or they have 
NEXPLANON and they just think it’s that. I do think that we could test for it more 
because I do think it is more common then. (ID29) 
family, 
R 
I think sometimes PCOS gets a little bit lost in general adolescent health of 
preventing pregnancy (ID40) 
NP, 
peds, U 
    Subcode: Normalizing symptoms (Providers normalize menstrual irregularities in the 
adolescent population.) 
Would definitely say I’m sure we don’t really do that enough [to diagnosis PCOS]. 
And part of it if we don’t ask and they don’t want to bring up the periods or their 
vague or we just think it’s just your period being abnormal because you’re a 
teenager then it probably doesn’t get addressed quite as often as it should because 





I think we normalize an irregular menstrual period or we normalize a little bit of 
overweight when they’re still young; eleven, twelve, thirteen but then by the time 
they’re sixteen and it’s more of a significant issue it’s already fostered itself for a 




So, I would say, I know sometimes in the teenage population it’s hard anyway since a 
lot of them will have abnormal periods, or irregular, I shouldn’t say abnormal but 




Code: Confusion about diagnostic guidelines (Adolescent-specific guidelines are not clear or 
known to the provider.) 
I do think every physician will probably tell you like a different lab workup that they 
do initially and would definitely be like I have to look that up. Every time, I get 
confused; I’m not sure which one. (ID69) 
 
MD, 
peds, U  
I think it’s kind of difficult, and this could just be myself that I haven’t really found 
the best resources, adolescents versus adults I think it’s kind of hard to find 




Okay so the thing with the twelve to fifteen age range is a lot of times girls are 
getting their periods for the first time and it’s pretty typical to have irregular periods 
like after the first two years from menarche so I would say probably twelve to fifteen 





I’m not super comfortable with those labs tests. I’ve ordered them for some families 
and been able to walk my way through that with them as needed but from a comfort 
level perspective if I really think it’s going to be a significant diagnosis or 
something’s that going to require more than just maybe a birth control pill then I 






But I don’t think a lot of parents, adolescents or even providers have much of a 
perspective on how to actually look for it and how to actually direct the patient in the 





I think it seems the diagnosis and management there’s so many options, there’s so 
many different guidelines and input. Yeah I think it’s an interesting topic that I think 
can be approached many ways. There probably is a best practice but it seems to me 
there’s a couple (ID40) 
NP, 
peds, U 
I think in general there’s not enough comfort with this diagnosis. And I think a lot of 
people probably, especially because we have the adolescent doctors who come to our 
clinic, I think a lot of people probably refer to the adolescent docs. (ID69) 
 
I do think every physician will probably tell you like a different lab workup that they 
do initially and would definitely be like I have to look that up. Every time, I get 
confused; I’m not sure which one. (ID69) 
MD, 
peds, U 
I feel like I’ve been to lots of talks and with PCOS there’s just so many different 
diagnostic criteria and so sometimes patients don’t necessarily meet all of them. 
(ID47) 
 
And I think too recently I’ve heard talk, and you kind of mentioned this in labeling or 
giving the diagnosis of PCOS, one of my colleagues had gone to the AAP conference 
and they were saying that, I don’t know if the criteria or things had been changed, 
but typically they’re not necessarily giving girls the diagnosis or they’re no longer 
doing that before the age of eighteen. So it was some talk she went to and then she 
came back and said “yeah there’s now new data that they’re not wanting to label 




And, maybe better, I would like it if we could do a lot of the workup in the primary 
care setting. I feel that my supervising physician doesn’t feel so comfortable with 
once the labs come back and maybe one thing is abnormal I don’t think that in 
general she or we would be doing much of the workup from there I think we would 
just refer but I don’t know if that’s necessary. (ID54) 
PA, 
peds, S 
Code: Concern with missing other endocrine disorders (Providers are concerned with missing 
other endocrine or gynecologic diagnosis that presents similar to PCOS) 
“I think anything with endocrinology feels a little bit like oh we’re already getting 
into something a little scary or a little like nebulous and a little confusing I think that 
part of it is not wanting to miss other things that can mimic PCOS. …. just not having 
that kind comfort and so feeling like they should see a specialist whether it’s 
adolescent or endocrinology first. I think that feels like a barrier.” (ID69) 
MD, 
peds, U 
Now you know part of the management for PCOS because they’re at high risk of 
insulin resistance and things like that is putting them on Metformin and that’s 
something that a lot of times these patients may already be on at our clinic so that’s 
something I’m comfortable managing but often I would have them just see 
gynecology just to make sure there are not other reasons that they’re having irregular 






Code: Harms of labelling (Providers are concerned with potential harm to adolescent by 
receiving a diagnosis of PCOS) 
So, I kind of have mixed feelings about it. I think from an overall health aspect it’s 
really important but I also think that the diagnosis comes with a psychological 
component that I worry that my adolescent patients don’t handle as well as if they 




I think sometimes in adolescence especially the disadvantage would be kind of a 
stigmatism of having PCOS and especially with the hirsutism being a part of it. But I 





…from a mental health standpoint of placing this in their mind that there can be 




Depending on how old the patient is, learning that they have a chronic disease so 





I think the diagnosis comes with a little bit of depression so that just becomes a lot 




Code: Point of Care Resources (Providers utilize point of care resources as a guide for 
diagnostic evaluation of PCOS) 
So I usually would look up the criteria just to determine where I am in the process 




I think I would like to see other guidelines are out there, other than just using 
UpToDate, which I think is pretty up to date, but it just to make sure that I am on the 




So that is the main reason that UpToDate is our go to is because it’s a collection of 
many different associations, evidenced based, to be able to practice accurately. So, 
where else I would go other than the associations that are collected with UpToDate 




So I really I go to UpToDate which has the guidelines from I think it’s the adolescent 
health, no maybe it’s the endocrinology guidelines. (ID69) 
MD, 
peds, U 
Honestly I probably usually check for updates in things like Epocrates and stuff to 




I kind of have my own things, favorites that I may have used in the past if I have to 
look it up. I would look it up on UpToDate as well though to see what the actual 











So typically I’ll get, and usually I have to, because I don’t do this I would say it’s not 




I usually will go on to UpToDate. Depending, so that’s my first line after that I would 




Category: Access to Specialty Care (Definition: Availability of specialist for 
consultation and multidisciplinary care (nutrition and behavioral health services)). 
Code: Specialty provider shortages  
Endocrinology, we don’t have pediatric endocrinology here in town. They 
have to go down to Richmond to VCU. (ID19) 
PA, 
family, S 
  And then we also live quite a distance from specialty care so most of our 
pediatric specialty care can be, or some of it can be up to an hour’s drive. 
And then in those instances we try to keep those families in house. So we 
do have some other providers in our offices that are a little more 
comfortable and provide more GYN services it’s just sometimes we’ll lean 




The distance, the specialty care if we were to feel like we needed that 





There are only 2 endocrine physicians in town. Takes 9-12 months for a 
new patient appointment. (ID15) 
PA, 
family, S 
We don’t have Peds endo in the county so it’s within the health system 
locally but they would have to drive for that out of county so that’s why we 
usually get stuck with just GYN and we only have two GYN providers, 
one’s a group and one’s an individual. And we’ve had some significant 




Yeah so that’s been difficult because like I said this is a rural community 
where I work at so we don’t have as many specialists. And so when we do 
refer out often that requires some travel and not all of our patients have 
transportation readily available to them so that definitely requires us to 
get social work involved or a case worker to help with that so I do say 
there’s definitely a delay in those kind of visits. (ID29) 
PA, 
family, R 
In my area, some of the GYN don’t like to manage PCOS they would 
rather that a primary care or an endocrinologist manage that. So, in the 
absence of having cystic ovaries they don’t really manage, they refer back 
to the primary. I’ve had a couple of people who said their gynecologist 
refused to give them Metformin or anything else then they’d come back to 








I have had experience with a gynecologist wouldn’t really address 




Often times patients will come back from a specialist and I won’t have 
notes, I’ll have to dig for them. There’s not a lot of counseling going on so 
the patients are confused about why they’re taking what they’re taking. 





Code: Limited options for multidisciplinary care (Limited options for nutrition and/or 
behavioral health both due to availability for these services and insurance coverage for 
these services) 




I don’t know if I ever did a psychologist but definitely a nutritionist and 
dietician. If I could get their insurance to cover it, which was a problem a 




as far as like counseling and nutritionists go it’s just patients with their 
insurance sometimes have very poor coverage for those services so 
depending on financial ability sometimes patients just don’t have, you 
know that’s a little bit different than just paying your consultation fee to 





I think one of the reasons is a lot of us don’t use dieticians as much for 
anybody, is that a lot of insurances won’t cover it. (ID71) 
PA, 
family, S 
Behavioral is tough because in Southern Maryland we just don’t have the 





It is 3-6 months for a mental health appointment in the community. I have 
never considered a mental health appointment for PCOS. I would like to 
use nutrition services, but those are not easy to access. There is only one 





So there are options for nutritionists, that would be, I generally wouldn’t 
go that route unless it’s, like I don’t start with that just with a diagnosis 
unless that’s something that’s like if they’re morbidly obese or if they’re 
really having concerns. But those are difficult appointments to get in and 
to get covered sometimes. (ID29) 
 
 
I think getting patients onboard with that is difficult just because a lot of 
our patients have a hard time getting to appointments anyway and it’s 





something that they think they can do on their own. So I think that’s, for as 
much as when we do use nutritionists for other health issues in general I 
would probably say fifty percent of our patients maybe go to those 
appointments. (ID29) 
with them taking all insurance, taking Medicaid because it’s in the system 
I think it’s pretty easy for them to get a referral. And I’ve never had 
patients say it’s not covered. I think on the flip side it would be maybe 
some of the patients that have private insurance that may not have great 
coverage that are probably more concerned about the expense of seeing 
specialists and in particular if gynecology is wanting them to get an 




I do not generally refer to nutritionists or dietitians; I would like to, but, 
not just for PCOS, I find that a lot of patients aren’t able, you know, their 




Code: Proximity to specialists (References the location of the practice setting in 
relation to specialty providers such as gynecologists and endocrinologists) 
..so it’s kind of a cohort where I think a lot of the doctors have affiliations 
with [named removed for confidentiality] and [named removed for 
confidentiality] so a lot of the physicians will work amongst the two 
institutions but it’s located in northern Virginia, which the private 
practice I work at is in northern Virginia so it becomes a lot more 
convenient in terms of referrals for them to go there versus a lot of times 




The big hospital systems are here and then we do have some outpatient 
whether it be endocrinology or OBGYN, there’s a lot of private practices 
too. And I feel like most of the practices are larger and so I think that they 
[patients] are able to get in easier than perhaps some other places” 
(ID50) 
 
…we reach out to the local hospital systems, they both have 
endocrinology, so they can kind of take over things once we’ve done that 
initial evaluation.  Or in some cases they’ll say “hey do you mind starting 
an oral contraceptive?”  Or “I feel like this patient would benefit from 
metformin.” And we might do that and then hand off that from there. 
(ID50, PA, peds, R&U) 
PA, peds, 
S&U 
I feel like I’m lucky because my primary care clinic has a lot of 
subspecialists in this area so I feel like I can consult with some of the 
attending in my teams for more advanced questions so I’ll often involve 
them when I need to. (ID40) 
NP, peds, 
U 
We have several local groups I usually see where they would be interested 
in traveling to and then I give them the contact information and they call 
and make an appointment and probably they get in within a week or two 






Category: Provider Interaction (Definition: Availability of specialist for consultation 
and multidisciplinary care (nutrition and behavioral health services). 
Code: Guidance from experienced providers 
Honestly I went to my supervisor and we kind of, she has the set rules of 
what bloodwork was ordered. (ID75) 
 
Yeah I think I learned a lot in my own, in the practice that I’m in because 
we have providers who have been there for thirty years and, you know, 
our program tends to stay on top of, you know, latest research and we try 
to implement or at least communicate what’s new, and so there’s always 
someone that you can bounce a case off of or discuss with. (ID42) 
 
So we do have some other providers in our offices that are a little more 
comfortable and provide more GYN services it’s just sometimes we’ll lean 
on them internally to get some help for those families. (ID25) 
 
There’s one of the other physicians that I work with, does largely, she is 
only in one of our offices that I visit, but she does much more with 
women’s health and especially with our pregnant patients. So she had 
created a little flow chart of management but I think she uses ACOG for 
most of her stuff. (ID29) 
 
I feel like I can consult with some of the attending in my teams for more 






















Code: Peer Collaboration 
I’ve been here a little over two years and when I started, the other PA and 
I did not really know a lot about PCOS, but working together we kind of 
did a little of our own research and kind of bounced ideas off of each 
other and put together, I think we got a little bit better at it. (ID07) 
 
 
I mean I think all of the providers in our offices are having conversations 
about concerns or other presenting pieces that might lead them to 
diagnosis of PCOS. (ID25) 
 
So, going to different trainings. We tend to, we all can’t go to Society of 
Adolescent Health Medicine annual conference but we all take turns and 




















And so I haven’t sat down to look at all of them and review them and do 
the research I’m just learning clinically from different people that I talk 
to. (ID40) 
 
It’s usually colleague input and then also some joint shared decision 
making with the family and different comorbidities and working with 
what’s bothering them and what they think could work with their lifestyle, 
usually. (ID40) 
 
And it’s something I’ve learned a lot about in this clinic and I’m still 
continuing to learn about and so I appreciate all these different inputs 








Code: Collaboration with Specialists (Collaborative relationship with specialists that 
allow for direct guidance versus reliance on patient referrals alone.) 
So that lab panel is what our practice decided on but it was in 
consultation with our local endocrinologists. (ID50) 
 
…because of us having pretty decent relationships with a lot of specialists 
we do manage a little bit more of our complex conditions at least to an 
extent. We manage a lot of conditions with either consultation by phone 
with the specialists or even just consultation with some of the providers 






But sometimes Endocrine can get busy with diabetics and other endocrine 
disorders so they may see them and then refer them back to you so you 
can manage….. they may make a recommendation and then we go ahead 




Category: Practice structure and policies (Definition: Practice or organizational 
policies or services that impact availability of resources or provider’s autonomy in 
addressing PCOS in adolescents. Practice settings vary, but it is the structure and 
policies unique to each practice that support or restrict provider practice.) 
Code: Restrictive practice policies 
I think that we could do more on our end with a full lab and diagnostic ability 
to help rule out or rule in a potential diagnosis and then refer as needed. But 
right now how our protocol is set up is if it’s a suspected PCOS we would do 
those three labs and then refer. (ID31) 
 
The practice that I mainly work in is urgent care. Percentage wise overall the 
company does twenty-eight percent of primary care. And really [we] would 






the potential for PCOS. But right now how our protocol is set up is if it’s a 
suspected PCOS we would do those three labs and then refer. (ID31) 
 
I will say I wish that we did more to help with some of the management but 
it’s tough  on the urgent care side because you don’t want to get into the 
primary care role. But the issue that we see is that because urgent care exists 
there’s a lot of teens, a lot of that tween age that do not have a primary care, 
they don’t have a pediatrician, they don’t have a family medicine doctor. And 
so I feel like that’s a group that’s missing some good guidance. (ID73)  
 
So right now with our being in urgent care what we’re sort of forced to do is 
not really do too much at the site testing wise or long-term medication wise 





Honestly I’m just there to do a quick visit and get them moving…. Weʻre sort 
of a hybrid practice where we do some primary care and some, mostly urgent 




PAs and NPs do not have their own panel of patients. [This is]one of the 
reasons that I do not see a lot of adolescents and adolescents with PCOS. 
PAs and NPs will get moved around. Ideally I would have I follow up with 
patients who I have ordered a diagnostic work up for or started treatment. I 
feel that it [PCOS] is under diagnosed, due to limitations as above in both 






And it’s really hard, I think follow-up is really inconsistent, follow-up and 
continuity and so it’s hard for me. I don’t always see a patient I diagnose or I 
saw for follow-up again all the time, sometimes but not always and I think I 




Probably one of the things that, again it’s probably my biggest concern is, 





Code: Healthcare Safety net programs 
We have a provider in school so if they leave me and go from the middle to 
the high, or the elementary to the middle we can continue those conversations 
to keep it important and relevant. I think that with a lot of our chronic 
conditions including just obesity in itself we have a much better way of 
managing it when we use our school based health centers within our own 
FQHC for our kids that we provide primary care to just because it is more 
individualized, it’s more one-on-one. They have more access to providers 








They [a federally qualified health center] have been around a long time and 
have this very unique partnership with the health department in that we 
manage all of their contraceptive needs and they manage all of our family 





Yeah at the [named removed for confidentiality] we do have a nutritionist on 
staff so the way the appointments flow is that they see myself and a 
nutritionist at each visit so that’s been really nice. (ID47) 
MD, 
peds, S 
Code: Patient exposure 
And in adolescents the hard part too, I don’t know what venue of medicine or 
what venue of research you do on a regular basis but adolescents are pretty 
tough because once they get over age twelve, thirteen and we give them that 
last tetanus booster so they can get into high school, basically we don’t see 





So we see that as early as really even thirteen years old is about when we 
start to think late menstruation. So I would say it’s on a differential as low as 
thirteen but to come back and confirm diagnosis really has been above 





I work at a primary care practice that primarily focuses on or sees almost 
exclusively adolescent patients twelve to twenty-two. And we also provide 
adolescent medicine consults for community providers. So I address PCOS in 
two ways by identifying it through surveillance or routine primary care and 
addressing acute concerns that are PCOS related and then a subsequent 
workup as well as tend to follow-up for already identified PCOS. And then 
sometimes, not too often, but sometimes consults or consult follow-up for 





We do see a lot of adolescents. We don’t have a separate nearby adolescent 
center so we do see a good amount of adolescents. (ID69) 
 
I think at our clinic we see a lot of teens and I think people are more 
comfortable dealing with teen adolescent issues but in general I know 
pediatricians tend to like, you know, the ones who like teens are doing 
adolescent health, and so, in general. There are a number of us who really do 
like working with adolescents and dealing with adolescent life issues. (ID69) 
 
I think we’re really focused on contraception with those teens [teen moms] 
it’s like a focus so a lot of them are on contraception so evaluating their 
menstrual cycles is a little bit difficult. So I don’t think it’s common to be 









I think the other practitioners do similar things although the other PA and I 
probably see more teenage girls than the doctors because they’re both male 
and older so I think a lot of times they would just feel more comfortable 





We do have a decent amount of patients who a lot of times they’re overweight 
and having that irregular cycles and their mom brings them in because of 






Category: Provider Behavior Evaluation 
(Definition: Provider perception their own personal comfort level/confidence in 
managing PCOS and patient benefit.) 
Code: Provider discomfort with treatment 
I’m not sure from a management perspective that a lot of providers are really 
comfortable with the management of it. I think we’re comfortable with talking 
about it, we’re comfortable with addressing it and pointing out features or 
things that we notice that may lead us to be suspicious. But I think once it 
becomes more of a management of it or we get close to a diagnosis then I 
think a lot of us feel more comfortable to refer. I know it a be a lot easier if 




I think it is an area where pediatricians don’t feel that much comfort. I think 





And I think that’s more of a reluctance to prescribe medications off label in a 




So I’d say I don’t know that my counseling [on life style modifications] 
changes a whole lot other than just letting them know your BMI is already 
elevated, you have PCOS, this is something that we’re watching. But I would 
say from a general pediatrician standpoint I don’t think most pediatricians 
though are going to be comfortable or be the ones that are managing 
Metformin, I think more so general pediatricians are comfortable with the 
birth control aspect but not necessarily the Metformin piece. (ID47) 
MD, 
peds, S 






I think when it comes to pediatric patients a lot of times it’s easier to just 
wash your hands of it and say this isn’t in my wheelhouse because people 
aren’t as comfortable with, okay what should I do in the pediatric 
population? Can I prescribe this in the pediatric population? And I think that 




Code: Provider confidence in treatment options 
 
 219 
Oh, and the people actually do really well and the Metformin along with diet 
changes just helps people control those cravings better. They have less 




But for a lot people their concern is this irregular menstrual cycle and so one 
thing that’s easy to start with is just like this [contraception] will help make 
your menses more regular and so they’re more predictable and so you’re 





My goal of treatment with metformin is to help regulate symptoms of weight 
gain and fatigue. Patients will have more energy when on metformin. 




And then I would say just the response of patients or the concerns that they 
have I think is the biggest thing. I try to make sure that I’m addressing their 
concerns and not just mine and so I try to listen to not only the teenagers but 
their parents and brothers and sisters, relatives that are there for them. I try 





Yeah usually it’s mostly I’ve got this pool of options, what’s most important 
to the family, what is needed, and medically kind of important for their health 
protection and what can they do with their routine and what else are we 
addressing like diabetes concern or a pregnancy prevention, acne, hair 




And sometimes we’ll go ahead and start the patient on Metformin if it’s a 
situation where the BMI is very elevated and pre-diabetic and its showing 
insulin resistance or, you know, manifestations of PCOS, we may just go 




But I think the advantage is that they can start working on treating the, not 
just covering up the symptoms, but treating the problem and understanding 
why they’re getting, you know, hairs on their chin or you know why they 
can’t lose weight when they’re eating what they consider a normal diet, 




I’d say the advantages is to get treatment early, make some behavioral 
interventions such as nutritional diet, weight loss, maybe hormone therapy if 
they need it earlier rather than waiting and then they have all these other 
issues that happen over time, maybe infertility or something like that. If it 
happens over time they’re confused about why is this happening to me when 




I think with all of those things the sooner you can get them into the right kind 
of treatment the downstream effects are pretty great and that’s from a 
psychological as well as a physical health perspective because it’s like you’re 
saying you’re decreasing body habitus and hirsutism and all those other kind 
of things where they’re not just standing out as much I think is pretty 
impactful. Do I think we’re doing a great job of it? No, but we can always be 







Category: Provider Perception of Patient Factors (Definition: Participants 
recognized multiple patient factors that are unique to the adolescent population and 
that may serve as barriers or facilitators to addressing PCOS with their scope of 
practice.) 
Code: Parent/caregiver influence 
  Subcode: Parent/caregiver hesitation and opposition to treatment 
  The disadvantage is parent involvement in this age group and the insertion 




So I think there’s sometimes a hesitancy to talk about it because there really 




Yeah I would think, yeah, yeah, birth control first parents it’s a really hard 
thing because they’re like “I don’t want my daughter to be promiscuous on 
birth control. That’s not something we’re ready for at this time.” And then 
sometimes for some, we talk about Metformin and they [parents] hyper focus 
on “well they don’t have Diabetes, it’s not Diabetes yet. You know, why do 
you want to use this? Why do we need this? Why do they have to take this?” 
So sometimes there is some barrier with that just by way of what the 
preconceived notion of what those medications treat and what kind of patient 




There are definitely some patients whose parents will not let them take birth 
control at all; no matter what symptoms their teenagers are having they’re 




Well you know, there, obviously oral contraceptives can bring up a whole 
host of problems in terms of whether or not their religious beliefs dictate that 
that should not be something that they should be using, so often times that 
does come up. There are a lot of patients in the Southern Maryland area that 




I think parents just really associate Metformin with saying my child has 
diabetes so I find that they tend to be, or parents have personal experience of 
being on it. (ID47) 
MD, 
peds, S 
So some of them the parents just aren’t comfortable with it even though I try 
to sit down with them and explain this is not just about birth control it’s a lot 
of not sexually active women who are doing this, it could be really be helpful 
for the hormone control. (ID54) 
PA, 
peds, S 
      Subcode: Adolescents with limited control 




A lot of kids don’t have full control over the advantage things especially 
when it relates to obesity. There’s not a lot of options around us for fitness 
and what they’re eating, what their parents buy and so those conversations 
are hard. Just try to expand it for them and let them see opportunities where 






And often I probably do talk about carbs and I guess engaging the parent too 
to make sure they have the choices and the right choice in the house and less 
of the other choices because I think that ends up being a lot of the problem 




    Subcode: Normalizing chronic conditions 
And then just the socio-economical piece of it like a lot of our families are 
overweight so they normalize it. A lot of them don’t have access to the 
healthier foods and opportunities for physical activity and so that’s a 




I do ‘cause I think there’s a misconception about hereditary diseases and so 
like for instance diabetes can run in people’s families that we tend to see and 
they may not be as alarmed. (ID42) 
 
Not that their health isn’t important but they may not see, you know, someone 




Code: Addressing Complex Topics 
Disadvantages are just the hard topics that we have to go through. The 




Disadvantages is in how you do it [counsel patient] going back to the fertility 
thing and the weight thing, you don’t want to freak them out for lack of a 
proper term and or freak out the family. You don’t want it to be something 
that they’re going to obsess about, oh I’m not going to be able to have a kid 
in ten years or I’m going to be obese in ten years. Try not to give them, 
making sure they have a positive outlook, letting them know that there are 
some risks or there can be some long-term effects but that it’s not definitely 




I also think from just the psych part of it understanding what’s going on, 
what’s going wrong and maybe why things are the way they are in your body. 




I think that a lot of girls when you talk to them about it, the only thing they 
know about it when they Google it really quick is that they’re not going to be 
able to get pregnant someday, which is just not true at all because we’ve got 
so many great management options for that and many women with PCOS 
don’t even have a problem getting pregnant. So I think that that is maybe one 
of the biggest downfalls of information that is available to patients. And I 





I’ve also been finding anecdotally in a lot of the teenagers with irregular 
periods with or without a diagnosis with PCOS seem to believe that they 
cannot get pregnant now, like in the moment. And so this was a number of 
patients. I’m not sure how they got that into their head and so I try and do 
some counseling related to that and address the education and medication 






important for addressing these immediate needs is the misconceptions around 
pregnancy 
(ID40) 
So I think prevention’s really important, so I, I usually try to talk with them 
about, you know, the course that their disease, you know, how to look for 




if I had to talk about infertility I really would just say in the future if and 
when you’re trying to have a baby you might have some difficulty with 
conceiving but there are ways to treat that and just so you know you can go 




I would say it may, especially if they’re engaging in high risk sexual activity. 
If you’re telling them it’s unlikely you’re going to be able to have a baby 
because of PCOS it may be less safe when they are having sex and things 
because they’re like I’m not going to get pregnant. (ID47) 
MD, 
peds, S 
So the way I try to explain to my teens is if you can work with some of these 
things early on it prevents them of a lifetime of chronic illnesses such as 




Code: Patient health seeking behavior 
I think it’s a growing diagnosis whether it be further recognized and people 
are following up and becoming more educated on it at this point. So, we’re 





And I’d say probably the biggest complaint that we have is girls who come in 
usually with facial hair growth that they’re concerned about. But sometimes 
we also just get late teens who girls, who have menstrual irregularities or 
amenorrhea and then you have more of a metabolic syndrome kind of picture 
but I would probably say hirsutism is probably the biggest presenting 
symptom. Hirsutism is probably the biggest thing that prompts the lab work 
and so that’s something that I find that girls are very self-conscious about 




Most patients are willing to try it because again if they’re overweight, maybe 
they have some other abnormal labs whether it’s cholesterol or something 
like that that they are willing to try something to see if it makes a difference 
in their, just how they feel energy wise. Or if the weight loss is a goal that 
they have sometimes they’re willing to try that just for that possible weight 
loss that Metformin can have. And I always tell them that my goal in seeing 
them is “if we can make you happy and healthy now you’ll be happy and 
healthy later” and so they tend to understand that and are okay with putting 








Ways to Address (Definition: Provider input regarding actions to address barriers 
and support facilitators in addressing PCOS among adolescents in primary care 
practice). 
Code: Improve Practice Support 
     Subcode: Change in practice policies 




I think something to show [to practice leaderships] the benefits of it, why 
it’s [addressing PCOS in primary care setting] important just something 
that I could bring to the table when we have our provider meetings and 
stuff to say “you know hey we should probably look into managing this a 





      Subcode:  Increase Patient Visit Duration 
In my ideal world I would have an hour time to talk to the teen and the 
parent about PCOS and be able to, you know, listen and educate and 
make sure they understood what they heard. You know. As opposed to you 
coming in and it’s a crazy day and you have a good twenty minutes with 
them and you’re shouting out, not shouting out but you know “we’re 
going to check you hemoglobin A1C today. We are going to look at your; 
we might need to start you on something to help regulate your period. 
And see you in three months.” That doesn’t feel so good sometimes. So in 
an ideal world you would be able to spend more time with a patient 




 I think the biggest thing I would like to change is having more time to be 
able to talk to them [patients and their caregivers] about it because it’s 





One would probably be more time with the patient, I feel like most people 
would say that. (ID75) 
PA, 
family, R 
    Subcode: Engagement of Clinical Staff 
So I think educationally, having the, I would like to see more 
educational opportunities on a variety of health literacy levels so that’s 
both from patient perspective, family perspective but also then staff 
training wise. We have individuals who are medical assistants or aides, 
they aren’t even technically MA’s that are helping with paperwork and 
scheduling appointments so if they could understand a little bit more what 
this means in a patient presentation. And that could flag it for us and also 
help them ask the right questions. (ID 16) 
PA, 
family, S 
I would say honestly more time with our patients, either more screening 
tools or more just time to ask those questions and delve into those 
histories as well as potentially having one of our providers or nurses or 





for depression and suicidality and we have someone who really focuses 
on Autism screening and developmental delays. And so if we could have 
someone who almost kept us accountable for that I think that would be 
helpful. (ID50)   
    Subcode: Process for Patient Follow-up 
My thing is sometimes we don’t have the best follow-up so it’s hard to 
say because you don’t really know. Someone could tell you in the office 
“yeah this is great. I’ll start it. And then you’re not really following 
through with it you don’t really know that they’ve actually started and 




And it’s really hard, I think follow-up is really inconsistent, follow-up and 
continuity and so it’s hard for me. I don’t always see a patient I diagnose 
or I saw for follow-up again all the time, sometimes but not always and I 
think I would like to do that to assess how many interventions are helping. 
Yeah, I think it would be great if we had a better follow-up system, some 




One, I think that there could be a better way of flagging any patient at 
risk. So any time anything like acne or irregular period or obesity comes 
up that that would be some way to flag every patient so that no one really 




I sort of would love to just have, have like an educational professional 
development session from an adolescent doctor or an endocrinologist of 
like this is what I do and make sure that it aligns with what I do or feel 
more empowered to be like okay this is what I’m going to do in every case 
so it didn’t feel like I was re-looking it up or re-figuring it out each time. 
…. kind of reinforcing what specific OCPs they use and when they would 
consider additional treatments like Metformin or Spironolactone; like are 
those things that are reasonable for us as general pediatricians to be 
prescribing? Is that something like if X, Y, Z isn’t going as expected then 
we would refer to adolescent and we would be the ones to decide to add 
those things.  (ID69) 
MD, peds, 
U 
 I think some sort of training, yeah I think a training. And my supervising 
physician has also mentioned that if she could go through a training, like 




New evidence based guidelines that I might learn about from UptoDate, 
in person CME.(ID15) 
PA, 
family, S 
Code: Point of Care Protocols 
I think it would be nice to have just more just almost like an algorithm 
that people are following just more regularly in the community I think. I 





different diagnostic criteria and so sometimes patients don’t necessarily 
meet all of them. (ID47) 
It really is just implementing a more specific flow sheet. So, all of our 
electronicmedical records are created in-house so they’re created by a 
group of medical providers and I think it would just be more education on 
our part to be able to accurately come up with a good flow sheet and say; 
patient presents with this, these are the labs that we’ll do and this is what 
we suspect. (ID31) 
 
So it would be helpful to have a deeper understanding of how to recognize 
it, warning signs of this and a kind of just a further protocol of what we 




New evidence based guidelines that I might learn about from UptoDate, 
in person CME. Sometime ACOG guidelines, but those are difficult to 
access unless you get them through another source. Cannot go through 
ACOG website easily if not a member.” (ID15 
PA, 
family, S 
Code: Collaboration with Specialists 
I guess what I would change [pause] is being a little bit quicker to treat 
and at the same time what I would love to do is just feel more confident 
and have, and that requires just some more knowledge and guidelines 




And we’ve had some significant turnover with OBGYN groups in the area 
so I would wonder if having us all be on the same page and maybe they 
can even do an in-service for us on how we can sometimes manage some 
of the stuff in-house for us. (ID16) 
PA, 
family, S 
Code: Resources for Provider-Patient/Caregiver Communication 
It would be nice to know early on if there’s things we could prepare them 
for especially for irregular periods and stuff so we can start giving them 




Maybe just learning about how to have that conversation with them even 
better in the young population. (ID07) 
PA, 
family, R 
NP=Nurse Practitioner; MD= Medical Doctor; PA=Physician Assistant; peds=pediatric 
practice focus; family=family medicine practice focus; R=rural practice region; S=suburban 
practice region; U= urban practice region 
 
 
